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Impact of the chromatin remodeller SMARCAD1 on murine intestinal 
intraepithelial lymphocyte and white adipose tissue biology. 
 
Chromatin remodelling factors use the energy of ATP hydrolysis to drive the movement 
of and/or affect molecular changes to the nucleosome. One such factor, SMARCAD1 
(SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily 
A containing DEAD/H box 1), has been previously shown to restore heterochromatin at 
the replication fork in vitro. This project aimed to assess the impact of SMARCAD1 on 
mammalian biology, utilising an animal model in which the catalytic ATPase domain of 
murine SMARCAD1 had been deleted using Cre/lox technology.  
Preliminary results had implicated SMARCAD1 in adaptive-immunity and white adipose 
tissue biology, and SMARCAD1 expression in these tissues/cells was confirmed by 
tissue-panel western blot. This project therefore aimed to build on these results to 
understand better the impact of SMARCAD1 on adaptive immune development and 
white adipose tissue biology. In addition, fewer than expected viable Smarcad1-/- 
homozygous offspring were produced during Smarcad1+/- x +/- matings, which both 
confirmed the observation from a previous knockout model of Smarcad1, and limited 
the number of knockout animals available for this study. 
Investigation of systemic B- and T-cells in the bone marrow, thymus and spleen had 
previously suggested there was no significant defect in adaptive immune development 
in Smarcad1-/- mice, however a tissue-specific and age-related loss of intra-epithelial 
(IEL) T-lymphocytes was found in the small intestine by flow cytometry. Analysis by 
qPCR of duodenal RNA suggested that differentiation rather than inflammation may 
underpin any loss-of-IEL phenotype, although further examination of cell-proliferation 
and crypt/villus anatomy by EdU incorporation and immunofluorescence revealed no 
overt cell-anatomical or proliferative difference in the knockout mice. The requirement 
for large numbers of aged mice made further investigation of the intestinal IEL 
phenotype logistically prohibitive. 
The reduction of epididymal white adipose tissue (eWAT) size had also been observed 
in male Smarcad1-/- mice, and serum from these mice showed elevated triglyceride (TG) 
and free fatty acids (FFA) levels. Transcriptomic analysis by RNA-seq of whole-WAT 
revealed an elevation in macrophage-related markers in knockout mice, which was 
confirmed by flow cytometry. As a number of reports have implicated SMARCAD1 in 
stem cell biology, putative adipose stem cells were isolated from +/+ and -/- mice by 
FACS and used for adipogenic differentiation assays ex-vivo  In parallel, mouse 
embryonic fibroblasts from +/- and -/- mice were also assayed for adipogenic 
differentiation. While no significant differences in adipogenesis were observed, 
Smarcad1-/- mice challenged with a (60%) high fat diet did show increased weight gain 
over +/+ mice, and measurements of adipocyte size and cell cycle/cell proliferation 
analysis suggested hyperplasia rather than defects in adipogenesis may drive any WAT-
related pathology in these mice. 
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1.1 Chromatin, nucleosomes and DNA compaction  
The mammalian cell contains around 2 metres of genomic DNA, which must be packaged 
tightly within the 3-dimensional constraints of the cell. The primary DNA sequence 
harbours functional and non-functional sequences, both of which must become 
accessible during processes such as replication. However, outside of replication many 
stretches of DNA are not required for cell-specific functions, and are repressed via 
compaction. Genes that are required for cell-specific function must remain accessible, 
along with binding sites for transcription factors and other sequences involved in gene 
regulation (e.g. repressors and non-[protein]-coding RNA). The ability to access the 
appropriate functional regions of DNA is key to cell-specific function. 
Compaction of DNA is achieved by the wrapping of DNA around a core of histone 
proteins in the form of the ‘nucleosome,’ and multiple nucleosomes package together to 
produce a chromatin fibre (Figure 1.1).  The nucleosome is the unit of packaged DNA 
comprising of 147 base-pairs of DNA helix wound around an octet of histone proteins to 
form the nucleosome core, with an additional stretch of around 80 base-pairs of DNA 
linking to the next nucleosome core (Luger, Mä, Richmond, Sargent, & Richmond, 1997). 
These higher order structures of chromatin structure form regions of open and 
accessible DNA, or conversely inaccessible compacted DNA sequences. 
Access to functional DNA sequences requires the ability to de-compact the chromatin 
structure and is achieved by two types of protein complex, (i) covalent histone 
modifying enzymes, which attach specific covalent groups to/from histone proteins, 
thereby creating a binding site for accessory factors or affecting the strength of 
DNA/histone interaction (ii) ATP-dependant chromatin remodelling complexes, which 
use the energy of ATP hydrolysis to drive the movement of and/or affect molecular 
changes to the nucleosome, affecting the overall shape of chromatin.  
1.2 Histone modification and the histone code. 
The presence of covalent modifications to core histone proteins was first described in 
1964 (Allfrey, Faulkner, & Mirksy, 1964) and underpins the “histone code” – the 
association of specific modifications with specific chromatin states or structures. The 
presence of these covalently attached groups can create a binding site for accessory 
factors, or aid in the opening of the nucleosome due to alteration of the electrostatic 
interaction between e.g. positively charged lysine amino acids on histones and the 
negatively charged phosphate backbone of DNA (Figure 1.2). Studies over the previous 
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55 years have unveiled the association between many histone-modifications and 
chromatin states. These covalent modifications exist dynamically and are enzymatically 
attached to (or removed from) amino acids on the exposed tails of histone core proteins 
(Bannister & Kouzarides, 2011). For example, acetylation of histone H3 on lysine 
residue number 4 (abbreviated to H3K4Ac) is associated with open chromatin and 
transcription. 
 
 
Figure 1.1. Structure of the nucleosome core structure at 2.8Å resolution. DNA (in the 
classic double-helix form) is wrapped around a core of 8 histone proteins (two each of 
H2A, H2B, H3 and H4 histone proteins), with 147 bases of DNA completing 1.67 turns of 
the core particle. Histone tails protrude from the central nucleosome particle, providing 
sites for covalent modification and the creation of binding sites for factors involved in the 
control of DNA function. From Luger et al., 1997.  
 
There are two main effects of covalent modifications to histones: changing the 
electrostatic forces between core histone proteins and the DNA backbone, and the 
creation or ablation of binding sites for histone-binding proteins. The presence of 
positively-charged lysine residues within histone proteins increases the electrostatic 
attraction between the negatively charged DNA backbone and the histone core. 
Modification of these lysine resides by addition of an acetyl or phophoryl group 
effectively neutralises the positive charge, weakening this attraction. Given the number 
of lysine residues within the histone tails (e.g. H3K4, H3K9, H3K14, H3K18, H4K5, H4K8 
and H4K12 (Kouzarides, 2007), a potentially large number of target sites exist for 
modification which can significantly impact chromatin structure.  
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The addition of acetyl residues to histone is catalysed by the histone acetyltransferase 
(HAT) enzymes, of which type A HATs can acetylate multiple lysine residues within the 
N-terminal tail of histones, whereas type B HATs primarily acetylate newly synthesized 
H4 histones at residues K4 and K12 in the cytoplasm (i.e. before histone deposition into 
the nucleosome - these marks being removed shortly after deposition (Sterner & Berger, 
2000)). By contrast to HATs, the histone deacetylase (HDAC) enzymes remove acetyl 
residues from histones, and are associated with chromatin compaction and gene 
repression. There are four families of HDACs, and - unlike HAT-type-B enzymes (which 
can specifically target H4) - many have low substrate specificity and are able to 
deacetylate multiple residues (Bannister & Kouzarides, 2011). 
 
Figure 1.2. Nucleosomes assemble into chromatin fibres, which are condensed in regions 
of transcriptional repression (heterochromatin) and associated with methylated (CpG) 
DNA. Covalent attachment of positive-charged acetyl groups to histone proteins introduces 
electrostatic repulsion between histones and the negatively charged phosphate back-bone 
of DNA, driving and aiding a relaxed chromatin structure accessible to transcription 
factors and other functional elements. From Y. Z. Kim, 2014.  
 
Of the other histone modifications studied to date, methylation of histone residues has 
been the focus of much study. Unlike acetylation, histone methylation does not affect 
electrostatic charges around the nucleosome, but rather creates sites for other 
chromatin-binding proteins. Both lysine and arginine residues in particular have been 
shown to become methylated, and multiple (mono- di- or tri-) methyl groups can be 
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added to residues. In one example, tri-methylation of H3K9 (H3K9me3) creates a 
binding site for heterochromatin protein 1 (HP1), which binds to H3K9me3 through its 
chromodomain. The remaining chromoshadow-domain of HP1 is able to dimerise with 
other H3K9me3-bound HP1 proteins, forming the closed heterochromatin structure 
(Thiru et al., 2004). In this way histone modification directs higher order chromatin 
structure. 
The addition of methyl groups to histone residues is catalysed by histone 
methyltransferase enzymes, which perform addition of methyl groups via their SET 
domain and are often target specific. For example, the methyltransferase Suv39H1 
trimethylates histone H3K9 (Chiba et al., 2015), whereas SET7/9 mono-methylates 
histone H3K4 (B. Xiao et al., 2003). Similarly, histone demethylases are functionally 
restrained to demethylate only certain residues. As such, enzymes such as LSD2 (lysine 
demethylase 2) specifically demethylate histone H3K4me1 and H3K4me2, whereas 
JMJD5 (JmjC-domain-containing histone demethylase 5) demethylates H3K36me2 
(Kooistra & Helin, 2012). Of the many histone demethylases now detailed, the majority 
contain a Jumonji C domain which catalyses the removal of mono- di- and tri- methyl 
groups from lysine residues (Klose, Kallin, & Zhang, 2006). In contrast, the original 
histone demethylase discovered (LSD1) is only able to remove mono- or di-methyl 
groups from lysine (Shi et al., 2004). The presence of multiple histone 
methyltransferases and demethylases adds flexibility and complexity to the histone 
code. 
While histone acetylation and methylation are two particularly well studied examples of 
covalent histone modification, many other covalent modifications exist (Table 1). 
Phosphorylation of threonine residues (H2A-Thr120, H3-Thr3 ) for example, is 
associated with mitosis (Aihara et al., 2004), whereas ubiquitination of H2A-K119 is a 
mark associated with gene silencing and spermatogenesis (H. Wang et al., 2004). In 
addition, sumoylation of H2B-K6 or K7 is associated with transcriptional repression, 
(Nathan et al., 2006), while by contrast citrullination of histone is linked to decondensed 
chromatin and pluripotency (Christophorou et al., 2014). More recently, covalently 
histone modifications derived from short-chain fatty acids linked to potential metabolic 
stress (such as lysine-crotonylate or lysine-hydroxybutyrate) have been described 
(Sabari, Zhang, Allis, & Zhao, 2016). It would seem likely that more modifications will be 
discovered in future, and the functional impact of these and currently known 
modifications will continue to be detailed.  
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Table 1.1. The histone code. Histone residues can be subject to post-translational covalent 
modification, and a large number have so far been characterised in the context of the 
functional or biological impact of the modification. Processes associated with specific 
histone modifications include gene expression, DNA repair and replication, to give an 
example. Table recreated from http://www.activemotif.com/documents/1815.pdf. 
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1.3 Chromatin remodelling and chromatin remodeller families. 
A further level of control is imparted onto chromatin by protein complexes that move 
nucleosomes with respect to the underlying DNA. Chromatin remodellers are multi-unit 
complexes that use the energy of ATP hydrolysis to move nucleosomes, and can be 
subdivided into four families based on sequence of the DNA-dependent ATPase domains 
(and adjacent domains): the SWI/SNF  (switching defective/sucrose non-fermenting) 
family of remodelers,  ISW1 (Imitation switch 1), CHD (Chromodomain, helicase, DNA 
binding) and INO80 (Inositol Requiring 80) (Figure 1.3). The ATPase domain of each 
protein contains two RecA-like folds, a DEAD-like helicases superfamily domain (DExx) 
and helicase superfamily c-terminus (HELICc) domain. The domains flanking this 
ATPase domain determine the differences in function between the families and peptides, 
with the ATPase domain itself being split in the INO80 family of remodellers (Längst & 
Manelyte, 2015). 
 
 
Figure 1.3. There are four families of chromatin remodellers based on sequence of the 
ATPase (DExx/HELICc) domain and the presence of associated functional domains 
(HSS,Bromo, HAND/SANT/SLIDE and Chromo): SWI/SNF family remodellers bind 
acetylated histones via the bromodomain and actin via the HSA domain, ISWI family 
remodellers bind the linker DNA between nucleosomes via the HAND-SANT-SLIDE domain, 
CHD remodellers bind methylated histones via the chromodomain, and INO80 proteins 
which can also bind actin via the HSA domain. From Längst and Manelyte, 2015. 
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1.3.1. Chromatin remodelling families. 
Members of the SWI/SNF family are involved in the sliding of nucleosomes to create 
space and e.g. the accessibility of DNA, and bind actin/actin-related proteins via the 
Helicase-SANT Associated (HSA) domain (allowing increased DNA 
translocation/nucleosome ejection) (Clapier et al., 2016). These can also bind acetylated 
histones via the bromodomain (Filippakopoulos & Knapp, 2012); indeed, many 
SWI/SNF family members were originally associated with active transcription (Kadam & 
Emerson, 2003), however - more recently – SWI/SNF family remodellers have been 
associated with DNA repair (Smith-Roe et al., 2015, Costelloe et al., 2012), and 
transcriptional repression (discussed later) (Rowbotham et al., 2011b).  
By contrast to the SWI/SNF family, members of the ISWI family of remodellers play a 
role in nucleosome assembly and the regular spacing of nucleosomes e.g. during DNA 
replication (Ito et al., 1999). In addition to the ATPase domain, ISWI family remodellers 
also contain a HAND-SANT-SLIDE (HSS) domain that binds unmodified histone tails 
(Boyer, Latek, & Peterson, 2004) and the stretch of ‘linker’ DNA that extends away from 
the nucleosome (Dang & Bartholomew, 2007). While many ISWI remodellers have been 
linked to transcriptional repression (e.g. Strohner et al., 2004) one ISWI complex 
(NURF) has been shown conversely to promote transcription (H. Xiao et al., 2001). As 
with the seemingly opposing functions of the SWI/SNF member SMARCAD1 in 
transcriptional activation/repression, these seemingly opposing functions reported for 
ISWI family members may reflect the influence of accessory subunits on the complex.  
While SWI/SNF and ISWI proteins perform (in the majority of cases) distinct activities, 
the functions of the CHD family remodellers are more heterogeneous. These proteins 
are characterised by the presence of two chromodomains, (which bind methylated 
histone H3), and have been shown to assemble regularly spaced nucleosomes (Lusser, 
Urwin, & Kadonaga, 2005) to facilitate the opening of chromatin during transcription 
(Murawska & Brehm, 2011) and catalyse histone exchange (such as the incorporation of 
histone variant H3.3 in the Drosophila embryos, (Konev et al., 2007)). By contrast, other 
members of the CHD family function in repression, such as CHD3/CHD4, which are 
components of the NURD (Nucleosome and Remodelling Deacetylase) complex along 
with histone deacetylases (HDAC1/2) and methyl CpG-binding domain (MBD) proteins 
(Denslow & Wade, 2007).  Some members of the CHD family (e.g. CHD1 and CHD2 in 
higher eukaryotes) possess SANT and SLIDE domains which serve as DNA binding 
domains (DBD), and preferentially bind to AT-rich DNA sequences (Stokes & Perry, 
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1995, Ryan, Sundaramoorthy, Martin, Singh, & Owen-Hughes, 2011). Interestingly, 
mutations in the CHD family member CHD7 have been found in patients with CHARGE 
syndrome (Coloboma of the eye, Heart defects, Atresia of the choanae, Retardation of 
growth and/or development, Genital and/or urinary abnormalities, and Ear 
abnormalities), in which haploinsuffiency of CHD7 (frequently due to mutation of one 
allele) leads to a spectrum of developmental anomalies (Lalani et al., 2006) 
The INO80 family of chromatin remodellers differs from the other 3 families in the 
ATPase domain due to the presence of an insertion between the DExx and HELICc 
domains, which is larger in higher organisms (~1000 amino acids in mammals) than in 
yeast (~250 amino acids). This inserted domain can bind the Ruv-like proteins RVB1 
and RVB2 (providing helicase activity to INO80 proteins (Huen et al., 2010)) in addition 
to binding an actin related protein (ARP) (Y. Bao & Shen, 2007). Indeed, INO80 
complexes bind to specialised DNA structures in vitro (e.g. structures similar to Holliday 
junctions) and are implicated in homologous recombination and DNA repair (S. Wu et 
al., 2007), in addition to transcriptional activation (through interaction with factors such 
as YY1, (Cai et al., 2007)). Furthermore, a number of studies have highlighted the role of 
INO80 members in nucleosome editing: the SWR1C, p400 and SRCAP (Snf2-related CBP 
activator) complexes are able to replace the histone H2A with the H2A.Z variant, while 
conversely the INO80C complex catalyses the reverse H2A.Z to H2A movement 
(Papamichos-Chronakis, Watanabe, Rando, & Peterson, 2011). In addition to H2A.Z 
replacement, INO80C also harbours the ability to remove the histone H2 variant γH2A.X 
from the vicinity of DNA double-strand breaks (van Attikum, Fritsch, & Gasser, 2007), 
and has been shown to regulate nucleosome spacing (Udugama, Sabri, & Bartholomew, 
2011). Another important editing function is the replacement of histone H3.1 with 
variant H3.3 in promoter regions during gene activation by E1A binding protein p400 
(EP400), which is done in combination with H2A.Z deposition (mentioned above, 
(Pradhan et al., 2016)). Together, these studies have highlighted the role of INO80 family 
remodellers in DNA repair, transcriptional activation and nucleosome editing. An 
overview of how these chromatin remodelling families impact chromatin is given in 
Figure 1.4.  
1.3.2. Impact of chromatin remodellers on development. 
Building on the knowledge of how chromatin remodellers interact with DNA, 
mammalian models have furthered the understanding of these factors during 
development.  Rodent  knockout  models   lacking   functional   subunits   of   remodelling  
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complexes present with developmental anomalies of varying severity, from prenatal 
lethality to more subtle later-onset phenotypes. However, many of the original 
remodelling complexes were discovered in yeast, and related proteins later identified in 
higher organisms. In each case chromatin remodellers typically function as part of a 
multi-subunit complex, and recruitment to specific genomic loci of the complex can be 
directed by other (non-remodeller) members of the complex (Hota & Bruneau, 2016). 
The importance of these complexes during development was highlighted by studies of 
the SWI/SNF Brahma complex in Drosophila (Marenda, Zraly, Feng, Egan, & Dingwall, 
2003), and the Brahma-related gene 1 (BRG1) complex factor during the peri-
implantation stage in mouse (Bultman et al., 2000). During development, the BAF 
complexes (BRG1 or hBRM Associated Factors) direct essential transcriptional 
programs and apply the changes to chromatin required for differentiation. In particular, 
the BAF complex was shown to direct early lineage specification in the mouse embryo 
(Panamarova et al., 2016). Furthermore, the ability of these complexes to control self-
renewal and pluripotency of embryonic stem cells has been linked to their binding to 
promoter sequences of key pluripotency genes (Kidder, Palmer, & Knott, 2009, (Ho, 
Jothi, et al., 2009), such as the esBAF complex (embryonic stem cell BAF, containing 
BAF155, and BAF60A). Interestingly, esBAF complexes differ in their composition 
between human and mouse, as the BAF170 subunit is present in human but absent from 
the mouse complex (Ho, Ronan, et al., 2009). Furthermore, the mouse/human esBAF 
complex contains the SWI/SNF member SMARCAD1 (discussed later). 
Later stages of development are also influenced by chromatin remodelling complexes. 
During neural development, BRG1 and BAF155 are required for neural tube closure in a 
dose-dependent manner. Indeed, heterozygous BRG1/BAF155+/- mutants show neural 
tube closure defects and exencephaly (Marathe et al., 2013). Other neural differentiation 
events need functional remodelling complexes: the differentiation of glial cells into 
functional myelin-producing oligodendrocytes requires BRG1 (Yu et al., 2013). In 
addition, the differentiation of neural progenitors to mature neurons requires the 
exchange of specific subunits within the BAF complex (Lessard et al., 2007), 
demonstrating the flexibility conferred by multi-subunit complexes. Upon terminal 
differentiation, the influence of chromatin remodelling is still evident as the BAF53B 
complex is required in post-mitotic neurons for dentrite growth and branching (J. I. Wu 
et al., 2007). Together these highlight the scope of chromatin remodelling impact 
throughout development. 
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Figure 1.5. Chromatin remodelling enzymes function within complexes. The BAF complex 
(A) includes BRG1/BRM remodeller subunit along with e.g. subunits BAF45A, BAF155, 
BAF170 in neural progenitor cells, although the BAF170 subunit is replaced by a second 
BAF155 subunit in embryonic stem cells. Similar subunit exchanges reflect functional 
differences within the NuRD complex (C). whereby the MTA2 subunit has been shown to 
be replaced by MTA1 in metastatic breast cancers. Subunit derivation of other remodelling 
complexes (WICH/RSF/NoRC/CERF/NURF/INO80/SRCAP/P400) are shown in (B) and (D). 
From Hota et al., 2016. 
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Other tissues and organs have also been studied with respect to remodelling complex 
function. Regeneration of cell types in the epidermis is directed by BAF complexes, and 
expression of the BAF53A subunit of BAF is required to maintain keratinocyte 
progenitors in an undifferentiated state (X. Bao et al., 2013) Furthermore, terminal 
differentiation of keratinocytes requires expression of SMARCAD4 (BRG1) and 
SMARCA2 (BRM), as conditional deletion of BRG1 leads to defects in the skin 
permeability barrier, which is exacerbated in SMARCA2 mutant mice (Indra et al., 2005).  
During heart development in mouse and zebrafish, BRG1 is required in a dosage 
sensitive manner. Animals heterozygous for BRG1 show morphological defects and 
cardiac gene expression dysregulation due to an allelic imbalance between BRG1 and 
the cardiac transcription factors Tbx5, Tbx20 and Nkx2-5 (Takeuchi et al., 2011). Prior 
to this, the differentiation of mesoderm cells into cardiac progenitors coincides with the 
expression of Smarcd3 (also known as Baf60c) (Devine, Wythe, George, Koshiba-
Takeuchi, & Bruneau, 2014). Indeed, the interaction of Smarcd3 with Tbx5 (and another 
transcription factor, GATA4) drives the production of cardiomyocytes from mouse 
mesoderm (Takeuchi & Bruneau, 2009).   
The development of the various cells and lineages of the immune system is controlled by 
the actions of chromatin remodellers. The conditional deletion of BAF53a was shown to 
impair proliferation of haematopoietic stem cells and formation of downstream lineages, 
while also reducing the survival of progenitors – leading to aplastic anaemia and rapid 
mortality (Krasteva et al., 2012). During B-cell development, which involves multiple 
stages within the bone marrow, the BRG1 and BAF155 subunits are required for 
successful formation of common lymphoid progenitors and development of pro-B cells, 
due to a loss of expression of the key transcription factors EBF1 and IL7ra and their 
downstream targets (Choi et al., 2012). 
In T-cell development, immature thymocytes express both CD4 and CD8 co-receptors 
before lineage specification and the expression of either CD4 or CD8. The choice of co-
receptor is reflected in the interplay between BRG1 and BAF57 remodelling complexes, 
whereby BRG1 is required for CD8 expression, but both BRG1 and BAF57 are required 
for the silencing of CD4. Reflecting this, BRG1 mutants produce fewer CD8+ T cells, 
whereas both BRG1 BAF57 mutants produce CD4+ at an inappropriate early stage (Chi 
et al., 2002, Chi et al., 2003). Indeed, binding of the transcriptional repressor RUNX1 to a 
434bp region proximal to the CD4 gene is increased by the actions of BRG1 and BAF57, 
reducing the content of the H1 linker histone and thereby increasing accessibility (Wan 
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et al., 2009).  A summary of some of the initial chromatin remodeller knockout mice and 
then range of phenotypic effects is given in Table 2, emphasizing the importance of these 
factors in mammalian development.  
 
 
 
 
 
 
Table 1.2. Initial murine knockout models of chromatin remodellers unveiled the 
importance of these factors in mammalian development. In some models the inactivation 
of such factors lead to embryonic lethality (e.g. BRG1) or less severe symptoms when 
tissue-specific knockout was employed (such as abnormalities of T-cell development with 
T-cell specific depletion of BRG1).  From de la Serna, Ohkawa, & Imbalzano, 2006.  
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1.3.3. SWI/SNF Chromatin remodellers. 
The SWI/SNF family of chromatin remodellers is a family of complexes of around 10 
proteins initially discovered in yeast, where mutants fail to undergo the mating type 
“switch” (SWI) and instead become “sucrose non-fermenters” (SNF). Like other 
chromatin remodelling families, the SWI/SNF complexes are conserved across higher 
eukaryotes, and use the energy of ATP hydrolysis to reposition nucleosomes and alter 
the accessibility of chromatin to activating or repressive factors. Such changes can have 
a profound impact on processes such as cellular differentiation, and are often 
accompanied by changes in gene expression (J. I. Wu, 2012). 
SWI/SNF remodelling complexes are formed from 8-11 components, within which the 
ATPase subunit (e.g. BRM/BRG1/hBRM) alone is sufficient to catalyse partial chromatin 
remodelling alone.  The other subunits aid in complex assembly and function specificity 
(e.g. promoter targeting), and allow for cell or tissue-specific complex function. For 
example,  SNR1 subunit has been shown to block BRM activity and associates with gene 
repression during Drosophila wing/vein and inter-vein cell development, in a histone 
deacetylase (HDAC) dependent manner (Marenda et al., 2003). The interplay between 
multiple units determines the molecular and biological impact, and sequence 
comparison of the ATPse domain reveals the evolutionary relationship between 
SWI/SNF family members (Figure 1.6).  
Interactions between SWI/SNF and other factors are important in human disease. As an 
example, the polycomb group repressor complex PRC2 often functions in an antagonistic 
manner to SWI/SNF complexes by promoting transcriptional repression (Kadoch, 
Copeland, & Keilhack, 2016). Mutation in either SWI/SNF or PRC complexes can lead to 
human malignancy, driven by a loss in the normal balance of SWI/SNF versus PRC 
action. Indeed, mutation in SMARCB1 is associated with malignant rhabdoid tumours, 
mutations in SMARCA2 and SMARCA4 with breast and lung cancer (Kadoch et al., 2016), 
whereas loss of function mutations in PRC2 complex subunit EZH2 or EED lead to T-cell 
acute lymphoblastic leukaemia (T-ALL) (K. H. Kim & Roberts, 2016). 
Initial tissue and organ development is also dependent on the action of SWI/SNF 
remodellers. As an example, normal cardiogenic development is driven by the 
transcription factors TBX5, GATA-4, and these have been shown to interact with the 
SWI/SNF  complex  subunit  BAF60c  (Bevilacqua, Willis, & Bultman, 2014).  In  addition, 
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Figure 1.6. Phylogenetic tree of SWI/SNF chromatin remodelling family members, based 
on comparison of 10 different conserved regions. SMARCA4 and SMARCA2 (top) are the 
mammalian homologues of Drosophila BRG1 and BRM respectively. SMARCAD1 is most 
closely related to Snf2 related CREBBP activator protein (SRCAP) and E1A binding protein 
p400 (EP400) based on these sequence comparisons.  From Okazaki et al., 2008. 
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cellular responses to environmental cues are also influenced by SWI/SNF remodellers – 
for example in the context of metabolism. SWI/SNF complexes containing BAF60a 
activate the transcription of fatty acid oxidation genes during fasting, whereas 
complexes containing BAF60c activate lipogenic genes in response to insulin, forming 
the lipoBAF complex that promotes lipogenesis and increased triglyceride levels (Zhang, 
Li, Bao, & Huang, 2016). In these examples, the role of SWI/SNF remodellers in cellular 
and physiological homeostasis has been made apparent. 
1.3.4. The SWI/SNF family chromatin remodeller SMARCAD1. 
SMARCAD1 (SWI/SNF-related, matrix-associated actin-dependent regulator of 
chromatin subfamily a, containing DEAD/H box 1, also known as ETL1/HEL1) is a 
SWI/SNF nucleosome remodeling enzyme that hydrolyses ATP driving histone/DNA 
structural compaction (Rowbotham et al., 2011). It is a member of the SWI2/SNF2 
family of nucleic acid dependent helicase/ATPases, which are implicated in cell cycle 
control, mitotic chromosome segregation, DNA repair and transcriptional control 
(Costelloe et al., 2012). SMARCAD1 orthologues are found across eukaryotic species from 
the budding yeast S. Cerivisiae (Fun30), to Drosophila (CG5899) to human and mouse 
(SMARCAD1/Etl1) (Neves-Costa, Will, Vetter, Miller, & Varga-Weisz, 2009) and contain 
conserved ATPase, helicase and CUE (coupling of ubiquitin to ER-degradation) domains 
(Figure 1.12, Section 1.3.9).  
1.3.5. Identification of mammalian SMARCAD1/ETL1 and initial studies. 
Smarcad1/Etl1 (Enhancer Trap Locus 1) was originally identified by Soininen et al in 
mouse (Soininen et al., 1992) as a gene highly expressed throughout development 
(especially in epidermal tissue and the central nervous system) with sequence similarity 
to the Drosophila gene Brahma and the (then) newly identified yeast transcriptional 
activator proteins SNF2/SNF2. A subsequent study using a mouse knockout model 
implicated Smarcad1/Etl1 in skeletal development, growth and fertility, with decreased 
peri- and postnatal survival (Schoor, Schuster-Gossler, Roopenian, & Gossler, 1999). 
This study also confirmed the expression of SMARCAD1 from the two-cell stage of 
development, and in other embryonic tissues including the inner cell mass and (later in 
development) the central nervous system, epithelia and thymus. Postnatally 
SMARCAD1/ETL1 was shown to be ubiquitously expressed in mouse tissues, and 
knockout mice were reported to have a decrease in body weight of up to 25% by 5 
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weeks of age (Figure 1.7), along with skeletal dysplasias and reproductive problems 
(Schoor et al 1999). 
1.3.6. SMARCAD1 is required for pluripotency in stem cells. 
Following the observations that Smarcad1 is expressed prenatally in embryonic and 
developing tissues, a study using cultured mouse embryonic stem cells (ESCs) showed 
that a number of highly expressed factors in cultured mouse embryonic stem cells were 
chromatin binding proteins, and upon differentiation (induced by removal of leukaemia 
inhibitory factor (LIF) from the culture media) this expression declines (Kurisaki et al., 
2005). Furthermore, the authors then focussed  on  one of  the factors identified (TIF1β) 
and showed that phosphorylated TIF1β forms a complex with the pluripotency-specific 
transcription factor OCT3/4 along with SMARCAD1, inhibiting differentiation (Seki et al., 
2010). The maintenance of pluripotency was not driven by SMARCAD1 alone, as 
Smarcad1 overexpression did not maintain the undifferentiated state, but rather the 
complex including SMARCAD1, TIF1β, OCT3/4 and other chromatin associated factors 
(BRG-1 and BAF155) were required to retain pluripotency. 
 
 
 
Figure 1.7. The original Smarcad1/Etl1 knockout mice showed (a) increased postnatal 
mortality (*as denoted by the lower than expected 25% ratio of -/- adult mice) and 
reduced body weight by 5 weeks old (median body weight shown by black down to the 
right of data points, with error bars).  From Schoor et al., 1999. 
* 
* 
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In agreement with this work, studies of gene expression patterns during the 
spontaneous differentiation of mouse embryonic stem (mES) cells into embryoid bodies 
revealed Smarcad1 as one factor expressed in the undifferentiated mES cells but not in 
embryoid bodies (Hong et al., 2009). To validate this finding, expression of Smarcad1 
was knocked-down (i.e. expression was reduced using short-hairpin RNA transfection) 
in mES cells, and the loss of pluripotency was confirmed by the change in cell 
morphology and loss of alkaline phosphatase staining. Furthermore, analysis of a 
marker of differentiation (FGF5) using quantitative PCR (qPCR) revealed an elevation of 
FGF5 expression in mES cells four days after Smarcad1 knock-down (Figure 1.8). These 
results confirmed that expression of Smarcad1 is linked to pluripotency in mES cells. 
Using a different cell type, a more recent study established a link between Smarcad1 and 
the pluripotency factor Sox-2 (SRY [sex determining region Y]-box 2). Smarcad1 had 
been previously shown to be a downstream target of SOX2 in embryonic stem cells 
(Boyer et al., 2005), and indeed SOX-2 was subsequently shown to be one of four key 
transcription factors required for induction of pluripotency (Takahashi & Yamanaka, 
2006). However, the role of SOX-2 and SMARCAD1 in tissue-resident precursor cells 
such as mesenchymal stem cells had not previously been elucidated. Osteoblasts and 
preadipocytes are both lineage-committed precursors derived from mesenchymal stem 
cells (which contribute to the production of bone, fat, muscle or cartilage). In this set of 
experiments, the deletion of Sox-2 in osteoblasts was shown to deplete the ability to self-
renew, and this loss was accompanied by the loss of Smarcad1 expression (alongside 
other markers of pluripotency) (Seo, Basu-Roy, Zavadil, Basilico, & Mansukhani, 2011).  
The molecular function and interactions of Smarcad1 during pluripotency have recently 
been investigated using pre- and post-implantation embryos in human and mouse. In 
this study, particular focus was given to histone modifications that are associated with 
SMARCAD1 at this early stage of development. Ten histone modifications were 
examined for potential genomic co-localisation with SMARCAD1, of which two 
demonstrated such genomic overlap; H3K27-acetyl and H3K27-citrullinate.  To further 
infer the role of these modifications in stem cell biology, the genomic binding sites of 
SMARCAD1 were compared with the pluripotency transcription factor OCT-4, and 
indeed enrichment of both SMARCAD1 and OCT-4 was found at sites of H3K27 
citrullination (Figure 1.9). Interestingly, loss of SMARCAD1 in these stem cells was 
associated with an increase in H3K9me3 marks, implying that SMARCAD1 functions to 
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oppose formation of repressive chromatin in this particular cell type (S. Xiao et al., 
2017). 
 
 
                            
 
Figure 1.8. SMARCAD1 is required for maintenance of pluripotency in mES cells (from 
Hong et al 2009). Knock-down of SMARCAD1 expression (a) results in altered morphology 
and reduced alkaline phosphatase staining (panels RNAi-1, RNAi-2, RNAi-3 above left) 
alongside increased expression of the differentiation marker FGF5 (above right). From 
Hong et al., 2009. 
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Figure 1.9. (a) SMARCAD1 associates with citrullinated histone H3-K26-Ci in mouse 
embryonic stem cells (top). (b) Smarcad1-depleted mESCs show a reduction in 
maintenance of pluripotency (shown be the drop in alkaline phosphatase staining 
between the two images in yet without significant reduction in expression of the 
pluripotency transcription factors OCT4, NANOG or SOX-2 (bottom). From Xiao et al., 2017. 
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1.3.7. SMARCAD1 and transcription. 
In addition to the work on mES cells, work in Drosophila and human cells has provided 
insight into the impact of SMARCAD1 on gene expression. Using nuclear extracts from 
the Drosophila S2 cell line, the ATP-dependent acetylation of histone H2A was shown to 
be driven by SMARCAD1 and CREB-binding protein (CBP) and associated with up-
regulation of a number of target genes (Doiguchi et al., 2016). Furthermore,  acetylation 
of H2A-K5 and H2A-K8 was a result of CBP action, and enhanced by SMARCAD1 - 
thereby suggesting SMARCAD1 was an accessory factor in histone modification. 
Subsequent chromatin immunoprecipitation (ChIP) analysis localised CBP and 
SMARCAD1 to the promoter region of a number of genes, and interestingly the initial 
CBP recruitment was required for subsequent presence of SMARCAD1 at these sites 
(Doiguchi et al., 2016). 
A previous study using human cancer cell lines described the binding of SMARCAD1 to 
the vicinity of the transcriptional start site (TSS) of 69 genes. Using a novel anti-
SMARCAD1 antibody (generated against 175 C-terminal amino acids of SMARCAD1) for 
chromatin-immunoprecipitation, genomic DNA bound to SMARCAD1 could be mapped 
back to the genome using DNA microarrays. Results from these experiments identified 
the region of -350 to -250 bases from the TSS as strongest for SMARCAD1 binding, with 
the region between -450 and +350 bases implicated in SMARCAD1 binding (Okazaki et 
al., 2008). Furthermore, this study revealed the association of SMARCAD1 with the 
transcriptional repressor KAP1 (TRIM-28) at these loci; however, any changes in 
specific gene expression in the absence of SMARCAD1 was not explored (Okazaki et al., 
2008).   
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Figure 1.10. Binding of SMARCAD1 to the vicinity of the transcription start site of 69 
candidate genes, revealed by ChIP-on high-resolution tiling arrays. Each peak corresponds 
to the array signal produced from SMARCAD1-associated DNA binding to (mapped) probes 
on the array. The probes on the array are approximately 100bp in length, and tile across 
regions +/- 1kb of Transcriptional Start Sites (TSS). From Okazaki et al., 2008. 
 
1.3.8. SMARCAD1 facilitates DNA repair after double-strand breaks. 
A number of studies have linked SMARCAD1 to DNA repair mechanisms. One group 
investigated both the mammalian and the yeast homologue (Fun30) and showed that 
SMARCAD1 is required for long range resection of DNA immediately after double-strand 
breaks (Costelloe et al., 2012). Further to this, a study investigating the mechanisms of 
DNA repair pathway choice demonstrated that the switch from the (resection-
inhibiting) 53BP1 repair pathway is driven by the ubiquitin ligase activity of the BRCA1-
BARD1 complex acting on histone H2A. Ligation of ubiquitin to H2A subsequently allows 
the binding of SMARCAD1, driving resection and homologous recombination with the 
remodelling of chromatin and repositioning of 53BP1. Indeed, the resistance to drug 
induced DNA damage (after e.g. olaparib or camptothecin treatment) facilitated by 
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SMARCAD1 can also be brought about by 53BP1 loss, enhancing selection of the BARD1-
BRCA1 repair pathway (Densham et al., 2016). 
 
 
 
Figure 1.11. Proposed model for the role of SMARCAD1 in DNA double-strand break repair. 
Initial DNA resection (i.e. production of a long single-stranded 3’ overhang for homologous 
recombination events) proceeds at a limited rate by the CTIP and MRN proteins. 
Ubiquitination of histone H2A by the BRCA1/BARD1 complex allows the binding of 
SMARCAD1 to H2A, and increased resection (facilitated by nucleosome sliding) with 
inhibition of the 53B1 mediated resection-block. From Densham et al., 2016. 
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1.3.9. SMARCAD1 and chromatin compaction. 
Further to the work linking SMARCAD1 to transcription and DNA repair, one study 
identified the role of SMARCAD1 in restoration of heterochromatin after DNA replication 
(Rowbotham et al., 2011). Mass spectrometry of purified (flag-tagged) SMARCAD1 and 
subsequent immunoprecipitation experiments identify a complex containing 
SMARCAD1, the transcriptional repressor KAP1, the histone deacetylases HDAC1/2, the 
histone methyltransferase G9a/GLP, heterochromatin protein 1 (HP1α), and 
proliferating cell nuclear antigen (PCNA), thus localizing this complex to the replication 
fork (Figure 1.13a). (Rowbotham et al., 2011). These data suggest that SMARCAD1 
influences known marks linked to epigenetic repression, and maintains these after cells 
divide (Mermoud, Rowbotham, & Varga-Weisz, 2011). 
While these associations link SMARCAD1 function to cell division, in the same study the 
loss of SMARCAD1 in vitro was shown to have no gross effect on either cell cycle 
progression or DNA synthesis (Figure 1.13b). Synchronized control of SMARCAD1-
depleted cells analyzed over a 24 hour time-course showed no significant difference in 
the proportion of cells present in each phase of the cell cycle at each time point, and 
studies of DNA synthesis using EdU incorporation again revealed no significant 
difference between control and SMARCAD1-depleted cells. However, a global increase in 
histone H3 acetylation and decrease in HP1α and histone H3-Lysine 9 (H3K9) tri-
methylation, was observed, suggesting SMARCAD1 loss also drives a global decrease in 
heterochromatin. Together these data indicate that loss of SMARCAD1 does not impact 
progression of the cell cycle itself, although global differences in markers of 
heterochromatin are found (Figure 1.14) (Rowbotham et al., 2011). 
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Figure 1.12. Schematic domain alignment of SNF2-factor family members showing ATPase 
domains (blue), helicase domains (red) and CUE motifs (green). Top to bottom 
(species/homologue) Saccharomyces cerevisiae (Sc) Fun30, Schizosaccharomyces pombe 
(Sp) Fft1, Fft2, Fft3, Neurospora crassa (Nc) CLOCKSWITCH, Arabidopsis thaliana (At) 
AT2G02090, Drosophila melanogaster (Dm) CG5899, Caenorhabditis elegans (Ce) 
M03C11.8, Human /mouse (Hs, Mm) SMARCAD1/ETL1    From Neves-Costa et al., 2009. 
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Figure 1.13. (a) Immunoprecipitation of SMARCAD1 reveals bound interaction partners 
associated with compact chromatin marks such as histone deacetylaces 1 and 2 
(HDAC1/2) and histone methyltransferase G9a, the transcriptional repressor KAP1, 
heterochromatin protein 1 α  (HP1α) and proliferating cell nuclear antigen (PCNA). (b) 
Proportion of cells in each phase of the cell cycle after synchronization with mimosine at 
time points up to 24 hours in control (ctl) HeLa cells and SMARCAD1 knock-down (KD) 
HeLa cells. No significant difference is seen at each time point. From Rowbotham et al., 
2011. 
(a) 
(b) 
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Figure 1.14. Model of the action and interactions of SMARCAD1 behind the replication fork, 
restoring markers of heterochromatin (e.g. H3K9me3) during DNA replication. SMARCAD1 
forms a complex with histone deacetylases 1 and 2 (HDAC1/2), the histone 
methyltransferase G9a/GLP and the KAP1 transcriptional corepressor protein, along with 
Proliferating Cell Nuclear Antigen (PCNA), placing the complex in the proximity of the 
replication fork. From Rowbotham et al., 2011.  
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1.3.10 SMARCAD1 in human disease. 
Shortly after the description of the Smarcad1/Etl1 knockout mouse, the human 
SMARCAD1 gene was described and mapped to chromosome 4q22 – a region  associated 
with genome instability and human diseases (in particular hepatocellular carcinoma / 
hematologic malignancies) (Adra et al., 2000). More recently, a screen of head and neck 
cancers identified this same genomic region as one frequently deleted in these cancers 
(Cetin et al., 2008), and furthermore increased survival time in bladder cancer has been 
associated with SMARCAD1 expression (Tapak, Saidijam, Sadeghifar, Poorolajal, & 
Mahjub, 2015). Further to these observations, a missense mutation of SMARCAD1 was 
shown to increase sensitivity to the oral 5-fluorouracil (5-FU) prodrug capecitibine 
(O’Donnell et al., 2012). This may be no surprise given the mechanism of action of 
capecitibine (DNA damage) and the role of SMARCAD1 in DNA repair. 
While it is likely that the direct interaction of SMARCAD1 with chromatin directly 
underpins these disease associations, one study implicated SMARCAD1 as an important 
factor in breast cancer migration, invasion and metastasis. Using the invasive breast 
cancer cell line MDA-MB-231, knock-down of SMARCAD1 was shown to increase cell-cell 
adhesion with decreased cell migration, invasion, and metastasis. This effect was shown 
to be linked to the inhibition of the transcription factor STAT3 phosphorylation, which 
may reflect the impact that chromatin interactions have on downstream cell biological 
events (Al Kubaisy, Arafat, De Wever, Hassan, & Attoub, 2016). 
In addition to these associations with cancer, a meta-analysis of 3 genome wide 
association studies (GWAS) - covering 931 individuals with testicular germ cell tumours 
(TGCT) and 1975 unaffected controls - identified the region containing SMARCAD1 
(4q22.2) as one of four genomic loci associated with TGCT (C. C. Chung et al., 2013).  
Interestingly, a reduction in expression of SMARCAD1 has also been reported in the 
sperm of infertile men (Bansal, Gupta, Sankhwar, & Rajender, 2015). RNA expression 
array analysis of spermatozoa from normal (fertile), normozoospermic (infertile but 
normal motility) and asthenozoospermic (infertile and impaired motility) men revealed 
a down-regulation of SMARCAD1 specifically in the asthenozoospermic group. This may 
be unsurprising given the reduced fertility reported in the original mouse 
Smarcad1/Etl1 knockout model (Schoor et al 1999). 
Two phenotypically overlapping diseases linked to epidermal differentiation have been 
associated with SMARCAD1 mutations. The inability to develop fingerprints is the 
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hallmark of human adermatoglyphia. A recent study of Autosomal-Dominant 
Adermatoglyphia (ADA) in humans identified a short isoform of SMARCAD1 - containing 
an alternative transcription start site, whose expression is required for the development 
of epidermal ridges in human fingerprints (Nousbeck et al., 2011). Tissue expression of 
this shorter isoform of SMARCAD1 was shown to be greatest in skin fibroblasts 
(compared to the longer isoform), and also present in keratinocytes and the esophagus. 
Loss of expression of the short isoform was reported in a family who lacked fingerprints 
and hence experienced repeated problems when trying to enter foreign countries during 
global travel (and hence the alternative name ‘immigration delay disease’). Linkage 
analysis and subsequent sequencing of SMARCAD1 identified a point mutation which 
ablated expression of the short isoform, leading to loss of fingerprints (Figure 1.15). 
A second disease linked to epidermal differentiation has also been associated with 
mutations in SMARCAD1. Symptoms of Basan syndrome are more severe then ADA, with 
widespread blistering, lack of sweating and palmoplantar epidermal ridges (i.e. lacking 
from the soles of the feet and palms of the hand) and thickening of the skin. A  
heterozygous splicing variant of the short isoform of SMARCAD1 was associated with 
Basan syndrome across a 3-generation pedigree (Marks, Banks, Cunningham, Witman, & 
Herman, 2014) in an American family, and variants at the same base were also reported 
across 8 individuals of a 4-generation pedigree in China (M. Li et al., 2016). Together, 
these associations of SMARCAD1 with numerous cancers and disorders of epidermal 
differentiation highlight the importance of this chromatin remodeler in differentiation 
and proliferation. 
While the short isoform of SMARCAD1 has to date been described in human, it is worth 
noting that the first exon of the alternative isoform is conserved and in-frame across a 
number of species (Figure 1.16). While expression of this short isoform is yet to be 
confirmed in mouse, the sequence conservation across multiple genomes lends weight 
to the possibility that short isoform expression is also conserved. Importantly, while the 
previously reported Smarcad1/Etl1 knockout mouse model introduced a frameshift 
mutation in the first exon of (canonical) Smarcad1 (ablating expression of the full length 
transcript), it is possible that these mice still expressed the short isoform of (Schoor et al 
1999). Targeting of the ATPase domain in exons 12 to 14 as described in this thesis 
thereby targets both short and long (canonical) isoforms of Smarcad1. 
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Figure 1.15 (a) Loss of epidermal ridges (fingerprints) visible in a patient with 
adermatoglyphia (b) presence of an alternative start site for SMARCAD1 producing a short 
isoform (red arrow) which is lost in adermatoglyphia. Previous Smarcad1/Etl1 knockout 
models introducing a nonsense 1.1 mutation proximal to the canonical transcription start 
site would have retained this isoform. From Nousebeck et al., 2011. 
 
 
 
 
(b) 
(a) 
Exon  1      2                     3             4   5     6             7 8 9                            10 -12-15-17  20    21 
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Figure 1.16. The alternative first exon of the shorter SMARCAD1 isoform is conserved and 
in frame across mammalian species such as (top to bottom) mouse, rat, dog and pig. The 
red arrow indicates position of the ATG start codon, and each sequence is aligned against 
the short isoform first exon from human.  
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(Table Overleaf) 
Table 3 (overleaf). Summary table of recent publications on mammalian SMARCAD1. 
Alongside the lead author and journal details, each publication is categorised by whether 
the focus of research was on the molecular, cell biological or biological impact of 
SMARCAD1 on the specific model organism used.   
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1.4 Genomic imprinting and the influence of imprinted genes 
on metabolism. 
Genomic imprinting refers to the dosage control of a gene via epigenetic repression of 
one or other of the maternally or paternally inherited alleles. Imprinted genes have been 
shown to play a role in fetal development and neonatal survival, and influence feeding, 
metabolism, body temperature and maternal nurturing behaviour (Peters, 2014). 
Control is exerted by regulating the expression of genes which impact these factors and 
behaviours, sometimes during critical developmental windows. Furthermore, tissues 
and organs involved in metabolism are a primary location for imprinting mechanisms to 
exert this control (Figure 1.17). 
1.4.1. Imprinted genes and metabolism. 
A number of murine models of imprinting dysfunction have been created to understand 
the role that these genes play (Table 4). The impact of the loss of this dosage control can 
be severe (e.g. prenatal mortality), can be visible at birth (e.g. increased or decreased 
birth weight) and/or present throughout life (such as increased adiposity or 
dysregulation of blood glucose levels) (Peters, 2014). Interestingly, a number of these 
imprinted genes have overtly opposing functions. For instance, insulin-like growth 
factor 2 (IGF2) promotes embryonic growth, whereas the receptor IGF2R binds to IGF2 
and facilitates clearance from the cell surface, preventing further IGF2-mediated 
signalling - thereby opposing IGF2 function (Gicquel et al., 2004).  Other imprinted genes 
such as delta-like 1 homologue (Dlk1) and growth factor receptor-bound protein 10 
(Grb10) also impart opposing functions. Loss of expression of Dlk1 leads to low birth 
weight with adult-onset obesity in mice, whereas the loss of Grb10 expression produces 
overweight pups which develop into lean adults (Haig, 2014).  
Interestingly, many imprinted loci contain reciprocally regulated genes, i.e. some of the 
genes in the region are expressed only from the maternally-inherited allele, others only 
from the paternal allele. As an example, in the Dlk1-Dio3 region of mouse chromosome 
12, the genes Dlk1, Retrotransposon-like 1 (Rtl1) and Iodothyronine deiodinase 3 (Dio3) 
are all expressed from the maternal allele, whereas in the same region the genes Gene 
trap locus 2 (Gtl2) and miRNA containing gene (Mirg) are exclusively expressed from the 
paternal allele (Figure 1.18). Aberrant expression of Dlk1 from the paternal allele or 
increased dosage of Dlk1 leads to an increase in body mass and adiposity in mice, 
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although, conversely, decreased Dlk1 expression is linked to dwarfism (Steshina et al., 
2006; Teixeira da Rocha et al., 2009).  
 
 
 
 
 
Table 1.4. Models of imprinted gene dysregulation lead to developmental and/or 
metabolism-related phenotypes. Above is a subset of imprinted genes and the effect of 
gain or loss of expression on murine phenotype. For example, mice with over-expression 
of Dlk1 exhibit increased birth weight with some neonatal lethality, post-natal growth 
retardation (with growth catch-up by adulthood), leanness and insulin resistance. 
Conversely, increased expression of Grb10 leads to decreased birthweight, with no catch-
up growth by adulthood (From Peters, 2014).  
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Figure 1.17. Imprinted genes impact mouse metabolism via expression in multiple 
metabolism-related organs. Effects include control of factors such as appetite in the brain, 
and regulation of blood glucose concentration. Dosage control may be evident during 
specific developmental windows, and hence identification of gene dysregulation in 
neonatal organs (e.g. WAT or liver) may identify the gene driving any subsequent 
phenotype (Kelsey, G, per comm.). From Peters, 2014. 
 
 
 
 
Figure 1.18 Imprinting in the Dlk1-Dio3 region of mouse chromosome 12. Delta like 
homologue 1 (Dlk1) is expressed on the paternally-inherited allele (blue), alongside 
retrotransposon-like 1 (Rtl1) and deiodinase, iodothyronine, type iii (Dio3). Inappropriate 
expression of Dlk1 has been shown to drive an increase in body mass and adiposity 
postnatally, with linked metabolic complications. By contrast, Gene Trap Locus 2 (Gtl2) is 
expressed from the maternally-inherited allele, and loss of the normal balance of 
Dlk1/Gtl2 expression (and decreased Dlk1 expression) is linked to dwarfism and partial 
neonatal lethality. From Edwards et al., 2008. 
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1.4.2. SWI/SNF chromatin remodellers and the KCNQ1 imprinted locus. 
The chromatin remodelling factors SMARCAD1 and SMARCA5 have themselves been 
implicated in imprinted dosage control at the KCNQ1ot1 imprinted gene locus. In this 
region, multiple genes are expressed from the maternally-inherited allele only 
(including Ascl2, CD81, TSSC4 and KCNQ1), and expression of the anti-sense non-coding 
RNA transcript KCNQ1ot1 from the paternal allele represses these genes (Figure 1.19). 
The knock-down of Smarcad1 and Smarca4 expression in embryo-derived stem cells led 
to increased expression of Kcnq1 and Cdkn1c, but no difference in Slc22a18, indicating 
that the control of expression is not domain-wide. Furthermore, ablation of Smarcad1 
and Smarca4 expression was linked to a decrease in Kcnq1ot1 levels, suggesting that the 
effect is not mediated by KCNQ1ot1 but instead is a direct result of SMARCAD1 and 
SMARCA4 (Landschoot, 2014). Whether either of these remodellers impact other 
imprinted gene loci has yet to be explored. 
 
 
Figure 1.19. Mouse distal chromosome 7 contains  the Igf2 / Kcnq1 imprinted region. 
Expression of the non-coding RNA Kcnqot1 leads to repression of the Ascl2, Cd81, Tssc4 
and Kcnq1 genes on the paternally-inherited allele. Repression of Cdkn1c and Kcnq1 is 
facilitated by the chromatin remodellers SMARCAD1 and SMARCA5. 
 
1.4.3. Chromatin remodelling controls Dlk1 expression during 
adipogenesis. 
Central to dosage control, chromatin binding factors direct the accessibility of imprinted 
genes. Dlk1 – which is also known as pre-adipocyte factor 1 (Pref-1) - inhibits 
adipogenesis and is regulated by the histone binding protein Cooperator of PRMT5 
(Copr5).  In fact, COPR5 directs the binding of PRMT5 (Protein Arginine 
Methyltransferase 5) to chromatin and the subsequent methylation of histone H4 R3. 
The binding of PRMT5 to the Dlk1 promoter reduces Dlk1 expression, thereby aiding 
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adipogenesis. In Copr5 knock-out mouse embryonic fibroblasts (MEFs) and white 
adipose tissue (WAT), expression of Dlk1 was up-regulated, and indeed knockout mice 
showed reduced retroperitoneal white adipose tissue size by 8 – 16 weeks old (Paul, 
Sardet, & Fabbrizio, 2015). In parallel to this observation, the adipocyte lineage-
controlling transcription factor, peroxisome proliferator-activated receptor γ2 (PPARγ2) 
requires the binding of PRMT5 to the PPARγ2 promoter region, leading to formation of 
an accessible 3D-loop and binding of the ATPse dependent remodeller BRG1 (LeBlanc, 
Wu, Lamba, Sif, & Imbalzano, 2016). 
 
1.5 Adipocyte lineage differentiation and chromatin. 
1.5.1. Chromatin remodellers and adipocyte differentiation. 
The pathways controlling adipogenic/osteogenic differentiation from bone marrow 
mesenchymal stem cell (MSC) precursors is known to be influenced by SWI/SNF 
chromatin remodelling complexes (Nguyen et al., 2015). Mesenchymal stem cells 
harbour the potential to differentiate into multiple different cell types, such as 
chondrocytes (which produce cartilage), osteocytes (bone cells), adipocytes (fat cells), 
myocytes (muscle), skin fibroblasts or astrocytes of the central nervous system (CNS) 
(Figure 1.20). Investigation of the SWI/SNF remodeller BRM revealed that Brm 
depletion favours differentiation toward the osteoblast lineage, as MSC populations 
depleted of Brm show an increase in the proportion of cells expressing the osteoblast 
markers Alkaline Phosphatase (Alpl) and Fibroblast Growth Factor Receptor type-2 
(Fgfr2), with a marked reduction in the ability to differentiate down the adipocyte 
lineage following in vitro adipogenic stimulation (Figure 1.21). Furthermore, the 
increased commitment to the osteoblast lineage and impaired adipogenesis was 
recapitulated in primary mesenchymal stem cells isolated from Brm-/- mice and the 
mesenchymal stem cell line C3H10T1/2 (MSC), in addition to mouse embryonic 
fibroblasts (NIH-3T3, which harbour adipogenic potential) and the lineage committed 
3T3-L1 preadipocyte and MC3T3‐E1 osteoblast cell lines. Interestingly, closer 
examination of bone marrow from Brm-/- mice revealed a reduction in bone marrow 
adiposity and resistance to age-related osteoporosis. These results highlight the 
importance and potential of SWI/SNF remodelling complexes in differentiation and age-
related pathologies (Nguyen et al., 2015). 
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Figure 1.20. Mesenchymal stem cells (MSCs) can differentiate down different lineages, 
many of which are involved in structural and support roles within mammals. After 
isolation, MSCs can be differentiation in vitro depending on the experimental focus. For 
example, differentiation of MSCs with TGF-β produces chondrocytes, involved in 
production of cartilage. By contrast, differentiation of MSCs with BMP-2, ascorbic acid and 
dexamethasone in a suitable support matrix (e.g. alginate) produces osteocytes, the 
cellular constituent of bone. Of particular interest is the potential to differentiate MSCs 
with BMP-2, insulin, dexamethasone and IBMX, producing lipid-filled mature adipocytes. 
From Democratizing Cell Technologies (2014).  
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Figure 1.21. Mesenchymal stem cells depleted of the chromatin remodeller Brm (Smarca2) 
demonstrate (A) increased alkaline phosphatase and reduced (oil-red-O) lipid staining, 
alongside a (B) gain in osteoblastic lineage marker expression (Alkaline phosphatase and 
Fgfr2) as identified by qPCR.  From Nguyen K.H et al (2015).  
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1.5.2. Major pathways involved in adipogenesis. 
The molecular pathways which drive adipogenesis and adipose tissue expansion are 
well characterised. A number of key transcription factors – which are considered to be 
‘master-switches’ in the cascade of signals that drive successful adipogenesis – have 
been studied over the previous decades, and serve as markers of adipogenic 
dysfunction. Of these, three particular ‘master-switches,’ Ppar-γ (Peroxisome 
proliferator-activated receptor-γ) C/ebp-α (CCAAT-enhancer-binding protein-α) and 
Srebp1c (sterol regulatory element-binding protein 1-c) are upregulated and begin the 
successful cascade of signals required for adipogenesis. Particular attention to these can 
reveal the mechanisms behind adipogenic dysfunction (Figure 1.22) (Siersbæk, Nielsen, 
& Mandrup, 2012). 
  
 
 
Figure 1.22. The major transcriptional networks controlling adipogenesis, with major 
nodes provided by C/EBPα, PPARγ and SREBP-1c. Aberrant levels of these transcription 
factors serve as markers for potential adipogenic dysfunction. From Siersbæk R et al 2012.  
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1.5.3. Approaches to the study of white-adipose tissue. 
Two types of fat depot are found in mammals, subcutaneous WAT (e.g. inguinal WAT), 
and visceral fat (e.g. epididymal WAT) (Figure 1.23). Although both types were 
originally considered a simple metabolic energy store, more recent evidence now shows 
that visceral and subcutaneous WAT are distinct tissues which arise from different 
developmental origins, for instance subcutaneous WAT contains smaller multi-locular 
adipocytes and is thought to protect against metabolic dysfunction (Berry, Stenesen, 
Zeve, & Graff, 2013). Interestingly, while initial adipose tissue organogenesis does not 
require the presence of a stromal vascular niche (i.e. the surrounding network of 
mesenchymal stem cells, endothelial progenitor cells, and immune cells such as B- and 
T-cells and macrophages), development and expansion of adult adipose tissue is 
dependent on the presence of Sma+ve (Smooth Muscle Actin+) mural cells for 
maturation. It has to be remembered therefore that any differences found in adult 
murine adipocyte stem cell function may be influenced by the niche. Other factors 
present in white adipose tissue which are required for adipose tissue expansion and/or 
homeostasis include tissue resident macrophages. These are thought to play a role in 
both in the clearance of dead cells and in mechanisms driving adipose tissue modelling 
such as during nutrient excess or nutrient deficiency (Martinez-Santibañez & Nien-Kai 
Lumeng, 2014). 
 
Figure 1.23. Location of brown adipose tissue, inguinal white adipose and epididymal 
white adipose tissue depots in mouse. Inguinal and epididymal WAT depots represent 
subcutaneous and visceral fat depots respectively. Image reproduced from:-                                       
http://www.nature.com/bonekeyreports/2015/150114/bonekey2014116/images/bonekey201
4116-f1.jpg. 
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Other sources of material can be used for the study of adipogenesis: multiple non-WAT 
derived cell types are able to differentiate and undergo adipogenesis (Figure 1.24). 
Mouse embryonic stem cells can be differentiated under the influence of Retinoic Acid, 
Ascorbic Acid, insulin, and Rosiglitazone to become mature adipocytes, which more 
closely resemble isolated subcutaneous adipocytes than a number of established pre-
adipocyte cell lines (e.g. 3T3-L1), based on gene expression profiles (Cuaranta-Monroy 
et al., 2014). Mouse embryonic fibroblasts (MEFs) can be prepared from disaggregated 
embryos at day E12 to E14 and subsequently differentiated into adipocytes (discussed 
later). These also harbour the potential for immortalization, providing a longer-lived 
substrate for studies of adipogenesis.  
Brown adipocytes can also be driven by hormonal inducers down the white adipocyte 
lineage, as can extracts from adult tissues containing multipotent cells (such as bone 
marrow, skeletal muscle or adipose tissue) (Rosen & MacDougald, 2006). Interestingly, 
the immortalized mesenchymal stem cell line C3H10T1/2 was originally isolated from 
bone marrow (Reznikoff, Bertram, Brankow, & Heidelberger, 1973), and can be 
hormonally induced to become mature adipocytes. Together these give multiple 
potential substrates for the study of adipogenesis and mesenchymal stem cell 
differentiation (Figure 1.24). 
1.5.4 Putative white adipocyte stem cells for studying adipogenesis. 
The isolation of white adipocyte precursors (adipocyte stem cells) to allow the 
examination of the adipocyte-lineage differentiation in e.g. obesity has been the target of 
multiple studies. Conflicting reports exist as to the bona fide cell surface phenotype of 
adipocyte stem cells (Cawthorn, Scheller, & MacDougald, 2012). While the trial of 
published approaches would be beyond the scope of this thesis, the use of a proven 
method where mature adipocytes can be successfully differentiated was essential for ex-
vivo investigation of murine SMARCAD1 in adipogenesis. The characterization of sorted 
cells by Church et al (2014) demonstrated the adipogenic potential of stromal vascular 
cells with the surface phenotype (CD45-CD31-) CD29+CD34+Sca1+, providing such a 
potential approach (Figure 1.25). 
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Figure 1.24. Anatomical and cellular sources for studying adipogenesis in mouse. Primary 
cells can be isolated from mouse embryos or blastocysts and stimulated to become mature 
adipocytes (panels a to c), and a stable substrate for the study adipogenesis can be 
generated from the serial passaging of mouse embryonic fibroblasts to generate an 
immortalized cell line (c). In a similar manner, extracted brown adipose stromal cells can 
be immortalized into brown pre-adipocytes, which are able to undergo adipogenesis into 
mature white adipocytes (d) and isolated bone marrow stromal cells (e) can also be 
immortalized to provide a substrate for studies of adipogenesis. From Rosen and. 
MacDougald (2006). 
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Figure 1.25. Strategy for isolation of adipocyte stem cells using collagenase digestion and 
flow cytometry. The stromal vascular fraction of white adipose tissue is first extracted by 
collagenase disaggregation and serial filtration, and the remaining cells are stained for 
flow cytometry using a panel of cell-surface markers specific for WAT-resident stem cells. 
From Church, Berry, & Rodeheffer, 2014. 
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1.5.5. Mouse Embryonic Fibroblasts (MEFs). 
An alternative substrate for the study of murine adipogenesis is mouse embryonic 
fibroblasts (MEFs). These cells are obtained from the extraction of embryos from the 
uterus of expectant mothers, followed by mechanical disruption and trypsinisation of 
embryonic cells (Lei, 2013). Subsequent culture expands embryonic fibroblasts, which 
retain multipotency and are able to differentiate into multiple cell types, such as 
adipocytes, osteoblasts and chondrocytes (Dastagir et al., 2014). Further in vitro 
passaging immortalizes MEFs, although this also induces a loss in potency, reducing 
practical utility. One of the most widespread uses of MEFs is as a ‘feeder’ layer in the 
culture of Embryonic Stem Cells (ESCs), providing metabolites for stem cells without 
dividing themselves (Llames, García-Pérez, Meana, Larcher, & del Río, 2015). However, 
MEFs also provide a useful tool for other studies of differentiation given their ease of 
handling. 
A number of studies highlight the utility of MEFs in non-mesoderm-type cell 
differentiation experiments e.g. for studies of innate immunity and responses to viral 
infection (do Valle et al., 2010, Balachandran, Thomas, & Barber, 2004) or studies of 
differentiation to lineages such as neurons or myocytes (Vierbuchen et al., 2010; Fong et 
al., 2012). The similarity between MEFs and bone marrow-derived stromal stem cells 
(BMSCs) has also been of specific interest, given that MEFs are often used as a surrogate 
for BMSCs during mesodermal differentiation experiments (Saeed, Taipaleenmäki, 
Aldahmash, Abdallah, & Kassem, 2012). Interestingly, MEFs exhibited higher telomerase 
activity and cell proliferation than BMSCs, while retaining the cell-surface phenotype 
characteristic of BMSCs (Sca-1+, CD73+, CD105+, CD29+, CD44+, CD106+, CD11b−, and 
CD45−). However, osteogenic differentiation of MEFs resulted in a less mature 
osteoblastic phenotype than BMSCs, even though the differentiation to adipocytes and 
chondrocytes appeared to be enhanced. 
A more recent study investigated the scope of heterogeneity within MEFs (Singhal et al., 
2016). Given the method of preparation (i.e. no isolation of specific cell types is 
involved), it is likely that MEFs constitute a mix of cell types – impacting any 
downstream application where a homogenous starting substrate has been perceived. 
Indeed, while this study highlighted that little morphological difference was visible 
among MEFs microscopically, the use of GFP expression driven from the vascular 
endothelial growth factor promoter (Vegf) revealed MEFs that were GFP-positive or 
MEFs that were GFP-negative. Interestingly, GFP-positive MEFs were shown to replicate 
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more quickly than GFP-negative cells, and became more prevalent in the population 
with serial passaging in culture. However, while GFP-negative cells were subsequently 
shown to subdivide into further distinct populations based on cell-surface markers, this 
(mixed) population retained the ability to differentiate into bone, muscle and fat 
lineages (Singhal et al., 2016). 
Such studies reveal the potential of MEFs to differentiate into different cell types, 
reflecting lineage commitment. In contrast, the seminal work by Takahasi and 
Yamanaka, uncovered the potential of MEFs to dedifferentiate upon transfection with 
four key factors: OCT3/4, SOX-2, c-MYC, and KLF-4, (now known as the “Yamanaka 
factors”), becoming inducible pluripotent stem cells (iPCs) (Kazutoshi Takahashi & 
Yamanaka, 2006). Following on from this, more recent work also shown that MEFs 
demonstrate greater potency (i.e. broader differentiation potential) than mesenchymal 
stem cells (MSCs). One particular study showed that MEFs were able to generate tissue 
similar to ectodermal, mesodermal and endo-dermal lineages when injected into Balb/c 
mice, reflecting natural embryonic stem cell (ESC) type potential  (Yusuf et al., 2013). 
Taken together, these studies demonstrate the utility of mouse embryonic fibroblasts for 
studies of adipocytic and chondrocytic differentiation in particular, while additionally 
showing the potential for use in other models of differentiation and areas such as innate 
immunity. 
 
Figure 1.26. Mouse embryonic fibroblasts (MEFs) are able to differentiate down different 
lineages and become (a) adipocytes (b) osteoclasts (c) neurons (d) embryoid-body like 
aggregates. Such potency underlines the utility of MEFs as models for studies of 
differentiation. From Yusuf et al., 2013. 
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1.6 Intestinal microbiota and metabolism. 
 
The mammalian intestine is host to a large number of microbes, and changes in the 
composition of intestinal microbiota have been the subject of many studies in the 
context of metabolic impact. Indeed, over 1000 different species of bacteria have so far 
been identified in the gastrointestinal tract of humans, including symbiotic commensal 
bacteria (which interact with and play a role in intestinal function), and species that 
contribute to pathology (Brown, DeCoffe, Molcan, & Gibson, 2012). Of the species 
present, four major phyla dominate: Actinobacteria, Bacteroidetes, Firmicutes and 
Proteobacteria. Firmicutes and Bacteroidetes make up the majority of species present in 
the mammalian colon, whereas Actinobacteria and Proteobacteria are found at much 
lower abundance. Furthermore, studies using an obese mouse model revealed an 
increase in the proportion of Firmicutes to Bacteroidetes of up to 50%. In line with this, 
germ free mice colonized with the intestinal microbiome derived from obese mice show 
increased weight gain compared to control mice fed the same diet, implicating microbial 
influence (Turnbaugh et al., 2006). 
Exactly how the gut microbiota influences distal organs in mammals is yet to be 
completely understood. Links have been made between the microbiota and 
tissues/organs such as adipose tissue, lungs, pancreas and the brain (Schroeder & 
Bäckhed, 2016). A number of microbially-derived molecules are now known to interact 
with both the intestine and with distal organs. As an example, interactions between the 
microbiota and host intestinal immune system are modulated by the microbial 
catabolism of tryptophan into indole-3-aldehyde,  which binds to the aryl hydrocarbon  
receptor  (AHR) in host innate-lymphoid cells (ILCs) and intraepithelial lymphocytes 
(discussed later), driving the production of the cytokine interleukin-22 (Zelante et al., 
2013). Dietary fibre can also be broken down by the microbiota into short-chain fatty 
acids (SCFAs) such as butyrate, propionate and acetate. These can themselves contribute 
to the daily energy requirement of humans, and in the case of calorie excess can be 
incorporated into white adipose tissue directly, thereby impacting adiposity (Bäckhed, 
Manchester, Semenkovich, & Gordon, 2007). However the same SCFAs provide signals to 
L-cells in the intestine, and bind to G-protein-coupled receptor (GPCR) GPR41, 
upregulating expression of glucagon-like peptide (GLP)-1. Secretion of GLP-1 increases 
insulin secretion from the pancreas and decreases appetite by delaying gastric emptying 
(Fava, 2014). A summary of associations between the microbiota, non-intestinal 
tissues/organs and pathology is shown in Table 5. 
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Table 1.5. The influence of intestinal microbiota on mammalian organs, and associated 
diseases. From Schroeder & Bäckhed, 2016. 
Microbiota can also directly impact host chromatin. A number of microbially-derived 
products such as SCFS can provide substrates for epigenetic modification of the host 
genome (Table 6). Indeed, carbohydrate breakdown products produced by intestinal 
bacteria consist of >95% acetate, propionate or butyrate (den Besten et al., 2013), which 
in turn can be used by histone acetyltransferases (after oxidation in the case of 
propionate and butyrate) in the form of acetyl Co-A to covalently modify chromatin. In 
addition to this, butyrate has been shown to inhibit histone deacetylases (Davie, 2003) 
providing a two-pronged increase to acetylated histone levels. 
An in-depth study of histone modifications (using mass spectrometry) in the context of 
different gut microbial populations built on these observations, and unveiled that these 
effects are not limited to the intestine. Comparison of histone modifications in 
conventionally raised (CONV-R) and germ-free mice (GF) revealed that acetylation of 
histone H4 at residues K5, K8, K12 and K16 was increased in both colon and white 
adipose tissue (WAT) of CONV-R mice, and that dual-acetylation of histone H3 at H3K9 
and K14, or at H3K18 and K23, were increased in both the liver and colon of GF mice 
after colonization with microbiota from CONV-R mice (age-matched at 15 weeks old). 
The same mice showed an increase in the K27me/K36unmodified pairing on histone H3 
in colon, liver and white adipose tissue in response to colonization, with additional 
increases in H3 K27me2 and H3 K27me3 in white adipose tissue (Krautkramer et al., 
2016).  
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To further assess the impact of these chromatin changes, transcriptomic analysis of 
these tissues was performed (using RNA-seq) to identify gene expression changes 
associated with chromatin modifications in the liver of each of three mouse groups 
(CONV-R, GF mice, and GF mice that were subsequently colonized with microbiota from 
CONV-R mice). A total of 623 genes were differentially expressed between these three 
groups, and interestingly one set of genes identified between CONV-R and GF mice were 
involved in processes linked to insulin, PPAR and SREBP signaling (important factors in 
adipogenesis, discussed earlier). Indeed, 4% of the differentially expressed genes 
identified are known targets of PPAR and SREBP transcription factors in the liver, 
providing a transcriptional link between the microbiota and fat metabolism 
(Krautkramer et al., 2016). 
To further investigate whether bacterially-derived SCFA were driving these changes, 
germ free mice were supplemented with dietary SCFAs (acetate, propionate and 
butyrate), and livers were again investigated for chromatin modification and 
transcriptional changes using mass spectrometry and RNA-seq as above. Comparison of 
histone modifications and differentially expressed genes between SCFA supplemented 
GF mice and the other three groups revealed that mice supplemented with SCFA closely 
resembled the GF mice supplemented with CONV-R microbiota in terms of gene 
expression and chromatin modifications. These data provide strong evidence that 
microbial populations in the intestine influence tissue and organs beyond the intestine 
at the chromatin and transcriptional level (Krautkramer et al., 2016). 
Other studies have also investigated how the gut microbiota impact global chromatin 
structures in intestine-resident cell types directly. In one set of experiments, regions of 
open chromatin were identified from murine epithelial cells of the ileum and colon using 
DNAse-seq (i.e. sequencing DNAse-I digested DNA fragments, which exploits the affinity 
of DNAse-I for open chromatin (Song & Crawford, 2010). These reads were then 
compared from mice raised either conventionally or in germ-free conditions (i.e. with a 
normal microbiome or no microbiome); interestingly no significant differences were 
found in the genomic location of regions associated with open chromatin between the 
groups. However, differences in gene expression were found between normal and germ-
free mice, suggesting that although the chromatin landscape may be pre-programmed in 
intestinal epithelial cells, the genes that are accessible can still be influenced by the 
microbiota (Figure 1.27) (Camp et al., 2014). 
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Table 1.6. Microbial breakdown of carbohydrate generates short-chain fatty acids (SCFAs) 
which impact the host epigenome.  SCFAs such as acetate, propionate and butyrate have 
been shown to increase histone acetylation, and supplementation of germ-free mice with 
these SCFAs partially replicate the histone acetylation and methylation patterns observed 
in colonized mice. From Krautkramer et al (2017). 
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Figure 1.27. Microbiota do not influence the landscape of accessible chromatin in the 
murine small intestine (ileum) or large intestine (colon). The graphs show reads from 
open chromatin after DNAse-seq with peaks at areas of open chromatin, with 
corresponding expression RNA level traces below. Four genes are shown (Angptl4 and 
Fgf15 from the ileum, top, and Cyp4b1 and Ang4 from the colon, bottom) with open 
chromatin peaks plotted from conventionally raised vs germ free (no microbiota) mice. 
From Camp et al 2014. 
 
 
Another study used a related technique (Assay for Transposase-Accessible Chromatin 
(ATAC)-seq) to examine intestine-related chromatin structure. Similar to DNAse-seq, 
ATAC-seq exploits the ability of the enzyme Tn5 Transpose to cut exposed DNA and 
ligate short external sequences (adaptors) onto the DNA fragment, thereby generating 
sequence-ready DNA templates from regions of open DNA (Buenrostro et al., 2015). By 
contrast, this study focussed on intestinal intraepithelial lymphocytes (IELs) rather than 
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intestinal epithelial cells (IECs); unlike IECs, IELs are not derived from the intestinal 
stem cell in crypt (discussed later) and can also be easily purified into homogenous cell 
types (e.g. γδ-T cells and αβ-T cells). Interestingly, the results from either γδ- or αβ-T 
cells revealed differing levels of open chromatin between conventionally raised or germ-
free mice within enhancer sequences (Semenkovich et al., 2016), indicating that changes 
in chromatin landscape can be driven by the microbiota in some intestinal-resident cells.  
The seemingly different conclusions from the two studies could be due to the input cell 
type, as IECs represent a heterogeneous population and thus some differences in open 
chromatin in one particular cell-type could be technically diluted beyond a detectable 
range by signals from multiple other cell types. Furthermore, the typical turnover for 
IECs in the mammalian intestine is 2-5 days (J.-H. Park et al., 2016), whereas IELs are 
resident for several weeks (Sheridan & Lefrançois, 2010), which thus presents a larger 
window for microbial influence.  
Taken together, the experiments above - which examine mice raised under different 
conditions and with or without dietary challenge – reveal how changes in intestinal 
microbiota can influence the chromatin landscape and gene expression of the host 
organism, driving phenotypic differences. With this in mind, it is important to rule out 
(or rule in) any changes in the intestinal microbiome if model organisms present with an 
intestinal, hepatic or adipose tissue phenotype (which are potentially driven by the 
microbiota). 
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1.7 Intestinal anatomy and development. 
 
Many insights into intestinal development and the importance of chromatin remodellers 
in intestinal function have been gained from studies in the Drosophila fruit fly. In the 
mammalian digestive tract, the intestine extends between the stomach and rectum, 
subdivided into the small intestinal duodenum, jejenum and ileum, the cecum marking 
the division between small/large intestines,  and the ascending, descending and 
sigmoidal colon forming the large intestine prior to the rectum and anus marking the 
exit from the body. By contrast, the Drosophila intestine is divided into the foregut, 
midgut and hindgut representing an equivalent anatomical stretch. Furthermore, at the 
microscopic level the mammalian intestine is formed of anatomical villi and crypts along 
the length, presenting an increased surface area along the proximal-distal axis. The 
Drosophila intestine harbours a more simple tube-type anatomy, and with decreased 
diversity of cell types within the anatomical structure (Figure 1.28) (Apidianakis & 
Rahme, 2011). 
The intestinal epithelia of higher organisms is one of the most rapidly renewing tissues, 
underpinned by high cell turnover (Vermeulen & Snippert, 2014). Within the 
mammalian intestine, stem cells reside at the base of the crypt and divide to produce the 
other cell types which project towards the lumen, forming the villi. By contrast, division 
of stem cells within the Drosophila intestine produce progeny which project along the 
anterior-posterior axis, extending the anatomical tube-like structure (Apidianakis & 
Rahme, 2011).  
1.7.1. Chromatin remodellers and intestinal development. 
The impact of chromatin remodellers and associated epigenetic factors in intestinal 
development/differentiation and function has been greatly informed by studies in 
Drosophila. In one study, the loss of function of the Osa-containing SWI/SNF chromatin 
remodelling complex altered the composition of cells in the Drosophila midgut, with 
increased numbers of intestinal stem cells present at the expense of enterendocrine cells 
and enterocytes (which normally differentiate from the iSCs) (Zeng, Lin, & Hou, 2013). 
This implies that specific chromatin remodelling is required for the production of 
appropriate cell populations from the intestinal stem cell. 
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Figure 1.28. Comparison of microscopic anatomy of mammalian and Drosophila intestine. 
(A) In healthy mammals, intestinal stem cells divide and produce a single layer of cells 
(containing multiple cell types) from the base of the crypt to the top of the villus. (C) In 
contrast, intestinal stem cell division in Drosophila drives the production of a single layer 
of cells longitudinally along the intestine. In diseased states (B and D), the normal 
structure can becomes altered with the presence of multiple layers. From Apidianakis Y, 
Rahme LG (2011). 
 
 
Another study looked at the impact of the chromatin remodeller Chd1 on the Drosophila 
gut microbiota. Loss of Chd1 was associated with a reduction in the diversity of bacterial 
species, with Acetobacteraceae becoming the dominant population in mutant intestines 
compared to wild-type flies. Furthermore, some bacterial species (such as Lactobacillus 
plantarum) could not be maintained in the midgut of Chd1-deficient over time. This 
study implicates chromatin remodellers in the establishment and maintenance of gut 
microbiota (Sebald et al., 2016).  Furthermore, the link between chromatin remodelling 
and intestinal immunity was highlighted by a study using a genome-wide siRNA screen 
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for genes that increase susceptibility to lethal Serratia marcescens infection. This screen 
identified CG5899 (the homologue of mammalian SMARCAD1) as a gene that confers 
susceptibility to lethal infection when ablated specifically in the intestine. Furthermore, 
many of the genes identified were involved in intestinal stem cell differentiation, and 
thereby regulation of the enterocyte compartment (Cronin et al., 2009). Taken together, 
these studies emphasize the importance of chromatin remodellers in intestinal biology, 
including intestinal immunity and microbial interaction on top of normal intestinal 
development or function.  
 
1.7.2 Development of the vertebrate intestine. 
Development of the gastro-intestinal (GI) tract follows morphological similarity in all 
vertebrate species studied (de Santa Barbara, van den Brink, & Roberts, 2003). At the 
end of gastrulation, two ventral invaginations at the anterior and posterior end of the 
embryo elongate in the endodermal layer and eventually fuse in the midline, producing a 
straight tube. Along the anterior-posterior axis, three distinct regions are then formed: 
the foregut (containing pharynx, oesophagus and stomach), the midgut (containing 
small intestines) and hindgut (containing the colon). Undifferentiated stratified cuboidal 
cells remain in place until midgestation when endodermal differentiation is driven by 
epithelial-mesenchymal interactions, and leads to mesodermal growth into the lumen 
and villi formation. Along the anterior-posterior axis differences appear between the 
villi in the small intestine (which are long and thin) and the colon (flatter and wider), 
and initially these villi are separated by intervillus epithelium. In the small intestine this 
intervillus epithelium is then reshaped downwards (i.e. in the opposite direction to the 
villi), producing crypts, while in the colon these crypts become tubular glands. By time 
of birth the villus-crypt anatomical unit is present in the small intestine, whereas the 
colonic villi reduce in length and disappear leaving just tubular glands (de Santa Barbara 
et al., 2003) (Figure 1.29). 
The majority of cells within the mammalian intestinal crypt/villus unit are produced 
from the intestinal stem cell. (The intraepithelial T-lymphocytes of the adaptive immune 
system are an exception and are discussed later). Intestinal stem cells reside at the base 
of the crypt, and produce the rapidly dividing progenitor cells that form the transit-
amplifying zone between the crypt and villus.  Within the transit amplifying zone, the 
cell lineage decision is made, and cells differentiate into either secretory precursor (SP) 
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cells or absorptive precursor cells (AP). The SP cells differentiate further to become 
either goblet cells or enteroendocrine cells within the villus or Paneth cells which 
migrate back towards the base of the crypt, serving an immune-protective function for 
the intestinal stem cells. AP cells migrate further towards the lumen in human before 
differentiating     into    enterocytes    within    the    terminal   differentiation    zone   (TD) 
(Benoit et al., 2012). The number of cell divisions undergone at this stage underpins the 
anatomical composition of the crypt/villus, as SP cells go through two rounds of cell 
division yet AP cells go through four, and hence AP cell-derived cells such as enterocytes 
make up the majority of cells within the intestinal villus. 
 
 
Figure 1.29. Development of mammalian small intestine and colon and formation of the 
crypt/villus unit. The embryonic intestine resembles a tube formed from stratified 
epithelium, from which villi and crypts are formed through postnatal differentiation. From 
de Santa Barbara et al., 2003.  
 
The adult intestinal epithelium is thought to be the most rapidly self-renewing tissue in 
mammals. Epithelial cell turnover is driven by stem cells in the base of the crypt, and it 
has been estimated that around six cycling stem cells are present at the base of each 
crypt, which express the cell surface receptor LGR5 (Leucine Rich Repeat containing G 
protein receptor 5). Initial studies had identified LGR5 as a marker on colorectal cancer 
cells, and more recently in other cancers (Sato et al., 2009). However, during an 
investigation of (intestinal-expression-restricted) Wnt-signalling target genes (i.e. genes 
involved in body patterning, cell migration and proliferation processes during 
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embryonic development) LGR5 was identified as a marker for crypt-localisation (Barker 
et al., 2007). Subsequent lineage tracing (using an inducible Cre-knock in / LGR5 
/Rosa26 reporter) demonstrated that Lgr5+ cells at the crypt base were able to generate 
all epithelial lineages along the crypt-villus axis over a period of 60 days, confirming 
their role as intestinal stem cells (iSCs). 
 
 
Figure 1.30. The crypt-villus unit in mammalian small intestine. The major cell types 
endogenous to the small intestine are derived from the intestinal stem cell (iSC) located at 
the base of the crypt (red). Adjacent to iSCs are Paneth cells which serve an immune-
protective function to the iSCs. From the base of the crypt upwards, the transient 
amplifying cells region contains cells undergoing differentiation, from which the 
characteristic cell types migrate upwards to the top of the villus where they are finally 
shed in a process called anoikis. The small intestinal villi contain mostly enterocytes 
(involved in nutrient absorption) alongside mucous-secreting Goblet cells, hormone 
producing Enteroendocrine cells and opioid/prostanoid producing Tuft cells. From   
Clevers & Batlle, 2013.  
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In addition to the rapidly dividing LGR5+ iSCs in the intestinal crypt, the identification of 
quiescent, label-retaining cells (LRCs) has prompted a model whereby a number of 
slow-turning over cells are retained in the crypt which can serve as both the precursors 
of Paneth cells (which are also retained in the crypt) or differentiate into any of the 
other lineages present in the crypt/villus on response to damage (Figure 1.30). Paneth 
cells themselves function in an innate-immunity capacity - i.e. without adaptive or 
pathogen-specific immune responses, but secrete anti-microbial peptides in response to 
microbial challenge. As Paneth cells are located adjacent to LGR5+ iSCs in the crypt, 
these are thought to confer direct protection to the intestinal stem cell niche (Clevers & 
Batlle, 2013). 
 
1.7.3. Chromatin remodellers in the mammalian intestine. 
As with studies in Drosophila, work on the mammalian intestine has illustrated the 
importance of chromatin remodellers in intestinal function and homeostasis. Following 
on from the Osa-ablated fly model, murine overexpression of the high mobility group 
protein 1a (Hmg1a) in mouse drives the expansion of the intestinal stem cell and Paneth 
cell niche. HMG1a is associated with active transcription (Ozturk, Singh, Mehta, Braun, & 
Barreto, 2014), and these changes are associated with an increase in multiple signals 
within the Wnt-signalling family (Xian et al., 2017). Previous work using a knockout of 
Smarca4 (the mammalian homologue of Brg1) also implicated this factor in the 
maintenance of intestinal stem cell turnover, and mice deficient in SMARCA4 showed a 
loss in villi segregation, while crypts lacking in SMARCA4 were gradually lost in these 
mice (Holik et al., 2013). 
Of particular interest is the interaction between the intestinal microbiota and host cells, 
especially intestinal epithelial cells (IECs) which form the villus. One study compared the 
differences in gene expression and accessible chromatin between mice raised under 
normal conditions versus mice raised under germ-free conditions. Surprisingly, while 
there was a marked changed in gene expression between germ-free and control groups, 
this was not accompanied by equivalent changes in chromatin accessibility. This 
suggests that flexibility in gene expression in intestinal epithelial cells is not due to 
changes in chromatin structure, as these are set during the differentiation process from 
intestinal stem cells (Camp et al., 2014). 
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1.7.4. Deletion of a SMARCAD1-related factor leads to intestinal pathology. 
Of the factors associated with SMARCAD1, deletion of murine histone deacetylase 2 
(Hdac2) has also been shown to cause intestinal defects. HDAC2 -/- mice are around 25% 
smaller than littermates, with macroscopically smaller intestines (i.e. reduced thickness 
and length) and microscopic reductions in mucosal thickness in the small intestine and 
the colon (Figure 1.31). Furthermore, these mice showed a lower rate of tumour 
formation in the colon when crossed with APCmin (adenomatour polyposis coli) tumour-
prone mice (Zimmermann et al., 2007). To what extent deletion of mammalian 
SMARCAD1 recapitulates this phenotype, and to what extent loss of SMARCAD1 directly 
impacts the normal function of HDAC2 is yet to be reported. 
 
 
 
 
 
 
Figure 1.31. Intestinal pathology visible in Hdac-/- mice. Hematoxylin and Eosin stained 
small intestinal (left hand frames) and colonic (right hand frames) show visible 
differences in villi length and organization between Hdac2 +/- (top) and Hdac2-/- (bottom) 
mice.  From Zimmerman et al 2007. 
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1.7.5. Intestinal pathology is promoted by increased expression of an 
innate immune receptor Toll-Like Receptor 4 (TLR-4). 
While the loss of expression of Smarcad1 related factors drives intestinal pathology, the 
over-expression of innate immune receptor TLR-4 is linked to onset of Inflammatory 
Bowel Disease in humans (Dheer et al., 2016), and hence expression is tightly regulated 
in the mammalian small intestine.  The conserved pattern recognition receptor TLR-4 
binds to bacterially derived lipopolysaccharide (LPS) and initiates immune responses in 
the host. Expression is epigenetically down-regulated in the small intestine during 
normal intestinal homeostasis (Figure 1.32) (Kyoko Takahashi, Sugi, Hosono, & 
Kaminogawa, 2009), and in a recent study, targeted overexpression of Tlr-4 in the small 
intestine of mice drove pathological changes and a change in the microbial composition, 
including impaired epithelial barrier function and exacerbated dextran-sodium sulfate 
induced colitis (Dheer et al., 2016). Tlr-4 expression in mice lacking SMARCAD1 is 
therefore of major interest in the context of small intestinal immunity. 
 
 
 
Figure 1.32. Schematic of the mammalian intestine and Toll-like receptor 4 expression. 
The innate immune receptor TLR-4 is epigenetically regulated in the small intestine, and 
expression is lowest in the villi of the duodenum where DNA methylation of the Tlr-4 gene 
is highest. From Takahashi et al (2009). 
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1.7.6. SMARCAD1 intestinal expression is conserved and is required for 
intestinal immunity. 
The pattern of SMARCAD1 tissue expression profiles is reported in numerous online 
protein-expression databases. Interestingly, specific SMARCAD1 expression in the 
intestine is evident in the human protein atlas (see http://www.proteinatlas.org/ 
ENSG00000163104), where anti-SMARCAD1 staining is visible in the nucleus of 
intestinal glandular cells (Figure 1.33). Furthermore, a role for SMARCAD1 in intestinal 
immunity is suggested by studies in the fruit fly Drosophila, where intestine-specific 
knockdown of the SMARCAD1 homologue (CG5899) impaired the ability to fight a 
specific bacterial infection and led to premature death (Cronin et al., 2009). Exactly 
which cells in the intestine require SMARCAD1 expression, and how this influences 
intestinal immunity remained to be reported at this point. 
 
 
 
 
Figure 1.33. (a) Expression of SMARCAD1 in the nucleus of human small intestine 
glandular cells (taken from the human protein atlas, see link in Section 1.7.6)  (b) Removal 
of SMARCAD1 homologue (CG5899) using siRNA leads to decreased survival by day 5 in a 
drosophila model of intestinal immunity. From Cronin et al 2009. 
 
 
 
(a) (b) 
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1.8  Intestinal immunity and intraepithelial lymphocytes (IELs). 
1.8.1. Immunobiology of intestinal intraepithelial lymphocytes (iIELs). 
Cells of the adaptive immune system migrate into and are resident in the intestine. T-
cells are found predominantly in two locations - in the epithelium (i.e. intraepithelial 
lymphocytes or iIELs) and in the lamina propria (the connective tissue beneath the 
epithelium, also known as LP T-cells) (Figure 1.34). In humans and mice, intraepithelial 
lymphocytes represent one of the largest populations of lymphocytes, and around 10-
15% of the intestinal epithelium is thought to be made up of iIELs (Janeway, 2001). 
Furthermore, these T-cells differ from systemic T-lymphocytes (i.e. splenic/ circulatory 
or lymph node T-lymphocytes) in the composition of co-stimulatory receptors 
expressed. In systemic T-cells, either CD4 or the dimeric CD8αβ co-receptors are 
expressed, and co-stimulate T-cell receptor (TCR) binding to class II major 
histocompatibility (MHC) molecules (for CD4) or class I MHC (CD8 αβ) on infected host 
cells respectively. However, the majority of iIEL T-cells express a CD8αα homodimer co-
receptor, which is thought to sterically interfere with co-stimulation and thereby confer 
a regulatory or tolerant phenotype (Cheroutre, Lambolez, & Mucida, 2011) (Figure 
1.35). It is also estimated that up to 65% of CD8+ T-cells in the intestine express a γδ-T-
cell receptor, which does not require antigenic peptide to be presented in host MHC 
molecules to initiate responses (Hayday, Theodoridis, Ramsburg, & Shires, 2001). 
 
1.8.2. Function of iIELs. 
While the function of these cells is the focus of much debate, iIELs are generally 
considered important for the conservation of epithelial integrity and prevention of 
microbial entry through the intestine. In addition to the expression of cytolytic factors 
(such as granzyme and perforin) and effector cytokines (such as interferon-γ (IFNγ), 
interleukin-2 (IL-2), interleukin-4 (IL-4) and interleukin-17 (IL-17)), these cells can also 
secrete keratinocyte growth factor (KGF), aiding the restoration of membrane integrity 
after physical or inflammatory damage (Boismenu & Havran, 1994). Indeed, mice 
lacking γδ-T-cells or deficient in KGF production demonstrate elevated intestinal tissue 
damage and are more susceptible to dextran sodium sulfate (DSS) induced colitis 
(Ferreira & Veldhoen, 2012). 
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Figure 1.34. Location of intraepithelial lymphocytes in the murine small intestine (above) 
(yellow) which are typically γδ T-cells or CD8αα αβ T-cells which are essential for 
maintenance of gut homeostasis, and can be resolved by FACS.  From  
http://www.prn.org/index.php/progression/article/hiv_1_gastrointestinal_galt_267 
 
 
Figure 1.35. T-cell responses are normally mediated via antigenic peptide (Ag) presented 
in class I MHC molecules on infected cells (top) binding to the T-cell receptor, with co-
stimulation from dimeric CD8αβ. Expression of the co-receptor CD8αα inhibits T-cell 
receptor/class I MHC binding and hence T-cell activation From Cheroutre et al., 2011. 
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While anti-bacterial responses of γδ IELs are initiated via signals from the epithelial cells 
(i.e. cell-extrinsic innate immune signals), the presence of γδ T-cells in undamaged 
intestinal tissue also suggests a homeostatic or regulatory role. Furthermore, the 
presence of species-specific microbiota in the gut has been shown as a requirement for 
the development and/or survival of intraepithelial lymphocytes, suggesting a symbiotic 
relationship between host immune cells and gut microbiota (H. Chung et al., 2012; 
Ferreira & Veldhoen, 2012). As the expression of the Aryl Hydrocarbon Receptor (AhR) 
– a cytosolic transcription factor activated by toxins (such as dioxins) and dietary 
breakdown products (such as 6-formylindolo[3,2-b]carbazole (FICZ) from cruciferous 
vegetables) - has also been shown as essential for maintenance of iIEL numbers in the 
gut (Y. Li et al., 2011), a more complex role beyond anti-microbial immunity for 
intestinal IELs clearly exists. 
1.8.3. IELs in pathology. 
Elevated numbers of iIELS are also associated with gut-related pathologies. In irritable 
bowel disease (IBD), the numbers of T-cells in the intestinal mucosa has been shown to 
directly correlate to the severity of the disease. Such findings are backed-up by mouse 
models in which T-cells have been shown to promote disease pathology in spontaneous 
colitis and other models of IBD (Hayday, A. Findly, R.C. Plehn-Dujowich, D. Viney, J.L. 
Owen, M.J. Roberts, 1994). The autoimmune disease Coeliac disease - in which aberrant 
responses to gluten-derived antigens (such as gliadin) lead to damage of the small 
intestine and reduced nutrient absorption – is characterized by elevated levels of γδT-
cells alongside infiltration of CD8αβ-αβT-cells, leading to villus atrophy. In this context, 
it is not clear whether the elevated levels of γδT-cell IELs may be a response to suppress 
infiltration, as peak levels of these cells have been reported to inversely correlate with 
pathology (Hayday, A. Findly, R.C. Plehn-Dujowich, D. Viney, J.L. Owen, M.J. Roberts, 
1994). 
1.8.4. Enumeration of iIELs. 
A number of studies enumerate intraepithelial lymphocytes in the small intestine of 
mice (Montufar-Solis & Klein, 2006). The ability of iIELs to degranulate quickly and 
without numerous co-stimuli also confers physical fragility, and so the careful manual 
handling required during extraction can confound accurate replication of cell counts. 
However, estimates as high as 2x107 iIELs present in the small intestine of 6-8 week old 
female C57BL/6 mice have been made, although these counts were based on subjective 
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counting of leukocyte common antigen (CD45)+ cells during fluorescence and light 
microscopy (Montufar-Solis & Klein, 2006). Another study using multiple T-cell 
associated cell markers to facilitate cell counting by flow cytometry suggested that up to 
1.1x107 small intestinal IELs are present in female C57BL/6 mice from 3 months of age, 
with this number declining to 0.9x107 at 12 months and 0.8x107 by 24 months of age 
(Suzuki, 2012). However, this study did not discriminate based on intestinal specific 
markers such as the αE integrin CD103, hence the authenticity of these cells as iIELs is 
unclear.  
One particular challenge in studies of iIELs is the degree of variability of iIEL numbers 
between mice. With the use of focused cell-surface markers, one study recently reported 
a numerical spread between 5x105 and 4x106 IELs per mouse (=mean of 2.25x106 +/- 
77%) (Figure 1.36) (X. Wang, Sumida, & Cyster, 2014). In this study, mice lacking the N-
arachidonyl glycine receptor GPR18 showed a change in the proportion of CD8αα and 
CD8αβ iIELs present in the small intestine compared to Gpr18+/- mice, despite there 
being no significant difference in the overall number of iIELs. 
1.8.5. Exogenous factors impact γδ T-cells numbers. 
Other factors which impact on iIEL enumeration include the level of hygiene in animal 
facilities (e.g. germ-free mice show markedly reduced numbers of iIELs  (H. Chung et al., 
2012) which can lead to inter-facility variation in iIEL numbers (M Veldhoen, per 
comm.). The impact of diet must also be taken into account, as the importance of 
cruciform vegetables in mammalian intestinal immune development was recently 
reported (Y. Li et al., 2011). Furthermore, a number of studies suggest that mice fed with 
a high-fat diet show a drop in the number of iIELs with accompanying changes in 
intestinal anatomy (Soares, Beraldi, Ferreira, Bazotte, & Buttow, 2015).  With the central 
role of iIELs in intestinal disease pathologies, understanding and controlling for such 
exogenous influences is of clear importance. 
 
1.8.6. γδ T-cells are found in the spleen and altered ratios are linked to 
immune pathology. 
While a large proportion of T-cells resident in the gut are γδ T-cells (~65%), the 
proportion of these cells in the circulation (or systemic immunity) is thought to be 
considerably lower - in the order of 5% of the total number of circulating T-cells 
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(Hayday et al., 2001). Investigation of γδ T-cell numbers in the spleen has been 
previously reported for indications of T-cell linked pathology. Following plasmodium 
infection, one study reported an increase up to four-fold in the proportion of splenic γδ 
T-cells over other splenocytes (van der Heyde, Batchelder, Sandor, & Weidanz, 2006). In 
addition, splenic T-cell proportions have also been used in the study of cellular 
responses to toxicological stimuli (Shieh, Varkey, Chen, Chang, & Huang, 2014) and 
changes in the splenic T-cell compartment have been reported after influenza infection 
(Hauge, Madhun, Cox, Brokstad, & Haaheim, 2007). These studies indicate that the 
proportion of specific T-cell populations within the spleen can provide a marker for 
immune-related pathology. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.36. Natural variation in the number of iIEL T-cell numbers in the small intestine. 
In this study, there was no significant difference in the total number of iIELs between 
controls (heterozygous for the N-arachidonyl glycine receptor GPR18) and GPR18-/- mice. 
However, mouse-to-mouse variation in iIEL numbers is apparent (5x10^5 to 2x10^6 per 
mouse in the control Gpr18+/- mouse above), reflecting the need to use large numbers of 
mice to reach statistical significance in studies of iIELs. From X Wang et al., 2014. 
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1.9  Background to this project. 
 
1.9.1. Construction of a ATPase (-) SMARCAD1 knockout mouse. 
Identification of a short isoform of Smarcad1 with an alternative transcriptional start 
site prompted the need for a new knockout model in which this isoform (which contains 
ATPase and helicase domains) was absent. For this reason a new murine knockout of 
Smarcad1 was constructed using a Cre/lox recombination based approach (work done 
by J Ross Miller, Varga-Weisz group). In brief, a plasmid cassette containing DNA from 
the Smarcad1 genomic region spanning exons 12 to 14 was created containing loxP sites 
flanking these exons, along with a selectable marker (Neomycin Resistance) (SEE 
Appendix 1 for schematic positioning of these features). This plasmid was then 
electroporated into murine embryonic stem cell (ES cell) lines, and incorporated into 
genomic DNA via homologous recombination. ES cell lines positive for a loxP-flanked 
(‘floxed’) Smarcad1 (exons 12-14) after G418 (NeoR) selection were injected into mouse 
blastocysts. Floxed SMARCAD1 mice were then mated with Cre recombinase+ mice to 
produce offspring containing Smarcad1 deleted (exon 12-14 delete) alleles. 
Confirmation of the floxed/deleted alleles was performed by quantitative PCR (qPCR) of 
Smarcad1 mRNA, and absence of full length SMARCAD1 peptide was confirmed by 
western blotting. The mating of floxed mice with mice expressing tissue-specific Cre-
recombinase was also used to allow the selective deletion of SMARCAD1 either globally 
(using germline specific Zona-Pellucida-3 (ZP3)-Cre) or specifically in lymphocytes 
(using CD2-Cre). 
 
1.9.2. Homozygous knockout of Smarcad1 affects viability of offspring. 
Initial genotyping of offspring from male and female mice heterozygous for Smarcad1 
revealed a bias against homozygous knockout mice in both sexes (Table 1). 
Furthermore, offspring from homozygous knockout female mice mated with 
heterozygous males revealed a reuction in the number of viable female offspring 
produced, with many Smarcad1-/- female mice dying perinatally. While a potential link 
to aberrant X-chromosome inactivation in these mice (i.e. due to a loss of SMARCAD1-
driven heterochromatin formation) is possible, this is beyond the scope of this project 
(see General Discussion, section 6.1.1). 
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Offspring from Male heterozygous +/- and female heterozygous +/- 
Ratio +/+ +/- -/- +/+ +/- -/- 
Expected % 25 50 25 25 50 25 
Obtained % 35 58 7 35.5 50.8 8.5 
Total Male offspring n=59 Female offspring n=59 
       Offspring from Male heterozygous +/- and female homozygous +/- 
Ratio +/+ +/- -/- +/+ +/- -/- 
Expected % 0 50 50 0 50 50 
Obtained % 5.4 58.9 35.7 7.3 80.9 4.8 
Total Male offspring n=73 Female offspring n=41 
 
Table 1.7. Initial analysis of offspring genotyped at 5 weeks old from Smarcad1 +/- and -/- 
mice reveals a bias against homozygous -/- offspring in both sexes from +/- x +/- mice, and 
a bias against female offspring from male +/- x  female -/-mice. Data courtesy of Dr 
Jacqueline Mermoud. 
 
 
 
 
1.9.3. Homozygous Smarcad1 -/- mice appear smaller than +/+ or +/-  mice. 
Homozygous knockout offspring were initially observed to be leaner and smaller than 
+/- or +/+ Smarcad1 mice, and weights recorded (at time of sacrifice) from male mice 
confirm a difference between Smarcad1-/- and +/+ or +/- mice (Figure 1.37), and 
further study will confirm the extent and timing of this difference during postnatal 
growth. 
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Given the original observation that Smarcad1 -/- mice weigh less than +/+ counterparts, 
it was important to determine the extent of this difference and at what stage of 
development these occur, e.g. are there differences in birth weight. Given the role of 
SMARCAD1 in the formation and maintenance of repressed chromatin, it seemed 
plausible that SMARCAD1 may impact the formation or maintenance of the repression of 
one allele as seen in imprinted genes, and furthermore given the metabolic impact of 
these genes, whether expression of these genes is affected in the absence of functional 
SMARCAD1. A closer examination of the metabolic physiology of SMARCAD1 mice, e.g. 
birth weights, onset of leanness or obesity, serum levels of key metabolic markers (such 
as insulin, glucose, free fatty acids) may implicate imprinted gene dysfunction during 
development.  
The original Smarcad1/Etl1 knockout mouse demonstrated low birth weight and growth 
retardation/leanness and neonatal mortality, which are phenotypic characteristics of 
the Dlk1/Pref1 loss of imprinting (i.e. inappropriate increase in gene dosage) mouse 
model. The initial data from the new knockout of Smarcad1 detailed in this thesis also 
revealed a reduction in body weight associated with smaller epididymal fat pads. As 
previous mouse models of Dlk1/Pref1 overexpression in white adipose tissue have 
previously shown the requirement for Dlk1 repression in adipogenesis (Lee et al., 2003), 
aberrant Dlk1 expression would be a candidate for these aspects of the Smarcad1 
knockout mouse phenotype. 
 
1.9.4. Adaptive immunity in Smarcad1 -/- and CD2-Cre fl/fl mice. 
Previous work investigating systemic adaptive immunity in mice with globally deleted 
(Smarcad1-/-) or lymphocyte-specifically deleted (CD2-Crefl/fl) mice revealed no 
significant difference in either B- or T-cell arms (Figure 1.39) in spite of clear 
SMARCAD1 expression in both the thymus and spleen (Figure 1.38), suggesting there is 
no direct effect of SMARCAD1 loss on adaptive immune development (work done by Dr 
Louise Matheson). However, recent investigation of iIEL T-lymphocytes suggested these 
cells may be lost as a result of SMARCAD1 deletion (work done by the group of Dr Marc 
Veldhoen, Figure 1.40), and so this will be the subject of further investigation. 
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Figure 1.37. Smarcad1-/- mice weigh less than +/+ (fl/fl) and +/- (fl/-) mice at time of 
death. (a) Physical appearance of epididymal fat pads from Smarcad1 +/+ and -/- mice. (b) 
Weights of male mice shown above were obtained at time of sacrifice, and trendlines 
indicate the difference between the two groups. Graph courtesy of Dr Patrick Varga-Weisz. 
(a) 
(b) 
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Figure 1.38. SMARCAD1 is expressed in major tissue and cells of the adaptive immune 
system, such as spleen and thymus. Western blotting of murine samples extracted from 
spleen and thymus reveal the expression of SMARCAD1 (band ~150kDa) in +/- animals 
and absence from -/- mice. Courtesy of Dr Louise Matheson. 
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Figure 1.39. No major proportional loss (>20%) of systemic B-cells or T-cells is found in 
the spleen of Smarcad1 knockout mice. Cells were stained with CD2 (all lymphocytes) and 
CD3 (T-cells only), CD4 (helper T-cells) and CD8 (cytotoxic T-cells), or IgM (B-cells) and 
B220 (common leukocyte antigen). Representative FACS plots illustrating the presence of 
CD2+/CD3+ T-lymphocytes (top), CD4+ or CD8+ T-lymphocytes (middle) and IgM+B220+ 
B-lymphocytes from WT, CD2-Cre Fl/Fl conditional knockout and ZP3-germline knockout 
mice. Courtesy of Dr Louise Matheson. 
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IgM 
B220 
WT -/- F/F-cre 
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Figure 1.40. Loss of  T-cells (both αβ and γδ T-cells) is visible in the small intestine of 
Smarcad1-/- mice (top row) compared to the small intestine of Smarcad1+/+ mice (bottom 
row). Loss is clear both in terms of % of T-cells in each plot and the total number events 
enumerated from equal intestinal starting material. Data courtesy of Marc Veldhoen. 
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1.10 Aims and objectives of this thesis: 
 
 
This thesis aims to :- 
 
 Describe the basic physical characteristics of mice lacking Smarcad1, including 
parameters such as mass and weight. The major tissues in which SMARCAD1 is 
expressed should also be elucidated and particular cells or tissues of interest 
identified to guide further studies. 
 
 Confirm the loss of intestinal Intraepithelial lymphocytes previously observed, 
and give insight as to what difference in the murine intestine exist which 
underpin this loss. 
 
 Detail the extent of the impact of SMARCAD1 loss on white adipose tissue. 
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2.1  Experimental Animals. 
All experiments were carried out in accordance with UK Home Office regulations. 
Animal breeding and husbandry was carried out by the Babraham Services Unit (BSU). 
Physical measurements (i.e. weekly weight measurements), extraction of blood and ear 
punches for genotyping were also performed by the BSU. Genotyping PCR, extraction of 
serum, additional weight (time of death) and length measurements, dissection of all 
tissue and organs and subsequent laboratory procedures were performed by Keith 
Porter. Selection of suitable animals for breeding was undertaken by Keith Porter and 
Patrick Varga-Weisz. All relevant procedures were covered under procedure project 
licence PPL 80/2488. 
 
2.2 Genotyping of Smarcad1+/+ +/- -/- and wild-type (WT) mice. 
DNA was extracted from murine ear punches by boiling in 50mM NaOH  (95°C) for 90 
minutes, vortexing on full speed for 15seconds and quenching in 25μl Tris (pH7,4) 
before centrifugation at 12000g for 15 minutes at 4°C. 2μl of supernatant was 
subsequently used as template in genotyping PCR reactions.  
Identification of Smarcad1 wild-type/floxed or deleted alleles was performed by PCR 
using primer pairs diagnostic for each allele (see Table 2.1) For Neo-cassette containing 
(i.e. floxed) or deleted alleles, primer pairs NeoF/NeoR (Floxed)  and Del-for/Del-rev 
(del) were used in a single PCR-reaction to amplify genomic DNA yielding 288bp or 
623bp products respectively. To identify thepresence of the wild-type allele of 
Smarcad1, primers WT/Flox-for and WT/Flox-rev were used to amplify a product of 
308bp, and combined in a single reaction with primers to identify Cre-recombinase 
alleles using primers Cre-For and Cre-Rev (CD2-Cre) to produce a 522bp product, or 
ZP3-for and ZP3-rev to produce a 656bp product. 
For each PCR reaction, 1x KOD Reaction Buffer and 1U of KOD Polymerase (Merck 
71086), was mixed with 3xSucrose/Cresol Red Loading Buffer (28% w/v Sucrose, 
0.008% Cresol Red in sterile water) and 0.3M Betaine was mixed in a final volume of 
20μl with primer concentrations as stated (see Table 2.1). Reactions were then thermal 
cycled as follows 95°C for 2min then 36 cycles of 95°C for 15s, 58°C for 30s, 72°C for 
2min, and a final extension of 72°C 2min. 10μl of each product was resolved on 2% 
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agarose/EtBr gel 120V 60min alongside 5μl MassRuler marker (ThermoFisherScientific 
SM0403). 
 
 
 
Table 2.1. Primer sequences, discrimination and concentrations required for genotyping 
of Smarcad1+/+, +/- and -/- mice with or without CD2- or ZP3-Cre. 
 
 
 
 
 
 
 
 
 
 
 
Target Primer Concentraton Sequence Product Size
Deleted allele Del-For 20μM TGTGATGCCATTTTTGTTATTTG 623bp
Del-Rev 20μM TTCCAAAATAGACCCTGACAGAA
Floxed Allele Neo-For 10μM GGCTATTCGGCTATGACTGG 288bp
Neo-Rev 10μM ATACTTTCTCGGCAGGAGCA
WT allele WT For 30μM  CTCTTCCCCCTGAATCCTTC 308bp
WT  Rev 30μM TGTGATGCCATTTTTGTTATTTG
CD2-Cre Cre-For 10μM GACAGGCAGGCCTTCTCTGAA 522bp
Cre-Rev 10μM CTTCTCCACACCAGCTGTGGA
ZP3-Cre ZP3-For 10μM GGTGTCATGGTAGGTATGGGT 656bp
ZP3-Rev 10μM CGCACAATCTCACGTTCAG
Discrimination
Floxed/Deleted alleles
WT allele and Cre Presence
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2.3 Physical dimensions and serum measurements of Smarcad1 
+/+ and -/- mice. 
 
2.3.1. Physical measurements of Smarcad1+/+ and -/- mice. 
For construction of growth curves, mice were weighed every 7 days from 14 days post-
partum up until day 102. Neonatal weights and lengths were recorded within 24 hours 
of birth. All length measurements were made by straightening freshly euthanized mice 
and the anal-nasal (A-N) length recorded.  
2.3.2. Serum analyses. 
Serum used for biochemical analysis was extracted from the tail immediately after 
sacrifice, dispensed immediately into anti-coagulant (EDTA) collection tubes and 
centrifuged at 1000g for 20 minutes at 4°C. The top clear layer was then aliquoted to a 
fresh tube and snap frozen. All serum analysis was performed by the Core Biochemistry 
Assay Laboratory at Addenbrookes Hospital, Cambridge. 
2.3.3. Measurement of fat pad mass. 
Subcutaneous inguinal and visceral epididymal fat pads were excised from surrounding 
tissue by examination of tissue colour contrast to mark fat-pad anatomical boundaries. 
Symmetry of pads from the left and right depots was visually checked at time of 
weighing to confirm accurate dissection.  
2.3.4. Tissue Panel western blotting for SMARCAD1.  
Western blotting of adult murine tissues for SMARCAD1 expression was performed on 
tissue snap-frozen in liquid nitrogen at time of sacrifice. Organs were dissected and 
snap-frozen in a time-critical order as follows: Brain, Small Intestine, Caecum, Large 
Intestine, Pancreas, Liver, Kidney, Stomach, Thymus Heart, Lungs, White adipose tissue, 
Testes, Brown adipose tissue, Muscle, Skin, and Bone. Organs were mechanically 
dissociated with a mortar and pestle on dry ice before transfer to RIPA lysis buffer (150 
mM sodium chloride, 1.0% Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS , 50 mM 
Tris, pH 8.0) and immediate addition of an equal volume of 2x Laemmli Buffer/5% βME, 
with repeated aspiration before boiling for 10 minutes at 95°C prior to loading.  
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Samples were resolved on a 16% polyacrylamide gel for 20 minutes at 70V then 60 
minutes at 130V. Transfer of samples to nitrocellulose membranes (Hybond-ECL, 
Amersham) was performed in Tris/Glycine/Methanol Buffer (150mM Tris, 770mM 
Glycine, 20% Methanol) at 15V for 50 minutes. Membranes were briefly washed in 
milliQ water before blocking in PBS/0.1% Tween20/5% milk for 1 hour at room 
temperature, and then incubating with primary antibody for 1 hour at room 
temperature (see Table 2.2). Membranes were then washed as follows: 3 washes for 1 
minute each in PBS/0.1% Tween20, then 2x 15 minute washes in PBS/0.1% Tween, 
before incubation with secondary antibody for 1 hour at room temperature. Wash steps 
were then repeated before detection using enhanced luminescent detection (ECL) 
(Amersham RPN2106/2109) of horse-radish peroxidase-linked secondary antibody and 
blue light radiography sensitive film (Amersham RPN2134). 
Equal loading of samples was determined empirically by iterative PAGE/western blot. 
Comparative analysis of peptide expression levels was performed using GelQuantNet 
densitometry software (see Appendix 1). In brief, band signals were obtained from 
scanned radiograph film images and quantified based on size/area and colour intensity, 
before local background signal subtraction. Each band of interest was then expressed as 
fold expression over the loading control (Lamin B1) for respective samples. 
 
 
 
 
 
Table 2.2. Antibodies used for tissue panel screening of SMARCAD1 expression. 
 
 
  
Antibody Company Dilution Secondary antibody Dilution
SMARCAD1 Sigma HPA016737 1:5000 anti-Rabbit-HRP 1:5000
Lamin B1 AbCam ab16048 1:5000 anti-Rabbit-HRP 1:5000
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2.4 Intestinal lymphocyte extraction and analysis by flow 
cytometry. 
  
2.4.1. Intestinal extraction and purification of intraepithelial lymphocytes. 
Intestines were dissected between stomach and cecum, flushed once with 20ml of cold 
PBS, cut longitudinally into 10mm fragments, then incubated in 20ml IEL buffer (Mg+ 
free PBS/5%FCS/10mM HEPES/PolymixinB)  in 50ml tubes place horizontally in a 
Infors HT Multitron Standard Shaker for 30 minutes at 37C, 100rpm. Supernatant was 
passed through a 100m cell strainer and centrifuged at 500g for 8 minutes at 4C. 
Pellets were re-suspended in 9ml 37.5% isotonic Percoll/5% FCS and centrifuged at 
700g for 10 minutes at room temperature, before washing in 5ml cold PBS/5% FCS and 
further centrifugation at 700g for 10 minutes at 4C. Cells were then re-suspended in 
1ml PBS/5% FCS, and 10% of the volume (100l) removed and stained for FACS.  
Spleens harvested from mice were mechanically disrupted and passed through a 40m 
cell strainer into a 50 ml tube containing 3ml cold PBS, with 2x 1ml cold PBS washes of 
the cell strainer to remove residual tissue (into a final volume of 5ml cold PBS). Cells 
were pelleted at 500g for 5 minutes at 4C, the supernatant removed, and re-suspended 
in 1ml cold PBS. 5% of the cell suspension was removed (50l) and stained for flow 
cytometry. 
 
2.4.2. Cell Staining for flow cytometry. 
Cells collected as described were pelleted and incubated for 1 hour on ice (in the dark) 
in a total volume of 100l PBS containing the following (final) concentrations of directly-
conjugated antibodies: 2.5ng/μl anti-CD3-FITC (Biolegend 100204), 0.33ng/μl anti-
CD8β-PerCP-Cy5.5 (Biolegend 126610),  0.5 ng/μl anti-CD103-AF647 (Biolegend 
121410),  2.5ng/μl anti-CD4-AF700 (Biolegend 100430), 2.5ng/μl anti-TCRβ-Pacific 
Blue (Biolegend 109226), 2.5ng/μl anti-CD8α -V500 (Biolegend 560776), 0.25ng/μl 
anti-TCRγδ-PE  (Biolegend 118108), and a live/dead amine-reactive cell viability dye 
was added to a final dilution of 1:10000 (Live/Dead near-IR fixable stain mix, Life 
Technologies L10119). 
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Cells were then washed twice by centrifugation 500g 5 min 4°C, tipping off supernatant 
and re-suspending in 200μl PBS/0.5% FCS. After the second centrifugation, cells were 
re-suspended in 240μl PBS/0.5%FCS (IEL prep) or 400μl PBS/0.5%FCS (spleen) and 
passed through a 40μm cell strainer prior to flow cytometric analysis using a Becton 
Dickinson LSR-Fortessa flow cytometer. 
 
 
2.5 Extraction of RNA from murine small intestine and qPCR. 
 
2.5.1. Dissection and preparation of murine duodenum. 
The first 4cm of small intestine adjacent to the stomach was removed from each mouse 
to provide duodenal samples. Each duodenum was flushed with ice cold PBS/5% FCS 
and snap-frozen in liquid nitrogen. Prior to RNA extraction and purification, each sample 
was weighed and 100mg of tissue was mechanically dissociated in 1ml Tri-reagent 
(Sigma) using a mortar and pestle on dry-ice. 
2.5.2. RNA Extraction. 
Total cellular RNA was extracted using Tri-reagent (Sigma) following the manufacturer’s 
instructions. In brief, homogenized material was centrifuged (12000g, 10 minutes, 4°C) 
and the top layer containing residual fat removed. Chloroform was then added (0.2ml 
per ml starting volume) and after vigorous mixing and standing at room temperature, 
phases were separated after centrifugation (12000g 15 minutes, 4°C). The colourless 
upper phase containing RNA was then removed into a fresh tube, and nucleic acid 
precipitated with 0.5ml isopropanol, then washed with 1ml 75% ethanol. RNA was 
pelleted at 7500g 5 minutes 4°C and resuspended in 100μl nuclease free H2O. RNA 
purity and concentration was determined using a NanoDrop 1000 Spectrophotometer 
(Thermo Scientific). 
2.5.3. Generation of cDNA using Reverse Transcriptase. 
Extracted RNA was then used to generate cDNA using the RevertAid Kit 
(ThermoFisherScientific EP0441) following the manufacturer’s instructions. In brief, 
500ng of total RNA was mixed with Oligo (dT) (100pmol) in a final volume of 12.5μl and 
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incubated at 65°C for 5 minutes before cooling on ice. This was then mixed with 20 units 
of Thermo Scientific™RiboLock RNase Inhibitor, 1mM dNTP mix, 200units of reverse 
transcriptase and 1x (final) reaction buffer in a final volume of 20μl, and incubated for 
60 minutes at 42°C before reaction termination at 70°C for 10 minutes. 
2.5.4. Quantitative PCR (qPCR) of transcript levels. 
Template cDNA samples prepared as above were diluted 1 in 2, then run in triplicate on 
an BioRad CFX96 qPCR station, in a total reaction volume of 25μl containing 1x SyBr 
Green mastermix (Applied Biosystems 4309155), 5μM of each primer and 5.5μl of each 
diluted template cDNA. Samples were cycled under the following conditions: 95°C for 15 
seconds, 60°C for 30 seconds for 45 cycles, then melt curve analysis performed by 
incremental temperature increases (ΔT) at +1°C/s from 55°C to 95°C. Threshold 
fluorescence was detected using default settings. Primers used for qPCR analysis can 
been found in Table 2.3 
 
 
 
Table 2.3. Primers used for qPCR analysis 
 
Gene Forward Primer 5' - 3' Reverse Primer 5' - 3'
Smarcad1 TCAGACATTGAAGGAACTGTTTC CATCAGCAAGGCAGCAG
HPGDS CACGCTGGATGACTTCATGT AATTCATTGAACATCCGCTCTT
TLR4 AAGCCGAAAGGTGATTGTTG CTGAGCAGGGTCTTCTCCAC
TNFα ACAGAAAGCATGATCGGCG GCCCCCCATCTTTTGGG
IFNγ AGCTCTTCCTCATGGCTGTT TTTGCCAGTTCCTCCAGATA
Myc  GCTCGCCCAAATCCTGTACCT TCTCCACAGACACCACATCAATTTC
Notch1 GATGGCCTCAATGGGTACAAG TCGTTGTTGTTGATGTCACAGT
Notch2  ATGTGGACGAGTGTCTGTTGC GGAAGCATAGGCACAGTCATC
Lgr5  TGCCCCGTGGCTTTCTTATC TTTCCCAGGCTGCCCATATC
Dlk1 CCCAGGTGAGCTTCGAGTG GGAGAGGGGTACTCTTGTTGAG
Gtl2  TTGCACATTTCCTGTGGGAC AAGCACCATGAGCCACTAGG
Actin GCCCTGAGGCTCTTTTCCAG TGCCACAGGATTCCATACCC
TBP AAGGGAGAATCATGGACCAG CCGTAAGGCATCATTGGACT
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2.6 Analysis of cell proliferation in the murine intestine by EdU 
incorporation. 
2.6.1. Administration of EdU and processing of murine intestine for cryo-
sectioning. 
Mice were administered 200μl of 0.75mg/ml EdU (in DPBS) via intra-peritoneal 
injection 18 hours prior to sacrifice following regulated procedures.  After euthanizing, 
small and large intestines were dissected, flushed in ice cold PBS/5%FCS, and fixed for 
24 hours in 4% formaldehyde at 4°C. Intestinal samples were then incubated in 30% 
w/v sucrose for 24 hours at 4°C and snap frozen in Shandon embedding matrix (Thermo 
Scientific) on dry ice.  Individual 8μm sections were cut using a Leica CM1950 cryostat at 
-18C° then adhered to frosted microscope slides on dry ice before storing at –80°C. 
2.6.2. Click-iT EdU fluorescence detection. 
Immunofluorescence detection of incorporated EdU was performed using the Click-iT® 
EdU Alexa Fluor® 594 Imaging Kit (Thermo Scientific) as per manufacturer’s 
instructions. Slide-mounted intestinal sections (described above) were heated at 65°C 
for 5 minutes, washed twice in PBS/3% BSA and permeabilised in 0.5% Tween20/PBS 
at room temperature for 20 minutes. After two further washes in PBS/3% BSA, slides 
were air dried and a hydrophobic barrier applied around the area of interest using an 
ImmEdge™ hydrophobic barrier pen (Vector Labs H-4000).  Covalent binding of 
fluorescent dye (Alexa-594) to EdU was then performed using 50μl Click-iT® reaction 
cocktail (1xTBS buffer, 20mM CuSO4, 1:100 Alexa-594 dye and 1x proprietary EdU 
buffer additive) for 30 minutes in the dark at room temperature. Slides were washed 
twice in PBS/3% BSA and stained with 5μg/ml Hoechst solution for 30 mins at room 
temperature in the dark, before two final washes in PBS and then mounting each slide 
with Vectashield (Vector Labs H-1000) under a varnish-sealed coverslip. Stained and 
mounted slides were stored at 4°C in the dark prior to analysis. 
2.6.3. Enumeration of EdU+ve cells. 
Images of in-plane intestinal crypt/villus units were captured on an Olympus BX61 
microscope on a 20x objective, and fields where clear EdU/Alexa594 signal and nuclear 
Hoeschst staining could be unambiguously identified were used to score the number of 
EdU positive cells from the base of the crypt along the corresponding villus.  
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2.7 Immunofluorescent detection of goblet and paneth cells in 
the murine small intestine. 
2.7.1. Slide preparation.  
Murine small intestine was dissected, fixed and cut to 8μm cryosections as detailed in 
section 2.6.1.  Slides were initially dried at room temperature for 15 minutes before 
fixing in 4% formaldehyde at room temperature for 15 minutes, washing twice in 
PBS/3%BSA (5 minutes each) and air drying. A hydrophobic border was applied to each 
area of interest on individual slides using an ImmEdge pen, and each section was 
permeabilised with 0.5% Triton/PBS for 20 minutes at room temperature.  
2.7.2. Antibody/fluorophore binding, stringency washes and slide 
mounting. 
Slides were washed twice in PBS, then blocked for one hour with blocking buffer (1% 
Triton X-100, 2% BSA, 5% FBS in PBS). Slides were then probed overnight at 4°C using 
either 12µg/ml anti-Lysozyme rabbit-pAb (AbCam ab2408) in blocking buffer, or 
0.8µg/ml anti-Mucin rabbit-pAb (Santa Cruz Biotechnology H-300) in blocking buffer. 
The following day slides were washed 3 times in PBS (5 minutes each) then probed with 
anti-rabbit-Alex-488 secondary antibody for 1 hour at room temperature in the dark. 
Slides were then washed 3 times in PBS (5 minutes each) before mounting with 30μl 
Vectashield (with DAPI) under varnish-sealed 22 x 40mm coverslips. 
2.7.3. Intestinal Immunofluorescence Analysis. 
Small intestinal sections were visualised using an Olympus BX61 microscope and a 20x 
objective. For each section the presence/absence and crypt/villus location of anti-
Lysozyme signal was recorded for the correct presence/location of Paneth Cells, and 
anti-Mucin for correct presence/location of Goblet Cells. 
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2.8 Analysis of intestinal microbiota. 
2.8.1. Extraction of microbial DNA. 
DNA from homogenized tissues was extracted using QIAmp DNA Stool Kit (Qiagen 
51504) according to the manufacturer’s instructions. In brief, a maximum of 220mg of 
fresh stool sample was removed from the small intestine or colon and lysed at 95°C for 5 
minutes in 2ml Buffer ASL. After vortexing for 15 seconds, samples were then 
centrifuged at full speed for 1 minute. Supernatant was transferred to a fresh tube and 
one INhibitEx® tablet added per tube and vortexed immediately for 1 minute to 
dissolve. Samples were then centrifuged for 3 minutes at full speed and supernatant 
transferred to a fresh tube containing Proteinase K, before addition of 200μl of Buffer 
AL, vortexing for 15 seconds and incubation at 70°C for 10 minutes. After incubation, 
200 μl of 96-100% ethanol was added to each sample and samples then applied to 
QIAmp spin columns. After centrifugation at full speed for 1 minute, DNA bound to 
columns was then washed once in 500μl Buffer AW1 then once in Buffer AW2 and 
centrifuged again to dry the column. Samples were then eluted into fresh collection 
tubes from QIAmp columns by addition of 50μl AE Elution Buffer, incubation at room 
temperature for 1 minute and centrifugation at full speed for one minute. Concentration 
of extracted stool DNA was confirmed using a Nanodrop 1000 Spectrophotometer 
(Thermo Scientific). 
 
2.8.2. Thermal cycling and selective amplification of microbial DNA by PCR. 
Extracted stool DNA was then analysed by qPCR using a CFX96 Real-Time system 
(BioRad). Reactions were prepared in a final volume of 20μl containing 2μl DNA, 10μl 
SyBr Green Mastermix (Applied Biosystems ), 10mg/ml BSA and 10μM of each Primer 
(see Table 2.4  for primer pairs and target species). Each reaction was set up in triplicate 
and cycled under the following PCR conditions: 20 seconds at 95°C, then 40 cycles of 30 
seconds at 95°C and 30 seconds at the appropriate annealing temperature (see Table 
2.5):- 
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Target group Primer sequence (5’- 3’) Primer name 
All groups ACT CCT ACG GGA GGC AGC AG Eub338  
All groups ATT ACC GCG GCT GCT GG Eub518 
αProteobacteria TCT ACG RAT TTC ACC YCT AC Alf685 
βProteobacteria TCA CTG CTA CAC GYG Bet680 
Actinobacteria CGC GGC CTA TCA GCT TGT TG Actino235  
Firmicutes GCA GTA GGG AAT CTT CCG Lgc353  
Bacteroidetes GTA CTG AGA CAC GGA CCA Cfb319 
 
Table 2.4 – Primer sequences for intestinal microbiota analysis 
 
 
 
Target group Forward primer Reverse primer Annealing temp. 
All Bacteria Eub338  Eub518 53 
αProteobacteria Eub338  Alf685 60 
βProteobacteria Eub338  Bet680 60 
Actinobacteria Actino235 Eub518 60 
Firmicutes Lgc353  Eub518 60 
Bacteroidetes Cfb319  Eub518 65 
 
Table 2.5 – Annealing temperatures for intestinal microbiota PCR 
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2.9 Library construction and RNA seq of murine white adipose 
tissue. 
2.9.1. DNAse and Ribolock treatment of RNA. 
A total of 100g RNA (extracted as in step 2.5.2) was treated with 10 Units DNAseI 
(Fermentas EN0521), 400 Units of Ribolock RNAse inhibitor (Fermentas EO0381) and 
2mM DTT for 1 hour at 37C. These were then applied to poly(dA) magnetic beads for 
mRNA purification (see below).  
2.9.2. Purification of polyA+ mRNA. 
Isolation of mRNA was then performed on DNAse/Ribolock treated total RNA using 
Oligo-dT magnetic beads (Dynabeads mRNA purification Kit, Ambion 61006) as per the 
manufacturer’s instructions. In brief, 100μg total RNA was diluted into 150μl nuclease-
free water and heat-denatured at 65°C for 2 minutes before placing immediately on ice. 
A total of 300μl Dynabeads was pre-washed with Ambion Binding Buffer, and 
resuspended in a total volume of 150μl Binding Buffer, prior to mixing in a 1:1 ratio with 
denatured total RNA for 5 minutes at room temperature. Bead-bound polyA+ mRNA was 
separated from supernatant on a magnetic stand, washed twice with Ambion Wash 
Buffer B, before elution in 30μl 10mM Tris HCl pH 7.5 for 6 minutes at 65°C. 
2.9.3. Fragmentation of mRNA.  
Purified mRNA was fragmented to yield single stranded RNA with a size range from 100-
300 bases as per manufacturer’s instructions. 250ng of purified mRNA was mixed with 
2l (10x) fragmentation buffer in a sterile PCR tube and made up to 20l with sterile 
nuclease-free water, then incubated on a pre-heated thermal cycler at 94C for 5 
minutes before placing immediately on ice and addition of 2l (10x) RNA fragmentation 
stop buffer. Fragmented mRNA was then precipitated using 2l (0.1x vols) 3M sodium 
acetate pH 5.5, 1.2l (10mg/ml) linear acrylamide and 60l (3x vols) 100% ethanol at -
80C for 1 hour, pelleted by centrifugation at 14000rpm for 25 minutes at 4C, washed 
with 300l 70% ethanol and air dried for 10 minutes at room temperature, before re-
suspension in 14.5l nuclease free water. 1l was then removed for quantitation on the 
Nanodrop ND-1000 spectrophotometer. 
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2.9.4. First and Second Strand Synthesis. 
For first strand cDNA synthesis, 13.5l of fragmented mRNA from above was mixed with 
1.0l random primer mix and denatured at 65C for 5 minutes before placing 
immediately on ice.  To these tubes were added 4l (5x) first strand synthesis reaction 
buffer and 0.5l Murine RNAse Inhibitor before incubation at 25C for 2 minutes, then 
addition of 1.0l M-MuLV Reverse Transcriptase and incubation at 25C for 10 minutes, 
42C for 50 minutes and inactivation at 70C for 15 minutes before returning to ice. For 
second strand cDNA synthesis, 8l (10x) second strand synthesis buffer and 4l second 
strand synthesis enzyme mix were added to the first strand synthesis reaction and made 
up to 80l with nuclease free water, before incubation at 16C for 150 minutes then 
holding at 4C before proceeding with magnetic bead purification (see below). 
2.9.5. Purification of double-stranded cDNA using Sera Mag beads . 
Double stranded cDNA synthesized above were then purified using Sera Mag beads 
(Fisher Scientific). Beads were prepared from concentrate (50x) using two washes in 
1ml TE buffer/20l concentrate (using magnetic stand to separate beads from TE)  prior 
to resuspension in 1ml binding buffer (1.8% PEG8000, 2.5M NaCl, 10mM Tris HCl pH 
8.0, 1mM EDTA, 0.05% Tween 20).  
1.8x volumes of SeraMag beads (144l) were then added to d/s cDNA, mixed by 
vortexing and incubating at room temperature for 5 minutes before placing on a 
magnetic stand to allow bead separation. Bound cDNA was then twice washed with 
fresh 80% ethanol before air drying (in magnetic stand) for 10 minutes at room 
temperature, elution with 52l sterile water and transfer to DNA Lo-Bind tubes (Sigma  
Z666548). 
2.9.6. End Repair of cDNA library. 
Purified d/s cDNA (50l from above) was then end repaired in a reaction mix using 10l 
(10x) phosphorylation reaction buffer, 4l dNTP mix, 5l T4 DNA polymerase, 1l E.Coli 
Large Klenow fragment, 5l T4 Polynucleotide Kinase and 25l nuclease free water  (to 
a final volume of 100l) before incubating at 20C for 30 minutes.  End repaired cDNA 
was then purified using 1.8x Sera Mag beads as detailed above, and eluted in 34l 
nuclease free water before transferring 32l to a fresh DNA Lo-Bind tube.  
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2.9.7. dA tailing of cDNA library. 
Purified end-repaired cDNA (32l from above) was then dA-tailed in a reaction mix 
using 5l NEBuffer 2, 10l deoxyadenosine 5’ triphoshphate (1mM) and 3l Klenow 
fragment (3’ – 5’ exo-) at 37C for 30 minutes. dA tailed cDNA was then purified using 
1.8x Sera Mag beads as detailed above, and eluted in 25l nuclease free water before 
transferring 23l to a fresh DNA Lo-Bind tube. 
2.9.8. Adaptor and index primer ligation. 
To allow sequencing using Illumina platforms, and subsequent identification of 
respective cDNA libraries, the dA tailed cDNA libraries were ligated with TruSeq 
universal adaptors (for Illumina sequencing) and single-ended barcoded adaptors 
(index primers for library ID). Adapters and Index Primers were diluted to 30μM each, 
then diluted 1:10 into a single mix containing 3μM adapter and 3μM index primer in 
sterile water. These were pre-annealed at room temperature for 30 minutes before 
addition to ligation reaction. The 23μl of A-tailed cDNA was then mixed with 1μl pre-
annealed primers, 25μl (2x) Quick Ligation Reaction buffer, 1μl T4 DNA ligase, and 
incubated at room temperature for 15 minutes. Adaptor and index primer ligated 
products were then purified using 1.8X Sera Mag beads as previously described, and 
eluted with 150μl nuclease free water. 
2.9.9. Size selection of adapter/index primer ligated cDNA libraries. 
The cDNA products with ligated adapter and index primers were then size selected 
using different relative volumes of Sera Mag beads to product. Larger molecular weight 
products were first removed by incubation and magnetic selection with 0.9x volumes of 
Sera Mag beads, after which the beads were discarded and the supernatant transferred 
to a fresh low bind tube. Next, smaller molecular weight cDNA was removed using 0.2x 
volumes of Sera Mag beads (with incubation and magnetic selection) after which 
supernatant was discarded, and bead-bound cDNA washed with fresh 80% ethanol then 
eluted with 35μl nuclease free water. 33μl was transferred to a fresh DNA lo-bind 
microfuge tube. 
Amplified libraries were then purified using 1.8x Sera Mag beads as previously 
described, and eluted into 40μl nuclease free water.  
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Quality control of the amplified adapter/index primer ligated cDNA libraries was 
performed by electropherogram using a BioAnalyzer (Agilent), providing size 
distribution and concentration (see Appendix). Concentrations were confirmed using 
qPCR against standards of known concentration. 
Libraries were sequenced using pair-end reads on an Illumina platform and aligned to 
mouse genome and analysed as described in the Results section of this thesis. 
 
 
 
 
 
Table 2.6. Oligonucleotide adaptor bar codes used for read/sample identification in RNA-
seq analysis of whole WAT extracts. 
 
TruSeq Universal Adapter AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCCGATCT
TruSeq Adapter, Index 1 GATCGGAAGAGCACACGTCTGAACTCCAGTCACATCACGATCTCGTATGCCGTCTTCTGCTTG
TruSeq Adapter, Index 2 GATCGGAAGAGCACACGTCTGAACTCCAGTCACCGATGTATCTCGTATGCCGTCTTCTGCTTG
TruSeq Adapter, Index 3 GATCGGAAGAGCACACGTCTGAACTCCAGTCACTTAGGCATCTCGTATGCCGTCTTCTGCTTG
TruSeq Adapter, Index 4 GATCGGAAGAGCACACGTCTGAACTCCAGTCACTGACCAATCTCGTATGCCGTCTTCTGCTTG
TruSeq Adapter, Index 5 GATCGGAAGAGCACACGTCTGAACTCCAGTCACACAGTGATCTCGTATGCCGTCTTCTGCTTG
TruSeq Adapter, Index 6 GATCGGAAGAGCACACGTCTGAACTCCAGTCACGCCAATATCTCGTATGCCGTCTTCTGCTTG
TruSeq Adapter, Index 7 GATCGGAAGAGCACACGTCTGAACTCCAGTCACCAGATCATCTCGTATGCCGTCTTCTGCTTG
TruSeq Adapter, Index 8 GATCGGAAGAGCACACGTCTGAACTCCAGTCACACTTGAATCTCGTATGCCGTCTTCTGCTTG
TruSeq Adapter, Index 9 GATCGGAAGAGCACACGTCTGAACTCCAGTCACGATCAGATCTCGTATGCCGTCTTCTGCTTG
TruSeq Adapter, Index 10 GATCGGAAGAGCACACGTCTGAACTCCAGTCACTAGCTTATCTCGTATGCCGTCTTCTGCTTG
TruSeq Adapter, Index 11 GATCGGAAGAGCACACGTCTGAACTCCAGTCACGGCTACATCTCGTATGCCGTCTTCTGCTTG
TruSeq Adapter, Index 12 GATCGGAAGAGCACACGTCTGAACTCCAGTCACCTTGTAATCTCGTATGCCGTCTTCTGCTTG
Oligonucleotide sequences for TruSeq™ RNA and DNA Sample Prep Kits
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2.10 . Measurement of adipocyte sizes. 
2.10.1. Fixing and sectioning of white adipose tissue (WAT). 
White adipose tissue from epididymal or subcutaneous fat depots were dissected and 
fat-pad pairs were visually inspected for symmetry (to check accurate dissection) before 
fixation in 4% formaldehyde overnight at 4°C. The following day sections were washed 
at room temperature for one hour each in 30%, 50%, 70% and 100% ethanol 
sequentially. After a further wash in 100% ethanol, sections were incubated twice in 
Xylene for 1 hour each (all at room temperature). Sections were then left overnight in 
the final Xylene wash at 4°C. The following day sections were incubated in Xylene at 
60°C for 30 minutes, then an equal volume of paraffin wax was added and samples were 
incubated again at 60°C for 30 minutes. The total volume of liquid was then removed 
and replaced with fresh paraffin wax, before incubation at 60°C for 1 hour. Samples 
were then embedded in a sectioning chamber and left overnight at room temperature. 
Samples were removed from the embedding chamber and maintained at 4°C, prior to 
sectioning to 10μm. Each individual section was immediately placed in a water bath at 
44°C and adhered directed to a Poly-L-Lysine coated microscope slide. Slides were dried 
overnight before further staining. 
2.10.2. Hematoxylin and Eosin staining. 
Slides containing WAT sections were incubated at 65°C for 20 minutes to melt the 
paraffin, then incubated with first Xylene for 10 minutes then 100% ethanol for 5 
minutes and air dried. Slides were then stained with Haematoxylin for 10 minutes at 
room temperature and rinsed in water  for 5 minutes, then stained in eosin (0.5% in 
95% ethanol) by transfer of slides through 8 sequential jars each containing eosin stain 
solution. Slides were then rinsed in water and dehydrated in a series of 50%, 70%, 95% 
and 100% ethanol jars before briefly incubated in xylene prior to mounting with 
cytoseal (VWR 48212-154). 
2.10.3. Imaging and measurement (ImageJ/Watershed). 
Images of adipocyte sections were captured on an Olympus BX61 microscope using a 
10x objective, and images were processed using ImageJ software and the Watershed 
algorithm (see http://dev.mri.cnrs.fr/projects/imagej-macros/wiki/Adipocytes_Tool) 
was utilised to calculate the sizes of each adipocyte clearly distinguishable in each 
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captured field (see Appendix 3). In brief, cell boundaries were identified by the software 
and estimates of cell length and width used to calculate the size of a best-fit ellipse. The 
area of each ellipse was then used as an estimate of individual adipocyte size. 
 
2.11 Isolation and enumeration of adipocyte stem cells and 
tissue-resident macrophages by flow cytometry. 
2.11.1. Isolation of stromal-vascular fraction of white adipose tissue (WAT). 
White adipocyte isolation and flow cytometry was based on the original procedure 
detailed by Church et al (2008). First, white adipose tissue was dissected from mice as 
described in section 2.10.1. Each pad pair was immediately placed in PBS/5% FBS on ice 
before cutting to 5-10mm pieces, then incubating in Collagenase buffer (10mg/ml 
Collagenase (Sigma ) containing 3% bovine serum albumin (BSA), 1.23mM calcium 
chloride, 1.03mM magnesium chloride and 0.83mM zinc chloride for 60 minutes at 37°C, 
followed by vigorous shaking by hand for 15 seconds, then a further incubation at 37°C 
for 15 minutes. Dissociated tissue was then centrifuged at 300g for 3 minutes, and the 
supernatant (containing a top layer of fat) removed. The remaining stromal-vascular 
fraction was washed in 5ml cold PBS/3% BSA and filtered through a 40μm cell strainer, 
washed again in 5ml cold PBS/3% BSA then pelleted again ahead of immediate re-
suspension in antibody staining mix for flow cytometry (below). For enumeration of 
adipocyte-stem cells, 10% of the total volume of isolated stromal-vascular fraction was 
pelleted and then stained for cytometry. 
2.11.2. Staining of WAT stroma-vascular fraction for flow cytometry. 
For enumeration of adipocyte-stem cells, 10% of the total volume of isolated stromal-
vascular fraction was pelleted and then stained for cytometry in 100μl of antibody-stain 
mix, for cell sorting 95% of the fraction was stained in 950μl stain mix; the samples were 
incubated for 1 hour on ice with the following antibody mix: 2µg/ml anti-CD24-e450 
(eBioscience 48-0242-80), 0.5µg/ml anti-CD29-PE-Cy7 (Biolegend 102221), 0.167µg/ml 
anti-CD31 (eBioscience 46-0311-80), 1µg/ml anti-CD34-PE (Biolegend 119307), 
0.1µg/ml anti-CD45-AF488 (Biolegend 103121), 0.2µg/ml anti-Sca-1-APC (Biolegend 
108111), Live/Dead fixable near IR viability stain (Life Sciences L10119) 1:10000 
dilution. After staining cells were washed twice in 1ml PBS/3%BSA (centrifuged at 300g 
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5 minutes, supernatant removed, pellet re-suspended in1ml PBS/3% BSA) then re-
suspended in 300μl PBS/1% BSA (enumeration) or 3ml PBS/1% BSA (sorting). For 
enumeration samples were then analysed on a Becton Dickinson LSRFortessa flow 
cytometer, for cell purification samples were run on a BD Influx cell sorter and collected 
in 3% BSA/PBS pre-coated FACS tubes containing DMEM/10% FCS/1x Pen/Strep. 
2.11.3. Culture of FACS-sorted putative adipocyte stem cells (ASCs). 
Cells purified by FACS in step 2.11.2 were pelleted by centrifugation (1200rpm, 5 
minutes, 4°C) and re-suspended in 1ml fresh media (DMEM/10% FCS/1xAnti-Anti). 
Three different fractions were sorted (Lin+ve [CD31/CD45+ve). “Lin-ve”(CD31-CD45-
CD29-CD34-) and “Sca1+ve” (CD31-CD45-CD29+CD34+Sca1+)) and each was seeded 
into 24 well plates (carboxyl coated) at a density of 5000 cells/well.  Plates were 
incubated for 48 hours before media was changed to DMEM/10% FCS/1xPen/Strep, 
then changed every subsequent 72 hours. Cells of the Sca1+ original lineage were 
expanded after morphological change to fibroblastic appearance prior to further 
experiments. 
2.11.4. Differentiation of ASCs into lipid-storing adipocytes. 
Cells expanded from the Sca1+ lineage were seeded into 12 well plates at a density of 
20,000 cells per well and allowed to grow to confluence (~72 hours). 2 days post-
confluence the media was changed to an adipocyte-differentiation cocktail (DMEM/10% 
FCS/Pen/Strep containing 30μg/ml IBMX, 1μg/ml Insulin, 0.25μg/ml Dexamethasone) 
for 72 hours, then media was again changed to maintenance media (DMEM/ 10% 
FCS/Pen/Strep) every 48 hours for 20 days. 
2.11.5. Oil-Red O staining and quantitation of differentiated adipocytes. 
After differentiation and maintenance culture, putative adipocytes were fixed in 1ml 2% 
formaldehyde at room temperature for 15 minutes, rinsed in 1ml PBS then 1ml water 
and 1ml 60% ethanol, before staining in Oil-Red-O solution (0.7%w/v Oil Red O (Sigma) 
in 60% isopropanol). 
2.11.6. RNA isolation and qPCR. 
Cells differentiated as in step 2.11.4 were carefully washed in PBS before scraping in 
200μl/well Tri Reagent (Sigma), transfer to a 2.0ml microfuge tube and snap freezing on 
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dry ice before storing at -70C prior to RNA extraction. RNA extraction was performed as 
detailed in step 2.4.2. 
2.11.7. Western Blotting of sorted fractions (Lin+, Lin-, Sca1+). 
Cells isolated by FACS as in step 2.11.2 were pelleted and re-suspended in RIPA protein-
lysis buffer then mixed in an equal volume of 2xLaemmli Buffer/5% βME Supernatants 
were boiled for 10 minutes at 95°C prior to resolving by PAGE and western blotting as 
previously described in section 2.3.4.  
2.11.8. Enumeration of WAT-resident macrophages by flow  cytometry. 
The stromal-vascular fraction of dissected white adipose tissue epididymal and 
subcutaneous fat pads was isolated as previously detailed in section 2.11.1. For 
enumeration of WAT-resident macrophages, 10% of the re-suspended fraction was 
pelleted and incubated for 1 hour on ice in 100μl of the following antibody stain mix: 
2µg/ml anti-CD45-AF488 (Biolegend 304019), 0.625µg/ml F4/80-AF647 
(Biolegend123121), Live/Dead near IR cell viability stain (Life Sciences L101l9) diluted 
1 in 10000. After washing, cells were washed twice in 1ml PBS/3% BSA (centrifuged at 
300g 5 minutes, supernatant removed, pellet re-suspended in 1ml PBS/3% BSA) then 
re-suspended in 200μl PBS/1% BSA  and analysed on a Becton Dickinson LSRFortessa 
flow cytometer. 
 
2.12 High fat diet (HFD) mice. 
 
Mice for high fat challenge were singly caged and allowed to feed modified 60% fat chow 
ad libitum. Each mouse was weighed at exactly 7 day intervals and the increase in 
weight plotted for each mouse/week. After six weeks of HFD, mice were euthanised and 
serum extracted for triglyceride and free fatty acid content (extraction as in section 
2.2.2). Subcutaneous inguinal and visceral epididymal WAT were then dissected and 
tissue-resident macrophages and putative adipocyte stem cells enumerated as described 
using 50% of each tissue. The other 50% of WAT tissue from each depot was fixed and 
analysed for adipocyte area (as described in section 2.10). 
In addition to metabolic experiments, intestinal sections were dissected and analysed 
for microbial content as described in section 2.8. 
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2.13 Differentiation of Mouse-Embryonic Fibroblasts to lipid-
storing adipocytes 
Mouse embryonic fibroblasts were generated as described and stored in liquid nitrogen. 
Cells were resuscitated in DMEM/F12 media containing 10% FCS and 1x penicillin/1x 
streptomycin using standard methods, and seeded into T25 flasks overnight. After one 
media change the next day, cells were split into T75 flasks 72 hours after thaw and 
maintained at >50% confluence for a maximum of 10 passages. Aliquots were taken and 
seeded at 10,000 cells per well in a 12 well plate for subsequent counting and cell 
differentiation experiments. 
For differentiation experiments, cells seeded into a 12 well plate were maintained until 
2 days post confluence, then media was changed to the differentiation mix as described 
in section 2.11.4. After 72 hours media was changed back to maintenance media, and 
from then changed every 2 days for a further 10 days. Cells were then fixed and stained 
for Oil Red O as described in section 2.11.5. Three wells from three MEF lines of each 
genotype were differentiated, in parallel to three wells each of undifferentiated cells as a 
control. 
For cell proliferation studies, 10,000 cells per well were seeded into 12 wells of a 12 
well plate from each of 8 MEF lines (4 experimental and 4 control). After 24 hours, four 
wells were trypsinized, washed in PBS and counted from each plate (phase-bright cells 
were counted), then after 48 and 72 hours this process was repeated. 
 
 
2.14  Cell Cycle analysis of Smarcad1+ve and –ve MEFs by flow 
cytometry. 
For cell cycle analysis, MEF cell lines were split and seeded at a density of 25000 
cells/well in a 12 well plate in DMEM/F12 media containing 10% FCS 100U Pen/Strep. 
After 24 hours cells were detached by trypsinisation, transferred to a 50ml tube and 
centrifuged at 1200rpm for 5 minutes. Supernatant was decanted and cells were washed 
in 10ml PBS and centrifuged again at 1200rpm for 5 minutes. After decanting of 
supernatant, cells were vortexed briefly in residual supernatant and resuspended by 
dropwise addition of 10ml ice-cold 70% ethanol while vortexing. Samples were 
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incubated for a minimum of 1 hour at 4°C before pelleting and two further washes in 
PBS (as performed above). After the second of these centrifugation steps, the 
supernatant was removed and cells were stained in 500μl of PI solution (0.1% TritonX-
100, 50μg/ml RNAseA (SigmaR6513), 25μg/ml propidium iodide) for 1 hour at room 
temperature prior to analysis by flow cytometry.  
 
 
 
2.15  Western blotting of MEFs for epigenetic marks. 
To assess whether the absence of SMARCAD1 impacted markers of repressive chromatin 
(previously linked to SMARCAD1 function), MEFs maintained in culture and split every 2 
days were harvested and lysed in RIPA buffer for 30 minutes at 4°C then boiled for 10 
minutes in an equal volume of 2xLaemmli buffer/5% β-ME and loaded onto a 16% 
polyacrylamide gel. The equivalent of 100,000 cells per lane was loaded and resolved for 
20 minutes at 70V then 1 hour at 130V before transfer as previously described. 
Membranes were probed with the antibodies as described in Table 2.7. 
 
Antibody Company Dilution  Secondary antibody Dilution 
HP1α  Cell Signalling Techology #2616  1:5000 anti-mouse HRP 1:5000 
H3K9me3 AbCam ab8898 1:5000 anti-Rabbit-HRP 1:5000 
SMARCAD1 Sigma HPA016737 1:5000 anti-Rabbit-HRP 1:5000 
Lamin B1 AbCam ab16048 1:5000 anti-Rabbit-HRP 1:5000 
 
Table 2.7 – Antibodies used for western blot analysis of Smarcad1+ve/-ve MEFs. 
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3.1 Introduction  
  
  
This chapter details the basic physical, genetic and metabolic characteristics of 
the Smarcad1-/- mice, and point towards key tissues where further investigation 
would give deeper insight into the impact of SMARCAD1 loss.  
 
 
 
3.2 Physical, genetic and metabolic overview of Smarcad1-/- 
mice. 
3.2.1 Fewer than expected Smarcad1-/- offspring are produced from +/- x 
+/- matings, as revealed by a novel genotyping strategy. 
To assess the impact of SMARCAD1 loss on neonatal/perinatal viability, offspring from 
Smarcad1 heterozygous inter-crosses (+/- x +/-) were genotyped at 10 days post-
partum. A novel genotyping PCR strategy was designed to facilitate multiplexing (i.e. 
primers with common annealing conditions, readily distinguishable PCR product sizes 
(Figure 3.1), see materials and methods section 2.1), facilitating large scale screens (e.g. 
>100 samples), thereby increasing sample size for analysis. Comparison of offspring 
genotypes with the expected genotypes from Mendelian inheritance revealed that fewer 
than expected -/- pups were present at day 10, with the number of female -/- pups more 
greatly reduced than male -/- mice (3.49% female and 6.25% male offspring 
respectively, cf. expected 25%) (Figure 3.2). Conversely, a relative increase in the 
expected number of +/+ offspring was seen in both female and male pups, with 37.2% 
and 40.0% respectively.  These data confirm that offspring lacking SMARCAD1 are more 
susceptible to pre/perinatal mortality, as was also observed in a previous knockout 
model of SMARCAD1 (Schoor et al., 1999). 
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Figure 3.1: Novel genotyping PCR design allows multiplexed and rapid resolution of offspring 
genotypes. (a) Primers designed to the floxed allele produce a band at 288bp, whereas primers 
targeted to the deleted (ATPase -ve) allele produce a band at 623bp. Heterozygous offspring 
produce both bands from the same reaction. (b) Two mice of each genotype were screened to QC 
the reaction, alongside a no DNA template control, and a control sample containing both deleted 
and floxed alleles. 
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As the observed genotypes were determined from samples obtained at day 10 post-
partum, the specific time of death is unknown for any pups that had deceased by the 
time of sample (i.e. ear punch) collection. However, clues as to a cause of death are 
available from the known impact of SMARCAD1 and other mouse models (Turgeon & 
Meloche, 2009). Respiratory failure can be an early driver of mortality in the hours 
immediately after birth, and is linked to factors such as lung function and rib cage 
development (Ivkovic et al., 2003). As Smarcad1/Etl1 knockout mice were previously 
reported with a reduced rib-cage size (and skeletal dysplasia), it is possible that this 
may underlie postnatal respiratory failure and mortality (Schoor et al., 1999). 
Alternatively, the expression of a short isoform of SMARCAD1 in human skin suggests 
that a similar skin-specific isoform of Smarcad1 may exist, and harbour an important 
function in murine skin. Failure of skin barrier-function in early-postnatal mice can lead 
to trans-epidermal water loss and mortality (Furuse et al., 2002). However, this 
particular defect is also associated with a loss of pup mass during the hours immediately 
after birth, and Smarcad1-/- neonates showed no significant difference in mass when 
weighed postnatally (alongside +/- littermates). Any defect in skin barrier function in 
Smarcad1-/- mice is unlikely to be as severe as those previously reported, which 
themselves lead to postnatal mortality (Turgeon & Meloche, 2009). 
 
 
 
 
Figure 3.2.  Offspring ratios of mice from Smarcad1 heterozygous inter-crosses (+/- x +/-) 
confirm that fewer than expected Smarcad1-/- mice survive pre- or perinatally by day 10 
post-partum. The cause of peri-natal mortality of Smarcad1-/- mice was not investigated 
in this study. 
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3.2.2 Growth and development of Smarcad1+/+ vs -/-  mice. 
Although preliminary data suggested that mice lacking SMARCAD1 weighed less than 
SMARCAD1 expressing counterparts (with smaller white-adipose tissue fat pads) (see 
Section 1.9.3), further experiments to clarify the magnitude of this difference revealed a 
more complicated picture.  Firstly, a compilation of weights obtained at time of death 
during this study were used to project growth curves for Smarcad1+/+ vs -/- mice 
(Figure 3.3a). Trend curves extrapolated from these data suggest that Smarcad1-/- mice 
initially weigh less than +/+ mice, but show subsequent catch-up growth. Next, to 
provide a more detailed picture, five mice from each genotype were weighed on a 
weekly basis from two weeks post-partum until the age of 16 weeks. Weights were 
combined by genotype, and mean weights plotted for each week (Figure 3.3b). Although 
growth curves constructed from these weekly time points mirrored the trend of curves 
extrapolated time-of-death, no significant difference in weight was seen over the 16 
weeks between the two genotypes. Interestingly, the magnitude of the difference in 
weight at 5 weeks of age was ostensibly smaller than the difference seen in a previous 
study of Smarcad1/Elt1 knockout mice (Schoor et al 1999, see Section 1.3.6). While 
further study with larger sample numbers and an increased number of time points may 
reveal statistical significance, this was beyond the logistical constraints of this project.  
 
3.2.3 Smarcad1-/- mice show weight-specific differences to Smarcad1+/+ 
mice, rather than generic development retardation from 4 months of 
age. 
Differences in weight empirically recorded in mice >4 months old were further 
examined to confirm whether any generic developmental retardation was present in 
Smarcad1-/- mice. As other physical or dimensional reasons may underpin a difference 
in mouse body mass (e.g. a general defect or delay in development), and as such plots of 
A-N length (anal-nasal length) vs weight were constructed for Smarcad1+/+ and -/- 
mice. Generalised development delay would follow the same combined linear increase in 
both weight and length at the same time, i.e. growth retarded mice would retain the 
same length/weight proportions as normal mice. However, if differences in weight are 
driven by different sizes of discrete organs within the body (e.g. adipose tissue), then 
mice of the same length would harbour differences in mass. Comparison of length vs 
weight of Smarcad1-/- v +/+ mice revealed precisely this (Figure 3.4).  
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Figure 3.3. Smarcad1-/- male mice show a difference in body mass compared to +/+ 
controls.  (a) Mice measured at time of death indicate lower post-natal weight with catch 
up growth (b) More detailed growth curves of male mice over the first 16 weeks post-
partum support an initial lean phenotype for Smarcad1-/- mice. 
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Figure 3.4. Changes in the mass v length proportions of Smarcad1-/- mice do not follow the 
same changes seen with natural (age-related) growth increase in Smarcad1+/+ mice. 
Trend lines plotted for weight versus A-N length for both groups, using mice 4 to 12 
months of age. 
 
3.2.4 Neonatal male Smarcad1-/- mice show no significant difference in 
birth weight compared to +/- litter-mates. 
To gain further insight into whether any physical defects in adult Smarcad1-/- mice 
were influenced by gestational development, littermates were weighed at birth to check 
for any gross differences in mass. Given the logistical challenges in producing +/+ and -
/- littermates, Smarcad1+/- and -/- littermates were bred and compared (Figure 3.5). 
While a number of developmental defects present with differences in birth weight, no 
statistical difference was observed between +/- and -/- groups. Furthermore, of the 
known developmentally-influential genes which impact birthweight (with potential 
post-natal metabolic impact), the genes Delta-Like 1 homologue (Dlk1) and Gene Trap 
Locus 2 (Gtl2) were analysed by qPCR in the liver of these neonates. No significant 
difference was found in Dlk1 or Gtl2 expression at time of birth (Figure 3.6). Taken 
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together, these data suggest that there are no significant differences during gestation 
which impact postnatal metabolism in (surviving) Smarcad1-/- male mice. 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.5. No difference is seen in birth weights between Smarcad1+/- and -/- litter-
mates. As very few +/+ and -/- littermates are successfully produced this study required 
the comparison of heterozygous Smarcad1+/- and Smarcad1-/- mice. 
 
 
 
 
Figure 3.6. Analysis by qPCR of the developmentally influential genes Dlk1 and Gtl2 in the 
liver of neonates shows that no significant difference in expression was observed for 
either gene. Four livers from each genotype were analysed, using the ddCT analysis and 
two housekeeping genes (Actin and TBP) as a basis for normalisaton. 
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3.2.5 Food intake is not affected by loss of SMARCAD1. 
To address whether any differences in food intake exist between Smarcad1+/+ and -/- 
mice (that may underpin difference in mass),  four singly-housed Smarcad1+/+ and four 
singly-housed Smarcad1-/- age-matched mice was recorded over a period of four weeks, 
(via change in food-hopper weight). Comparison of the 16 food intake values per 
genotype revealed no significant difference in food intake between the two groups 
(Figure 3.7). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.7. No significant difference in food intake was observed between four +/+ and 
four -/- mice over a period of four weeks (giving n=16 for each group). These data suggest 
that any change in the mass of Smarcad1-/- mice are not due to differences in appetite. 
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3.2.6 Serum free-fatty acid and triglyceride concentrations are elevated in 
mice lacking SMARCAD1 but not serum Insulin or Glucose 
concentrations. 
The concentrations of serum peptides and metabolites from six Smarcad1+/+ and six 
Smarcad1-/- mice before and after a 16 hour (overnight) fast was assayed to give insight 
into any basal metabolic differences in mice lacking SMARCAD1.  No significant 
difference was found in serum glucose or serum insulin concentrations between +/+ and 
-/- groups before or after fasting.  However, serum triglyceride levels were significantly 
higher in Smarcad1-/- mice prior to fasting, and a trend was observed for elevated 
serum concentrations of Free Fatty Acids before and after fasting in the Smarcad1-/- 
animals (Figure 3.8).  
 
While the increase in serum triglycerides found in Smarcad1-/- was statistically 
significant, the proportional increase over +/+ mice (~30% increase in serum [TG]) was 
not at a level comparable to other mouse models of metabolic dysfunction, such as the 
obese (ob/ob) mice (~50% increase in serum [TG] over WT mice, with blood 
concentration of 1.31mmol/L cf. 0.83 for Smarcad1-/- mice) (Ku et al., 2016), or the 
growth-retarded and obese Dlk1-/- mice (34% and 76% increase in serum [FFA] and 
[TG] over WT respectively, cf. 20% increase [FFA] and 30% [TG] for Smarcad1-/- mice 
over +/+ mice respectively) (Moon et al., 2002). These results suggest that any 
metabolic phenotype observed in Smarcad1-/- mice is not as severe as m other mouse 
models of metabolic pathology. 
 
 
 
Chapter 3 - Phenotypic overview of Smarcad1-/- mice. 
109 
 
 
 
 
+
/ +
+
/ +
 f
a
s
t e
d - /
-
- /
-  
f a
s
t e
d
0
4 0 0
8 0 0
1 2 0 0
1 6 0 0
S e r u m  [ F F A ]
[
F
r
e
e
 
F
a
t
t
y
 
A
c
i
d
s
]
 u
m
o
l
/L
 
 
 
Figure 3.8. Serum analysis of six Smarcad1+/+ and six -/- mice, before and after a 16 hour 
fast. Prior to fasting, a significant difference was seen in serum triglyceride levels between 
the +/+ and -/- groups (student t-test), but not between serum glucose or insulin levels.  
Power calculation indicated that an increased sample number (to n=9) would prove 
significant for serum free fatty acid concentrations between fasted +/+ and -/- groups.  
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3.2.7 The liver of Smarcad1 -/- mice shows a greater increase in size with 
ageing compared to Smarcad1+/+ mice.  
In parallel to the examination of fat-related metabolites in serum, livers from 
Smarcad1+/+ and -/- mice were weighed to determine if any gross anatomical 
differences were present. Firstly, trend lines were constructed to provide an overview of 
increasing size in the context of age (Figure 3.9). As the trend lines were divergent and 
suggested that the increase in liver size was greater in Smarcad1-/- mice, two specific 
age groups were selected to assess potentially significant size differences.  
 
As suggested by the trend lines, mice aged 4-5 months old did not show any significant 
difference in liver mass (n=12), however by 10-12 months of age the livers from 
Smarcad1-/- mice were significantly larger than +/+ counterparts (n=4). This may 
reflect an increase in hepatic metabolic challenge over time in the Smarcad1-/- mice 
(Figure 3.10), although interestingly no visible liver tumours were observed in these 
mice. 
 
 
 
 
Figure 3.9. The age-related increase in liver size in Smarcad1-/- mice is greater than in +/+ 
mice. A total of 28 murine livers were weighed for each genotype, from mice of ages 
between 10 weeks to 60 weeks old, and trend lines plotted for each genotype. 
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Figure 3.10. Liver masses of Smarcad1-/- and +/+ mice are not significantly different at 4-5 
months of age, but become significantly different as the mice age to 10-12 months of age 
(student t-test). 
 
3.2.8 The canonical SMARCAD1 peptide is expressed in the majority of 
murine tissues including lymphoid organs, the intestine and adipose 
tissue. 
To identify suitable tissues for further investigation of the impact and function of 
SMARCAD1, a panel of mouse tissue and organs was probed by western blot to identify 
where SMARCAD1 is expressed, and which tissues contain the highest levels of 
expression. Samples prepared as described in section 2.2.4 were resolved by 
polyacrylamide gel electrophoresis (PAGE) and probed initially for presence of 
SMARCAD1 before equal loading was confirmed using a probe directed against the 
nuclear protein LaminB1. 
 
As expected, SMARCAD1 was widely expressed across the majority of murine tissues 
with notably strong staining in testes, spleen and thymus as had been previously 
observed (L. Matheson, per comm.). Of particular interest was the expression of 
SMARCAD1 in the small and large intestine, and organs with metabolic function (white 
adipose tissue and pancreas). Of major interest was the visible increase in SMARCAD1 
expression in WAT versus Liver and brown adipose tissue, which would suggest that any 
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WAT-related phenotype is mostly due to a tissue-intrinsic loss of SMARCAD1 in WAT 
(Figure 3.11). 
 
To confirm the successful knockout of SMARCAD1 peptide in -/- adult tissue, and 
investigate the relative levels of peptide in +/+ vs +/- metabolism-related organs, 
protein extracts from WAT, BAT, Muscle and Pancreas were probed from -/-, +/- and 
+/+ mice (Figure 3.12).  The successful removal of full length SMARCAD1 peptide was 
confirmed in all -/- tissues, and of the level of peptide detected in +/- and +/+ extracts 
mirrored the level of RNA seen in duodenal extracts (Section 4.2.3) in WAT, BAT and 
pancreas.   However, protein extracts from muscle suggested that the level of peptide 
present in both +/+ and +/- were similar, and hence further experimentation is needed 
to clarify the relationship between gene copy number and peptide expression level in 
Smarcad1+/+ and +/- mice (see Section 6.1.3). 
 
 
 
 
 
 
 
 
Figure 3.11. SMARCAD1 is widely expressed in mouse tissues, and elevated in white 
adipose tissue over liver (see arrows) while also highly expressed in testes, spleen,  
thymus and lungs in particular. These tissues therefore make appropriate substrates for 
the investigation of SMARCAD1 function. 
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Figure 3.12. Full-length SMARCAD1 peptide is not found in tissue from adult -/- mice, and 
levels of peptide in +/+ and heterozygous +/- mice reflect the gene copy number in WAT, 
BAT and Pancreas.  (a) Western blot of WAT, BAT, Muscle and Pancreas tissue, from -/-, +/- 
and +/+ mice respectively. (b) Densitometry of each SMARCAD1 band expressed as fold 
over each Lamin B1 loading control band. Heterozygous Smarcad1+/- mice express 
SMARCAD1 peptide at lower levels to +/+ mice as expected in WAT, BAT and Pancreas. 
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3.3 Perspectives. 
 
Physical measurements of Smarcad1-/- mice from birth show that phenotypic 
differences are not immediately apparent in surviving knockout mice. Furthermore, the 
emergent phenotype with age does not accurately mirror those of known disorders of 
genomic imprinting. While a physical and metabolic phenotype does emerge after 
several months (e.g. elevated serum markers, increased liver mass) this would appear 
not to be linked to gestational development or dysregulation of the imprinting-
associated genes Dlk1 and Gtl2, and hence is more likely driven by cell or organ 
endogenous defects later on in life.  
 
Examination of adult mouse tissue for the presence of SMARCAD1 by western blot 
confirms wide expression of SMARCAD1, and candidate tissues such as white adipose 
tissue, the small intestine, lungs, and organs of the immune system (e.g. spleen and 
thymus) are suitable targets for further investigation of the impact of SMARCAD1 on 
murine biology. In addition, blots using specific tissues from Smarcad1-/- , +/- and +/+ 
mice confirm the absence of SMARCAD1 peptide expression in metabolism-related 
tissues of Smarcad1-/- mice (and also the ablation of SMARCAD1 peptide expression in 
adult tissue), while also agreeing with transcriptional data from the duodenum - 
whereby Smarcad1 +/- mice produce SMARCAD1 peptide (and RNA) at reduced levels in 
+/- mice compared to +/+ mice. 
 
Taken together these data suggest that adult tissues such as white adipose tissue, small 
intestine, lung and cells of adaptive immunity – would be suitable for the investigation of 
SMARCAD1 function and impact. 
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Chapter 4 – Intestinal intraepithelial lymphocytes 
(iIELs) are reduced in number in Smarcad1-/- mice by 
12 months of age. 
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4.1 Introduction 
 
This chapter follows up previous work which had investigated the impact of 
SMARCAD1 on B- and T-cells in adaptive immunity, alongside previous 
observations of the impact of chromatin remodellers on the mammalian adaptive 
immune system. Of the cellular subsets investigated, T-cells resident in the small 
intestine epithelium (intestinal intra-epithelial lymphocytes or iIELs) appeared 
to be depleted in Smarcad1-/- mice. Mice harbouring a global loss of SMARCAD1 
(using ZP3-Cre) in addition to lymphocyte-specific deletion of SMARCAD1 (CD2-
Cre) were used to address this question. In addition, the impact of SMARCAD1 
loss on related factors within the small intestine (e.g. transcriptional impact, cell 
proliferation within the crypt/villus, anatomical loss of secretory cells and 
changes in microbiota) were also addressed.  Finally, the loss of iIELs was 
examined in the context of age. 
 
4.2 Results 
 
4.2.1 Smarcad1 full-length transcript expression is deleted in iIELs by 
CD2-Cre. 
While CD2-Cre is known to be expressed early in lymphocyte development, it is not clear 
whether intestinal IELs follow the same developmental route as other lymphocytes or 
indeed whether CD2 is expressed in iIELs. As such, the success of Cre-recombinase 
expressed from a CD2 promoter (CD2-Cre) in deleting floxed Smarcad1 alleles (and 
hence ablating expression of the canonical transcript) was confirmed by qPCR analysis 
of iIELs isolated by flow cytometry (Figure 4.1a).   
 
Cells extracted from the murine small intestine as described were stained for the T-cell 
co-receptor CD3, the T-cell receptor γδ and the integrin molecule CD103 to allow flow 
sorting of a defined intra-epithelial lymphocyte population (Figure 4.1a).  Sorted cells 
were analysed by qPCR to confirm the presence of the floxed Smarcad1 allele, in 
addition to the deleted allele (Figure 4.1b).  
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Figure 4.1. (a) Gating strategy for isolation of CD3+γδTCR+CD103+ iIELs by flow sorting. A 
more detailed description is available in Appendix 3. (b) qPCR of sorted iIELs confirms the 
expression of the Smarcad1fl allele from Smarcad1+/+ and CD2-Cre fl/wt (+/-) mice but not 
CD2-Crefl/fl (-/-) mice, whereas the deleted allele is detected in CD2-Cre fl/wt mice and CD2-
Crefl/fl mice but not Smarcad11+/+ mice. Expression of Smarcad1 is shown as the mean fold 
over the housekeeping gene TATA-binding protein (TBP).  
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4.2.2 Enumeration of iIELs by flow cytometry  
 
To build on initial the observations that Smarcad1-/- mice lose iIELs, the gating strategy 
described in section 4.2.1 was used to enumerate iIELs  from mice with Smarcad1 (+/+), 
without (-/-),  and with the conditional lymphocyte-specific knockout of Smarcad1 
(CD2-Cre). For each group, splenic T-cells were also examined for the ratio of γδ to αβ T-
cells as a control for systemic T-cell proportional aberrations (Figure 4.2). 
 
No significant difference was found in iIEL number between groups either at 2-4 months 
of age or 4-6 months of age (Figure 4.3). Inspection of splenic ratios also revealed that 
no significant differences were seen in the proportions of circulating T-cells, which 
confirms the previously observed parity between Smarcad1+/+, -/- and CD2-Cref/f 
groups in this age range.  
 
 
 
 
Figure 4.2. Gating strategy for the enumeration of splenic γδ and αβ T-cells ratios. Cells are 
first identified based on Size (FSC setting) and Granularity (SSC) (above left) and 
subsequently appropriate anti-γδ or αβ T-cell receptor fluorescence recorded.  
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(a) Counts of CD103+γδ T-cells from 2-4 and 4-6 month old mice. 
 
 
 
 
(b) Ratios of αβ /γδ T-cells from the spleens of 2-4 and 4-6 month old mice. 
 
 
Figure 4.3. (a) Total iIEL numbers are not significantly different between control mice 
(+/+), mice globally lacking Smarcad1 (-/-) and mice with lymphocyte-specific deletion of 
Smarcad1 (CD2-Cre) (Mann-Whitney test). (b) Analysis of splenic T-cell ratios confirms 
that there is no significant difference in circulating γδ v αβ T-cells between (+/+), (-/-) and 
CD2-Cre mice. 
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4.2.3 Expression analysis of whole-duodenum RNA by qPCR. 
  
To investigate the impact of SMARCAD1 loss on the small intestine, duodenal RNA was 
analysed by qPCR for the expression of immune-related, intestinal development-related 
and intestinal stem cell markers (Figure 4.4). Each of these factors could impact the 
numbers and presence/absence of iIELs. Three Smarcad1+/+ and three Smarcad1-/- 
mice (aged 4 months) were screened using two housekeeping genes (TBP and β2M), and 
the mean fold over housekeeping for each sample was normalised to that of 
Smarcad1+/+ mice. Two control genes were also screened, Smarcad1 itself and the 
genomically adjacent gene, Hpgds (hematopoietic prostaglandin D synthase).  
 
As expected, the expression level for Smarcad1 reflected the genotype of the subject 
mice (i.e. Smarcad1+/- mice showed reduced Smarcad1 RNA levels to +/+ mice, and 
Smarcad1-/- mice do not produce any detectable levels of transcript). Importantly, no 
significant difference in the level of Hpgds was seen in either +/- or -/- mice, as this gene 
has potent immunomodulatory effects, and hence the removal of exons 12 to 14 of 
Smarcad1 in the mouse genome does not ostensibly impact expression of this 
genomically adjacent gene (Figure 4.4). 
 
To address whether any immune-phenotype (e.g. inflammation) was present in the 
small intestine of Smarcad1-/- mice, three genes involved in inflammatory responses 
were screened by qPCR. Of these, Tlr-4 (which binds to bacterial-derived LPS) 
expression was elevated in Smarcad1-/- mice, although by contrast the pro-
inflammatory cytokines Tnfα and Ifn-γ showed little change and a decrease in 
expression respectively. Together these suggest that inflammation is not increased in 
the small intestine of Smarcad1-/- mice (Figure 4.4). 
 
Differences in genes linked to intestinal development and the cellular make-up of the 
small intestinal crypt/villus was also assayed. No significant difference was seen in the 
intestinal stem cell marker Lgr-5, suggesting that there is no difference in the number of 
stem cells present in this niche. However, the developmental markers c-Myc (which 
antagonises Paneth Cell development), and Notch-1 and 2 (that promote stem cell 
maintenance and antagonise the formation of Goblet secretory cells) all reflected an 
increase in expression in the murine duodenum (Figure 4.4).  
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Taken together, these results suggested that development of the small intestinal 
crypt/villus may be altered in Smarcad1-/- mice, but not due to differences in the 
intestinal stem cells.  
 
 
 
 
 
 
 
 
 
 
Figure 4.4. Analysis of key markers of inflammation and intestinal development by qPCR. 
Each bar represents the three dCt values obtained from three mice, using the mean of two 
housekeeping genes (Tbp and β2M) with standard error mean plotted. These data suggest 
that developmental differences – rather than intestinal inflammation – may underpin any 
intestinal phenotype in Smarcad1-/- mice linked to iIEL biology. 
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4.2.4 Immunofluorescence staining of the small intestine confirms the 
presence of Paneth cells and Goblet cells in SMARCAD1-/- mice. 
To investigate whether the presence of secretory cells (Goblet cells and Paneth cells) 
was affected in the small intestine of Smarcad1-/- mice, duodenal sections from three 
+/+ and three -/- mice (aged 4 months) were examined by immunofluorescence 
microscopy. In both experimental and control mice the presence of Goblet Cells (α-
Mucin antibody) was readily seen along small intestinal villi (Figure 4.5a), and clear 
Paneth Cell staining (α-Lysozyme antibody) was apparent within small intestinal crypts 
(Figure 4.5b). While more subtle changes in population number or proportion could not 
be ruled out, the parity of iIEL number found in the intestine of age-matched mice 
suggested that such subtle changes would not impact the original question of iIEL loss.  
 
4.2.5 EdU incorporation assay to assess cell proliferation in the small 
intestine. 
Elevated expression of cMYC in the murine small intestine has previously been 
associated with both a vastly reduced number of Paneth Cells and intestinal 
tumorigenesis. To assay whether cell proliferation was indeed affected by the lack of 
SMARCAD1 in the murine small intestine, mice were fed ad libitum with EdU-containing 
drinking water for 18 hours and duodenal cryosections screened for EdU incorporation 
(Figure 4.6a).  
 
Cells which stained positive for EdU were enumerated from the base of the crypt to the 
top of each adjacent villi. Fifty crypt/villi units were scored from each of three 
Smarcad1+/+ and three -/- mice, and results collated for both genotypes. No significant 
difference was found in cell proliferation in the small intestine of Smarcad1+/+ and -/- 
mice (Figure 4.6b). 
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Figure 4.5. Immunofluorescent staining of duodenal sections from 4 month old 
Smarcad1+/+ and -/- mice. (a) Signal from anti-Mucin antibody indicates the clear 
presence of Goblet cells along the intestinal villi in both Smarcad1+/+ and -/- mice. (b) 
Paneth cells are visible in the crypt of both Smarcad1+/+ and -/- mice after anti-Lysozyme 
fluorescence staining. 
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              +/+                   -/- 
 
Figure 4.6 (a) Immunofluorescence detection of EdU incorporated into the small intestine 
of Smarcad1+/+ and -/- mice. (b) No significant difference was found in the number of 
EdU+ve cells present in the duodenal crypts/villi of three Smarcad1+/+ versus three -/- 
mice, indicating no difference in cell proliferation between these mice (n=150 crypt/villi 
units counted for each genotype) 
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4.2.6 SMARCAD1 does not significantly impact the murine intestinal 
microbiome.  
To further understand the impact of the loss of SMARCAD1 on murine intestinal biology, 
the small and large intestines of 6 month old Smarcad1+/+ and -/- mice were analysed 
for microbial content. Intestinal microbiota are known to influence the presence of iIELs 
within the intestine, along with factors outside the intestine (such as white adipose 
tissue/metabolism) and host chromatin (see Section 1.6).  Excluding changes in the 
microbiota (such as changes in the proportions of the major species present) as a cause 
of any iIEL/intestinal (or metabolic) phenotype observed in Smarcad1-/- mice was 
required to allow the focus to remain on host cell-intrinsic mechanisms. Hence, the four 
known dominant phyla present within the mammalian gut (Actinobacteria, 
Bacteroidetes, Firmicutes and Proteobacteria) were assayed for proportional content by 
qPCR. Microbial subpopulations were quantified against total microbial DNA using qPCR 
and primers targeting the 16S rRNA of individual populations normalised against 
primers targeted to a common microbial rRNA sequence.  
 
As expected, levels of Firmicutes and Bacteroidetes were elevated in the colon over the 
small intestine, however no significant difference was seen between Smarcad1+/+ and   
-/- groups for any of the bacterial phyla examined. Furthermore, no Proteobacteria were 
detected in the small intestine of mice using this approach (Figure 4.7). These results 
suggest that any changes in intestinal expression brought about by the lack of 
SMARCAD1 do not impact the microbial content in the murine gut, although more 
detailed approaches more give deeper insight. 
 
4.2.7 Intestinal IEL numbers are significantly reduced in SMARCAD1-/- 
mice by 11-12 months of age. 
To examine further the age-related changes in Smarcad1-/- mice, intestinal IELs were 
enumerated from normal (+/+), global knockout (-/-) and conditional knockout (CD2-
Cre) mice alongside splenic controls (Figure 4.8). While no significant difference was 
seen between Smarcad1+/+ mice and the lymphocyte specific CD2-Cre knockout, mice 
with a global knockout of Smarcad1 (-/-) showed a significant loss in intestinal IELs.  
Furthermore, examination of the splenic ratios of αβ versus γδ T-cells revealed a 
significant increase in this ratio, concordant with the intestinal loss of γδ T-cells.  
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Figure 4.7. No significant changes in the major intestinal bacterial phyla are seen in 
Smarcad1-/- mice compared to +/+ mice (n=3). Expected elevations in the proportion of 
Firmicutes and Bacteroidetes were found in colon versus small intestine, and no 
Proteobacteria were detected in murine small intestine using this approach. Intestines 
from three Smarcad1+/+ and three -/- mice were examined each case. 
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(a) 
 
 
(b)           (c) 
  
 
 
 
Figure 4.8. By 11-12 months Smarcad1 -/- mice significantly lose iIELs compared to +/+ 
mice (Mann-Whitney statistical test). (a) Flow cytometric plots for 12 month old Smarcad1 
-/- mice demonstrate a loss of CD103+ iIELs. (b) and (c) Changes in iIEL number and 
splenic ratio of  αβ to γδ T-cells by 11-12 months of age indicated a decrease in the 
systemic  γδ T-cell population with respect to systemic αβ T-cells in plot (c).  
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4.3 Perspectives. 
 
This chapter confirms that Smarcad1-/- mice present a significantly reduced number of 
intestinal intraepithelial lymphocytes by 11-12 months of age. This loss is not due to 
cell-intrinsic loss of SMARCAD1, as lymphocyte-specific CD2-Cre SMARCAD1 deleted 
mice do not reproduce this loss. However, changes in the ratio of T-cell subsets within 
the spleen (i.e. fewer γδ T-cells with respect to αβ-T cells) suggest that γδ T-cell 
numbers are affected both inside and outside the intestine, hence the loss of γδ T-cell 
iIELs may not be due to intestine-intrinsic causes. 
 
Closer examination of the murine intestine suggests that in the absence of SMARCAD1, 
changes in the expression of developmentally-influential genes (such as Notch-1, Notch-
2 and cMyc) exist alongside a reduction in the expression of inflammation-related genes 
(e.g. TNFα and IFNγ). Further investigation of cell proliferation and the 
presence/absence of key secretory cells revealed no significant difference in the 
intestinal anatomy or intestinal cell turnover within Smarcad1-/- mice.  While deeper 
insight into differences in intestinal function and phenotype may be revealed with 
alternative experimental approaches (such as next-generation sequencing of microbial 
populations, use of intestinal specific (villin-Cre) SMARCAD1 knockout mice) the parity 
in iIEL number in mice aged 2-6 months suggests that this would shed no further light 
on the original investigation of iIEL loss in age-matched mice. 
 
The challenge of breeding adequate numbers of of Smarcad1-/- males for iIEL-based 
experimentation - in addition to the financial and time cost of housing mice until one 
year of age – made further investigation of the loss of iIELs logistically prohibitive within 
this project. A parallel phenotype that was apparent in younger mice was therefore 
pursued in spite of the clearly fascinating observation of iIEL loss with age. 
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5.1 Introduction. 
 
This chapter presents the differences found in white adipose tissue and related factors 
(e.g. macrophages and intestinal microbiota) between Smarcad1-/- and +/+ mice. A 
number of previous reports had linked chromatin remodellers to white adipose tissue 
development (see Section 1.5.1), and while differences in weight had been reported 
between Smarcad1+/+ and -/- mice (Schoor et al., 1999), this previous study did not 
specifically investigate whether these differences (in body mass) were influenced by 
differences in adiposity. The initial observation that epididymal fat pads are reduced in 
size (in the Smarcad1-/- mice described in this thesis) was investigated in greater detail, 
and understanding of WAT-related factors (adipose depot size, macrophage infiltration, 
related microbiota and expression of adipogenesis-related factors) is described under 
both normal conditions and after high-fat-diet challenge. Particular focus was given to 
putative adipocyte stem cells (ASCs) isolated from control and experimental mice as 
previously described. In parallel, mouse embryonic fibroblasts (which can also undergo 
adipogenic differentiation) were also used to confirm in-vivo and ex-vivo observations. 
 
 
5.2 Biology of white-adipose tissue in Smarcad1-/- and +/+ 
mice. 
5.2.1 Subcutaneous and epididymal white adipose tissue fat depot sizes do 
not significantly differ between Smarcad1-/- and +/+ mice. 
To investigate further whether significant differences are found in the sizes of white 
adipose fat depots, the mass of subcutaneous and epididymal fat pads was compared 
between experimental and control mice aged 4-5 months old (Figure 5.1).  While an 
initial observation had suggested a potential difference in fat pad size, no significant 
difference was seen in either fat depot with an increased sample size. It seems likely that 
initial observations had been skewed by out-lying data points as seen within the larger 
sampling size, and would be expected should one of the two initial mice observed be an 
alpha animal within the litter (hence would take a more dominant position with respect 
to food intake). 
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Figure 5.1 Epididymal (left) and subcutaneous (right) fat pads were visually checked for 
symmetry prior to weighing, as a measure of accurate dissection. No significant difference 
was found between epididymal or subcutaneous fat pad sizes from Smarcad1+/+ (blue) or 
Smarcad1-/-(red) mice. 
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5.2.2 SMARCAD1 does not impact the size of white adipocytes. 
 
Although there was no significant difference in the size of WAT-depot fat pads examined 
from experimental or control mice, it was still unclear as to why the serum levels of 
triglyceride and free-fatty acids differed between +/+ and -/- groups, and what impact 
this may have on adipocyte biology. To assess whether adipocyte size was affected, fat 
pad sections from three +/+ and three -/- mice were stained with hematoxylin and eosin 
(to mark cell boundaries) and images captured to determine adipocyte cell size 
distribution. Multiple sections for each fat-pad were analysed in ImageJ using the 
Watershed algorithm (as described), then adipocyte sizes were combined from three 
mice of each genotype. Ranked adipocyte sizes for each genotype were then used to 
construct a cumulative frequency curve, and curves compared from both genotypes (see 
Figure 5.2). For both genotypes, 95% of white adipocytes had an area of 2300μm2, and 
both curves demonstrated a near-transposable pattern of distribution, indicating that no 
significant difference in adipocyte size is seen in the absence of SMARCAD1, also 
inferring that no major difference in adipogenesis is also present. 
 
These results revealed no clear difference in the size of white adipocytes between 
control and experimental mice, indicating that any difference in fat pad size observed 
was due to an increased number of adipocytes present (cell hyperplasia) rather than an 
increase in adipocyte size (cell hypertrophy).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 5 – Differences in white-adipose tissue are found in mice lacking SMARCAD1, but are not linked to adipogenesis. 
 
133 
 
 
 
 
 
 
 
Figure 5.2. No difference is seen in adipocyte size between Smarcad1+/+ and -/- mice.  
Formalin fixed WAT sections were stained with hematoxylin and eosin (top) and captured 
images analysed using the Watershed algorithm appended to ImageJ software.  Images 
capture using 10x magnification, scale bars represent 20μm. A cumulative distribution of 
adipocyte sizes was plotted, which reveals almost identical adipocyte size distributions 
within +/+ and -/- tissue. 
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5.2.3 Transcriptomic analysis of whole WAT by RNA-seq.  
 
To investigate further the impact of SMARCAD1 on white adipose tissue biology, 
transcriptomic analysis was performed to identify changes in gene expression between 
experimental and control groups. Four mice approximately 6-months old were analysed 
(2x Smarcad1+/+, 2x Smarcad1-/-), using RNA extracted from whole epididymal white 
adipose tissue, from which mRNA was isolated using poly-dT magnetic beads (see 
Materials and Methods or full details). Library content size and concentration (checked 
by Bioanalzyer) is shown in Appendix 4, and paired-end reads (aligned to the mouse 
GRCM38/mm10) visualised in SeqMonk. Relative transcriptomic profiles were 
compared to confirm the clustering of same-genotype murine transcriptomes (shown as 
cluster tree, Figure 5.3) and probe-intensity cumulative plots were normalised to allow 
subsequent differential transcription analysis. 
 
 
 
 
Figure 5.3. Transcriptomic reads are most similar from mice of the same genotype. 
Comparison of RNA-seq read intensity distributions confirms the clustering of Smarcad1-
/- whole-WAT transcriptomes as expected. 
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Identification of differential gene expression was performed using the DeSeq algorithm 
(see https://www.bioconductor.org/packages/devel/bioc/vignettes/DESeq2/inst/doc/ 
DESeq2.pdf ) and results were visualised using SeqMonk software 
(http://www.bioinformatics.bbsrc.ac.uk/projects/seqmonk/).  A list of differentially 
expressed genes was then examined by literature searching on PubMed to identify 
candidate genes linked to known aspects of the mouse phenotype. 
  
From the differential expression analysis, two genes of interest were identified due to 
the known expression by macrophages. As macrophage infiltration into white adipose 
tissue is a known marker for WAT-related pathology (Surmi & Hasty, 2008) (as necrotic 
adipocytes are phagocytosed by macrophages), these findings were investigated further 
to confirm the putative increase in macrophage levels in the white adipose tissue of 
Smarcad1-/- mice (see section 5.2.3) .  
 
In agreement with the result of adipocyte size measurement (section 5.1.1), 
transcriptomic analysis revealed no difference in the major adipogenesis-related factors 
between Smarcad1-/- and +/+ mice. The major factors upregulated during adipogenesis 
are well characterised, and serve as markers for potential adipogenic dysfunction. 
However, none of the following demonstrated significant differential expression: PPARγ 
(Peroxisome proliferator-activated receptor γ – a nuclear receptor critical for 
adipogenesis and maintenance of the differentiated state); C/EBPβ and C/EBPδ  
(CCAAT/enhancer-binding proteins which induce the expression of PPARγ); SREBP1 
(Sterol regulatory element-binding protein-1, which is involved in cholesterol 
homeostasis and is upregulated during adipogenesis); ZFP423 (a zinc finger 
transcription factor enriched in preadipocytes which also induces PPARγ expression) 
and KLF2 (Kruppel life factor has been reported to inhibit PPARγ expression). 
 
To examine whether groups of genes from common functional pathways were affected 
(thereby implicating the pathway) Gene Ontology analysis was also performed using the 
list of genes identified prior to intensity filtering. As such genes may not on their own 
report a significant change in expression between experimental and control groups, the 
weighting of significance based on linked function provides an alternative analysis to 
identify potentially important transcriptomic effects. Analysis of differentially expressed 
genes in this way revealed that the major biological processes impacted by the loss of 
SMARCAD1 were linked to metabolism (Figure 5.5A). Furthermore, a second analysis of 
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intensity filtered (differentially expressed) genes suggested that the cellular pathways 
most affected were the ‘Inflammation mediated by chemokine and cytokine signalling’ 
and ‘Integrin signalling pathways’ (Figure 5.5B). As integrin signalling pathways are 
important in macrophage-driven WAT inflammation (Zheng et al., 2015), these likely 
reflect stages of the same inflammatory process in the white adipose tissue of Smarcad1 
-/- mice. 
 
While the genes identified provide insight into a WAT-related phenotype in Smarcad1-/- 
mice, it should be noted that a subset of differentially expressed genes identified in this 
screen (see section 5.2.4), are implicated in testis/ spermatozoa biology (e.g. the 
following genes: sperm mitochondria-associated cystein-rich protein (smcp), outer 
dense fiber of sperm tails 1 (odf1), spermatogenic leucine zipper 1 (spz1), Germ cell 
specific gene 2 (gsg2), histone H1-like protein in spermatids 1 (hils1), Poly (a) 
polymerase beta (testis specific) (papolβ)). The identification of these implies that RNA 
originating from the testis (or testis-related material) was present in this screen, and 
hence the original dissection contained non-WAT material in addition to the epididymal 
fat pad. Any future experiments would benefit from more accurate dissection and/or 
isolation of white adipose tissue from a different fat depot (e.g. subcutaneous WAT). 
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Figure 5.4. Scatter plot comparison of transcriptomic reads from two Smarcad1+/+ mice 
versus two Smarcad1-/- mice. Genes which show differential expression diverge from the 
central cluster and appear as outliers.  A number of genes associated with macrophage 
function are elevated in Smarcad1-/- mice over +/+ mice.  Absent from the  differentially 
expressed genes are genes known to have a major influence during adipogenesis, 
suggesting this process is not grossly affected in the absence of SMARCAD1. 
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Table 5.1. List of genes identified as differentially expressed between Smarcad1+/+ and   
Smarcad1-/- mice. Genes in blue background = elevated in +/+, red = elevated in -/- mice. 
Literature searching using the gene name  in addition to the terms “adipogenesis” or 
“adipocyte” highlights a subset previously identified as influential in white-adipose tissue 
biology. The fold value indicates the level of expression difference between control and 
experimental groups. 
 
 
Fold Feature ID Description
9.199899 Tnp2 ENSMUSG00000043050 transition protein 2 [Source:MGI Symbol;Acc:MGI:98785]
9.040754 Prm1 ENSMUSG00000022501 protamine 1 [Source:MGI Symbol;Acc:MGI:97765]
8.96953 Tnp1 ENSMUSG00000026182 transition protein 1 [Source:MGI Symbol;Acc:MGI:98784]
8.88594 Prm2 ENSMUSG00000038015 protamine 2 [Source:MGI Symbol;Acc:MGI:97766]
8.713503 Fhl4 ENSMUSG00000050035 four and a half LIM domains 4 [Source:MGI Symbol;Acc:MGI:1338765]
8.543867 Akap12 ENSMUSG00000038587 A kinase (PRKA) anchor protein (gravin) 12 [Source:MGI Symbol;Acc:MGI:1932576]
7.897457 Akap4 ENSMUSG00000050089 A kinase (PRKA) anchor protein 4 [Source:MGI Symbol;Acc:MGI:102794]
7.795123 Dbil5 ENSMUSG00000038057 diazepam binding inhibitor-like 5 [Source:MGI Symbol;Acc:MGI:108039]
7.657875 Smcp ENSMUSG00000074435 sperm mitochondria-associated cysteine-rich protein [Source:MGI Symbol;Acc:MGI:96945]
7.5197725 Pgk2 ENSMUSG00000031233 phosphoglycerate kinase 2 [Source:MGI Symbol;Acc:MGI:97563]
7.4771447 Ybx2 ENSMUSG00000018554 Y box protein 2 [Source:MGI Symbol;Acc:MGI:1096372]
7.3203406 Atp8b3 ENSMUSG00000003341 ATPase, class I, type 8B, member 3 [Source:MGI Symbol;Acc:MGI:1914581]
7.2822294 Odf1 ENSMUSG00000061923 outer dense fiber of sperm tails 1 [Source:MGI Symbol;Acc:MGI:97424]
7.226114 Oaz3 ENSMUSG00000028141 ornithine decarboxylase antizyme 3 [Source:MGI Symbol;Acc:MGI:1858170]
7.155739 Spz1 ENSMUSG00000046957 spermatogenic leucine zipper 1 [Source:MGI Symbol;Acc:MGI:1930801]
7.137503 Crisp2 ENSMUSG00000023930 cysteine-rich secretory protein 2 [Source:MGI Symbol;Acc:MGI:98815]
7.0009 4933411K16Rik ENSMUSG00000090369 RIKEN cDNA 4933411K16 gene [Source:MGI Symbol;Acc:MGI:1914015]
6.9516263 Hmgb4 ENSMUSG00000048686 high-mobility group box 4 [Source:MGI Symbol;Acc:MGI:1916567]
6.81175 4930571K23Rik ENSMUSG00000090457 RIKEN cDNA 4930571K23 gene [Source:MGI Symbol;Acc:MGI:1923111]
6.81175 Gsg2 ENSMUSG00000050107 germ cell-specific gene 2 [Source:MGI Symbol;Acc:MGI:1194498]
6.81175 Hils1 ENSMUSG00000038994 histone H1-like protein in spermatids 1 [Source:MGI Symbol;Acc:MGI:2136691]
6.7371926 Tcp11 ENSMUSG00000062859 t-complex protein 11 [Source:MGI Symbol;Acc:MGI:98544]
6.658594 Papolb ENSMUSG00000074817 poly (A) polymerase beta (testis specific) [Source:MGI Symbol;Acc:MGI:1932115]
6.4456058 1700003F12Rik ENSMUSG00000038523 RIKEN cDNA 1700003F12 gene [Source:MGI Symbol;Acc:MGI:1922730]
5.922679 Lrrc8b ENSMUSG00000070639 leucine rich repeat containing 8 family, member B [Source:MGI Symbol;Acc:MGI:2141353]
1.7899683 Gpnmb ENSMUSG00000029816 glycoprotein (transmembrane) nmb [Source:MGI Symbol;Acc:MGI:1934765]
1.7899683 Lgals3 ENSMUSG00000050335 lectin, galactose binding, soluble 3 [Source:MGI Symbol;Acc:MGI:96778]
-0.06991831 Itgb2 ENSMUSG00000000290 integrin beta 2 [Source:MGI Symbol;Acc:MGI:96611]
-0.16991831 Mmp12 ENSMUSG00000049723 matrix metallopeptidase 12 [Source:MGI Symbol;Acc:MGI:97005]
-0.3320362 Ctsk ENSMUSG00000028111 cathepsin K [Source:MGI Symbol;Acc:MGI:107823]
-0.945378 Clec12a ENSMUSG00000053063 C-type lectin domain family 12, member a [Source:MGI Symbol;Acc:MGI:3040968]
-0.945378 Trem2 ENSMUSG00000023992 triggering receptor expressed on myeloid cells 2 [Source:MGI Symbol;Acc:MGI:1913150]
-1.8741144 Itgax ENSMUSG00000030789 integrin alpha X [Source:MGI Symbol;Acc:MGI:96609]
-1.8741144 Ubd ENSMUSG00000035186 ubiquitin D [Source:MGI Symbol;Acc:MGI:1344410]
-1.8741144 Emr1 ENSMUSG00000004730 EGF-like module containing, mucin-like, hormone receptor-like sequence 1 
-2.1304328 Tph2 ENSMUSG00000006764 tryptophan hydroxylase 2 [Source:MGI Symbol;Acc:MGI:2651811]
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Figure 5.5. (A) Gene Ontology analysis of (non-intensity filtered) differentially expressed 
genes from Smarcad1+/+ vs -/- whole-WAT RNA-seq experiments. As expected, the 
category “Metabolic Processes” is the largest Biological Process group identified as 
different between +/+ and -/- mice indicating that further investigation of WAT-tissue is 
warranted. (B) Identification of common pathways within the GO search engine revealed 
the defined “Inflammation…and cytokine signalling pathway” and “Integrin signalling 
pathway” were different between Smarcad1+/+ and -/- mice, both of which are connected 
to macrophage-driven mechanisms of inflammation. Analysis was performed using the 
online analysis tool at http://pantherdb.org/geneListAnalysis.do using default settings. 
(B) 
(A) 
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5.2.4 Genes elevated in Smarcad1-/- mice over+/+ mice. 
Literature searching of genes differentially expressed produced four candidates with 
potential impact on white adipose tissue. In each case the genes are linked to the 
presence of macrophages within adipose tissue, which are known to increase in number 
as adipose tissue expands and contribute to inflammation during adipose tissue 
pathology.  
 
MMP12 (Matrix Metalloproteinase 12) is an elastinolytic protease highly expressed by 
macrophages, which is highly expressed in tissue resident macrophages. Recent studies 
suggest that MMP12+ve adipose tissue macrophages help protect against obesity, while 
also promoting insulin resistance (M. Park et al., 2015). Ctsk (Cathepsin K) is a cysteine-
protease also expressed by macrophages, and degrades type I collagen during adipocyte 
differentiation.  It has been shown to be over-expressed in the white adipose tissue of 
obese mice (Yang et al., 2008), and promotes dyslipidaemia during high-fat diet 
challenge (Funicello et al., 2007).  Trem2 (Triggering receptor expressed on myeloid 
cells 2) is expressed on inflammatory macrophages and promotes macrophage survival, 
and is also implicated in adipogenesis and diet induced obesity (M. Park et al., 2015).  
Itgax (Integrin alpha X, also known as CD11c) is highly expressed on inflammatory 
macrophages, and this subset of macrophages have been shown to increase in number 
in the white adipose tissue of diet-induced obese mice (Lumeng, Bodzin, & Saltiel, 2007). 
 
Taken together, the elevated expression of these genes in the white adipose tissue of 
Smarcad1-/- mice suggests an increased presence and/or function of macrophages in 
the absence of SMARCAD1.  These findings were therefore followed up by flow 
cytometry to confirm the increase in macrophage numbers in these mice.  
 
5.2.5 Flow cytometric analysis confirms an increase in white-adipose-
tissue resident macrophage numbers in Smarcad1-/- mice. 
The elevated expression of the macrophage markers in whole-adipose tissue RNA-seq 
suggested an increase in infiltration of macrophages into the white-adipose tissue of 
Smarcad1-/- mice.  To confirm this, multicolour flow cytometry was performed to 
enumerate macrophages from the epididymal and subcutaneous WAT depots of 
Smarcad1-/- and +/+ mice. Stromal-vascular fractions of white adipose tissue were 
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stained with a cell-viability marker and for the common lymphocyte marker CD45 in 
addition to the macrophage-specific marker F4/80 (Figure 5.6). Live cells positive for 
CD45 and F4/80 were counted as tissue-resident macrophages.  
 
 
 
 
Figure 5.6. Flow cytometric gating scheme to enumerate tissue-resident macrophages in 
the white adipose tissue of Smarcad1+/+ and -/- mice.  Cells with the phenotype 
Live/Dead-ve CD45+ve F4/80+ve were counted as macrophage positive.  
 
 
 
 
Analysis of white adipose tissue from 4-6 month old mice revealed that 
macrophage numbers are significantly increased in the epididymal fat of 
Smarcad1-/- mice (mean nos. 3983 and 1815 respectively) (Figure 5.7) and 
although a similar trend appears with subcutaneous macrophage numbers 
(mean nos. 621 and 232 respectively) a power calculation based on these data 
indicates that an increase in sample size up to n=9 for both experimental and 
control groups would also result in statistical significance. 
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Figure 5.7. Flow cytometric analysis of Macrophages resident in the stromal-vascular 
section of white adipose tissue. The mean number for each genotype is shown above the 
error bars. Macrophage numbers are significantly increased in epididymal WAT of 
Smarcad1-/- mice (p<0.05, students t-test), whereas the same trend is seen in 
subcutaneous WAT - which would reach significance with an increase in sample number 
(up to n=9). 
 
 
+/
+ 
 
-/-
 
0
2000
4000
6000
8000
10000
Epididymal WAT
T
o
ta
l 
n
o
. 
m
a
c
ro
p
h
a
g
e
s
+/
+ 
 
-/-
   
0
500
1000
1500
2000
2500
3000
T
o
ta
l 
n
o
. 
m
a
c
ro
p
h
a
g
e
s
Subcutaneous WAT
3983 
1815 
621 
232 
p<0.05 
Chapter 5 – Differences in white-adipose tissue are found in mice lacking SMARCAD1, but are not linked to adipogenesis. 
 
143 
 
5.3 Flow cytometric analysis of putative adipocyte-stem cells 
from Smarcad1 +/+ mice. 
Putative stem cells resident in white adipose tissue have been described which retain 
multipotency and are able to differentiate into mature adipocytes (see references 39 and 
42). Of the putative stem cell phenotypes published, common cell surface markers used 
to isolate ASCs from the stromal vascular fraction of adipose tissue include CD45 and 
CD31 (to negatively select cells already lineage-committed), the cell-adhesion molecules 
CD24, CD29 and CD34, and stem-cell antigen-1 (Sca-1). While some debate may remain 
as to the authenticity of CD24 as an adipocyte stem cell marker these markers were used 
to create a cell staining panel for flow cytometric analysis of ASC numbers and allow 
flow sorting of this cell population (Figure 5.8). Sorted Lin-(CD31-CD45-) 
CD29+CD34+Sca-1+ cells were then cultured in vitro to confirm adipogenic potential via 
differentiation with known activators of adipogenesis (Insulin, IBMX and 
dexamethosone). After differentiation, cells from Smarcad1+/+ and -/- mice were 
stained for lipid content using Oil Red O and adipogenesis compared between control 
and experimental groups. 
 
5.3.1 No difference in numbers of putative ASCs are seen in SMARCAD1-/- 
mice. 
Mice aged 4-5 months were analysed for the number of putative ASCs present in both 
epididymal and subcutaneous white adipose fat depots. No significant difference was 
found between experimental and control groups with either depot (Figure 5.9).  
However, a significant difference in ASC numbers was observed in the epididymal WAT 
of older (11-12 month old) mice, with fewer ASCs observed in Smarcad1-/- mice (Figure 
5.10).  
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Figure 5.8. Flow cytometric gating strategy for the analysis of Lin-(CD45-CD34-) 
CD29+CD34+Sca1+ adipocyte stem cells. While debate remains as to the authenticity of 
CD24 as a bona-fide adipocyte stem cell marker, both CD24+ and CD24- cells were pooled 
and sorted/used in subsequent studies together. 
 
 
  
Chapter 5 – Differences in white-adipose tissue are found in mice lacking SMARCAD1, but are not linked to adipogenesis. 
 
145 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.9. No significant difference was observed in the number of (putative) adipocyte 
stem cells between 4-5 month old Smarcad1+/+ and -/- mice, in either epididymal or 
subcutaneous WAT depots. 
 
 
 
 
 
Figure 5.10. A significant decrease was observed in the number ASCs in the epididymal 
WAT depot of 11-12 month old Smarcad1 -/- mice (n=4)  (p<0.05, students t-test). 
1332 1300 
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5.3.2  SMARCAD1 is expressed in putative adipocyte-stem cells and 
lineage-positive cells within the stromal-vascular fraction of white 
adipose tissue. 
To confirm whether the cells described in section 5.3.1 were bona fide adipocyte 
precursors and expressed SMARCAD1, flow sorted cell fractions were analysed by 
western blot for the presence of SMARCAD1, then cultured/differentiated in-vitro to 
assess adipogenic potential. Results of the three different sort fractions (Lin+ve, Lin-ve, 
Sca+ve, see Figure 5.7) blotted and probed for SMARCAD1 are shown in Figure 5.11 
(below). Highest expression of SMARCAD1 was seen in the Lineage positive population 
(as expected) and expression was also seen in the Sca1+ve fraction (Figure 5.11), 
confirming the expression of SMARCAD1 in putative adipocyte stem cells. 
 
 
 
 
 
 
 
                               
 
                               
 
 
 
    
 
Figure 5.11. SMARCAD1 is expressed in the Lineage positive (CD31/CD45+ve) fraction 
from murine white adipose tissue, in addition to the Sca1+ve (Lin-ve, CD29+CD34+) 
putative adipocyte stem cell fraction. 
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5.3.3 Ex-vivo culture and differentiation of flow-sorted adipocyte stem 
cells confirms that adipogenesis is not impaired in the absence of 
SMARCAD1. 
 
Cells sorted using the gating strategy outlined in Figure 5.8 were cultured and 
differentiated in vitro to confirm adipogenic potential. After the first 5 days in culture 
morphological changes could be seen, as cells increased in size took on a fibroblast-like 
appearance. Confluency was reached after a further 5 days, and subsequent application 
of the differentiation cocktail led to the appearance of lipid droplets after a further week 
(Figure 5.12), indicating that successful adipogenesis was underway. Cells were fixed 
and stained with Oil Red O to confirm lipid content after a total of 21 days in culture.  
 
While this confirmed that cells of the Lin-ve, CD29+ve CD34+ve Sca1+ve phenotype are 
authentic adipocyte precursors, subsequent measurement of Oil Red O content indicated 
that there was no significant difference in adipogenesis between ASCs isolated from 
Smarcad1+/+ and -/- mice (Figure 5.13). Together with the equal size of adipocytes seen 
during histological of WAT tissue, these data suggest that any difference in fat pad size 
observed between Smarcad1+/+ and -/- mice is not driven directly by adipogenesis-
related mechanisms. 
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Figure 5.12. Morphological changes seen in flow-sorted adipocyte stem cells (ASCs) during 
culture and adipogenic differentiation. After 5 days post-sort cells start to assume a 
fibroblast-type morphology, which becomes the majority cell type by day 10. After 17 days 
lipid-droplets become visible within both Smarcad1+/+ and -/- ASC-derived cultures. 
Images capture using 20x magnification, scale bars represent 10μm. 
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Figure 5.13. (a) Oil Red O staining of differentiated adipocyte stem cells confirms the 
adipogenic potential of sorted Lin-ve/CD29+ve/CD34+ve/Sca1+ve WAT-resident cells. (b) 
Quantitation of solublised Oil Red O reveals no significant difference in adipogenesis 
between Smarcad1+/+ and -/- mice. 
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5.4 Mice challenged with a high-fat diet show increased weight- 
gain in the absence of SMARCAD1.   
 
Eight Smarcad1+/+ and eight Smarcad1-/- mice were individually caged and fed a 60% 
high fat diet for 6 weeks, with weekly recording of body mass for each mouse. At the end 
of high-fat diet challenge, mice were euthanized and white adipose tissue analysed for 
mass, stem cell number and number of adipose-tissue resident macrophages, alongside 
measurement of adipocyte size (i.e. area) using fixed WAT sections from both groups. In 
parallel, intestinal sections were taken from each mouse and used for microbiota 
population analysis using qPCR, alongside small intestinal iIEL counts (see appendix for 
results). 
5.4.1 Changes in Smarcad1-/- vs +/+ mice after 6 week high-fat diet. 
All mice challenged with a 60% high fat diet increased weight as expected, and showed 
an increase in the size of white adiocytes compared to normal chow-fed mice but no 
significant difference was seen in adipocyte size between Smarcad1+/+ and -/- groups. 
(Figure 5.14). Mice lacking SMARCAD1 showed a significant increase in body mass by 
week 2, which continued to increase compared to Smarcad1+/+ mice over the 6 weeks 
(Figure 5.15a).  Furthermore, this increase was accompanied by a significant increase in 
the mass of subcutaneous WAT in -/- mice over +/+ mice (Figure 5.15b). Although both 
triglyceride and free fatty acid serum concentrations increased in comparison to chow-
fed mice, there was no significant difference between +/+ and -/- groups (Figure 5.16). 
In addition, while the numerical value of mean adipocyte stem cells increased after high 
fat diet (compared to previous normal chow-fed mice) there was no significant 
difference between +/+ and -/- mice in ASC numbers (Figure 5.17). 
Alongside the significant increase in subcutaneous WAT mass, Smarcad1-/- mice also 
show a significant increase in the number of tissue-resident macrophages after high fat 
diet. While normal chow-fed mice show a significant increase in macrophages numbers 
in the epididymal fat of Smarcad1-/- mice, this was not seen after high fat diet (Figure 
5.18). 
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Figure 5.14. The size of adipocytes in subcutaneous WAT is not significantly increased 
after 6 weeks of high fat diet between Smarcad1+/+ and -/- mice. Subcutaneous WAT 
sections were fixed and quantified as in Figure 5.2. Images were captured at 10x 
magnification, and the scale bars represent 20μM. 
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Figure 5.15 (a) High fat diet challenged Smarcad1-/- mice gain significantly more body 
weight than +/+ mice by week 2 of challenge, increasing over 6 weeks (p<0.05, students t-
test).  (b) Increase in body weight is associated with a significant increase in the mass of 
subcutaneous WAT, but not epididymal WAT.  
(a) 
(b) 
* 
* 
* 
* 
* 
* p < 0.05 
p < 0.05 
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Figure 5.16. No significant difference was seen between Smarcad1+/+ and -/- mice in the 
serum free fatty acid and triglyceride concentrations after 6 weeks of high fat diet. 
 
 
 
 
 
Figure 5.17. No significant difference was seen in the number of adipocyte stem cells 
resident in epididymal or subcutaneous WAT between Smarcad1+/+ and -/- mice after 6 
weeks of high fat diet. 
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Figure 5.18. Tissue resident macrophages are significantly increased in the subcutaneous 
WAT of Smarcad1-/- over +/+ mice after 6 weeks of high fat diet (p<0.05, studens t-test), 
but not in epididymal WAT. 
 
 
 
 
 
5.4.2 Changes in microbiota after high-fat-diet. 
Sections of small intestine (ileum) and colon were taken from mice euthanized after 6 
week high fat diet challenge, and analysed for microbial content. The proportional 
microbial subpopulations present can be quantified using a qPCR-based method with 
primers specific for the 16S rRNA genes of each subgroup. Relative proportions for each 
subpopulation are calculated by comparison with the total microbial content using 
primers common to all microbial groups known to inhabit the murine gut.  
 
p < 0.05 
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Figure 5.19. No significant difference is seen in the microbial subpopulations in the small 
or large intestine of Smarcad1+/+ and -/- mice fed on normal chow diet. After a 6 week 
high-fat diet challenge numerical changes in the proportion of actinobacteria and 
firmicutes are seen in the small intestine (a) and (b) of HFD v chow diet mice, but not 
between Smarcad1+/+ vs -/- mice. Similarly after 6 weeks of high fat diet the proportion of 
colonic bacteroidetes is significantly reduced between HFD and chow mice, but not 
between Smarcad1+/+ and -/- mice (c). No proteobacteria were detected in the small 
intestine, and no significant difference was found between any groups in the colon. No 
difference in microbial populations were observed between Smarcad1+/+ and -/- mice. 
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5.5 Investigation of SMARCAD1 impact on adipogenesis using 
Mouse embryonic fibroblasts. 
As the availability of adipocyte stem cells from mice is limited, an alternative source of 
cells with adipogenic potential was used to study the effects of SMARCAD1 on 
adipogenesis. Mouse embryonic fibroblasts are capable of differentiation into mature 
adipocytes using the same differentiation cocktail and conditions as used to differentiate 
purified murine ASCs or pre-adipocyte cell lines (such as 3T3-L1 cells) into mature 
adipocytes. As MEFs are readily expanded in vitro, these also lend utility to experiments 
where cell numbers can be limiting (such as western blots).  
 
MEFs previously isolated from Smarcad1+/- and -/- mice were used to assay for 
differences in epigenetic-related factors previously associated with SMARCAD1, in 
addition to the effect of SMARCAD1 on cell proliferation, adipogenesis and the cell cycle. 
 
 
5.5.1 Adipogenesis assay of +/- vs -/- MEFs. 
Mouse embryonic fibroblasts were grown until confluence and adipogenic 
differentiation was induced two days post-confluence. After 10 days cells were fixed and 
stained with Oil Red O, before dye re-solubilisation and optical density measurement at 
510nm. (Figure 5.20a) Three wells each of four +/- and four -/-MEF lines were 
differentiated and adipogenesis quantified.  In agreement with the in vitro studies on 
differentiated ASCs, no significant difference was found between Smarcad1+/- and -/- 
groups after differentiation (Figure 5.20b). 
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Figure 5.20 (a) Oil Red O staining of differentiated mouse embryonic fibroblasts and re-
solublisation in 60% isopropanol. (b) Optical density read at 510nm of Oil Red O reveals 
no significant difference in adipogenesis between MEFs from Smarcad1+/- and -/- mice. 
 
+/
-  -/-
  
0.0
0.2
0.4
0.6
0.8
Oil Red O staining
A
b
s
o
rb
a
n
c
e
 @
5
1
0
n
m
+/- 
-/- 
Chapter 5 – Differences in white-adipose tissue are found in mice lacking SMARCAD1, but are not linked to adipogenesis. 
 
158 
 
5.5.2 Growth curves of MEFS from +/- vs -/-. 
 
To understand further whether SMARCAD1 impacts cell proliferation, mouse embryonic 
fibroblasts from four +/- and four -/- MEF lines were cultured until regularly dividing 
(i.e. cultured cells would need to be split every 2 days to avoid confluency) and then 
10,000 cells/well were seeded into 12 wells of a 12 well plate. Four wells of each MEF 
line were then harvested and counted after 24 hours, another four wells after 48 hours 
and the final four wells from each plate counted after 72 hours. Counts from each 
genotype were combined for each time point and plotted to construct growth curve for 
both genotypes. 
 
After 72 hours there were significantly more viable (phase bright) Smarcad1+/- cells, 
suggesting that either proliferation is increased or fewer cells perish during the growth 
of Smarcad1+/- MEFs (Figure 5.21).  
 
 
Figure 5.21. Growth curves of Smarcad1+/- and -/- MEFs indicate that cell proliferation is 
significantly reduced in Smarcad1-/- MEFs after 72 hours compared to  Snarcad1+/- MEFs 
(* p < 0.05  students t-test). 
 
* 
* p < 0.05 
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5.5.3 Cell cycle analysis. 
As MEFs lacking SMARCAD1 show a statistically significant reduction in the 
number of successfully proliferated cells after 72 hours of culture, the cell cycle 
was analysed in each MEF line by FACS using Propidium Iodide incorporation 
measurement. In brief, as cells begin the process of division and the genome is 
replicated, the net amount of DNA within a cell increases from G1 (Gap-1) phase 
with a ploidy number of n=2, increasing through in S-phase (Synthesis phase) 
until G2-phase (Gap-2) before division to 2 daughter cells (ploidy number 4) 
(Figure 5.22). Interestingly, while no difference was seen in the proportion of 
cells in G1 phase, there was a significant increase in the proportion of MEFs 
lacking SMARCAD1 in S-phase, and a decrease in the proportion of Smarcad1-/- 
MEFS in G2 phase (Figure 5.23). This is consistent with a model where impaired 
histone supply leads to a delay in the transition of cells through S-phase and 
reduced cell proliferation (Günesdogan, Jäckle, & Herzig, 2014). 
 
 
 
 
Figure 5.22. Flow cytometric gating scheme for cell cycle analysis of fixed, Propridium 
Iodide stained mouse embryonic fibroblasts. Quantitation of each phase of the cell cycle 
(G1, S, G2) is performed using FlowJo cytometry software (www.flowjo.com).  
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Figure 5.23. Significant differences are found in the proportion of cells in S and G2 phases 
between Smarcad1+/- and -/- MEFs. (a) Flow cytometry plots of PI stained MEFs, showing 
peaks at G1 and G2 phases of the cell cycle. (b) A significant increase in the number of cells 
in S-phase (p<0.05, students t-test) and decreased number in G2 phase are observed in 
Smarcad1-/- MEFs. Six replicates per genotype were used for each plot. 
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5.5.4 Western blotting of mouse embryonic fibroblasts reveals no 
difference in heterochromatic marker expression. 
As human SMARCAD1 has been previously reported to impact the level of 
heterochromatic markers such as H3K9me3 and HP1γ, these marks were assessed by 
western blot to give insight into whether disruptions to the level of heterochromatin 
could underpin differences in the cell cycle or proliferation that were seen. 
 
MEFs cultured as previously described were harvested and 100,000 cells per well were 
loaded and resolved by PAGE on a 16% gel. Four Smarcad1+/- and four Smarcad1-/- 
MEF lines were analysed for the presence of H3K9me3 and HP1γ signal (Figure 5.24). 
No binary difference was seen in the presence/absence of these marks, suggesting that 
different mechanisms may be responsible for differences seen in mouse cells that lack 
SMARCAD1. Furthermore, densitometry of these blots revealed no significant difference 
between the levels of H3K9me3 and HP1γ expressed in Smarcad1+/- and Smarcad1-/- 
MEFs (Figure 5.25). 
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Figure 5.24.  Western blotting of MEFs generated from Smarcad1+/- and -/- mice show that 
there is no difference in the levels of two markers of heterochromatin (H3K9me3 and 
HP1γ) in the absence of SMARCAD1. 
     
 
 
 
Figure 5.25.  Densitometric analysis of MEF western blots (from figure 5.23). (a) Each of 
the probe intensities was calculated as fold intensity over loading control (Lamin B1) 
intensity for each MEF line. (b) Mean fold over loading control was calculated for each 
genotype. No significant difference is found in levels of H3K9me3 or HP1γ in the absence 
of SMARCAD1. Each bar represents the mean of n=4 MEFs (with S.E.M.) for each genotype. 
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5.6 Perspectives. 
 
In spite of initial observations, mice lacking SMARCAD1 do not have smaller epididymal 
or subcutaneous white adipose tissue fat pads. However, in the absence of SMARCAD1 
mice show elevated serum triglyceride and free fatty acid concentration. Closer 
examination of the size of adipocytes within white adipose tissue suggests that excess 
serum fat is not absorbed within the tissue itself as no difference was seen in adipocyte 
size between Smarcad1+/+ and -/- mice . This may explain the increase in liver size also 
seen in Smarcad1-/- mice and it is therefore likely these mice have fatty livers.  
 
Transcriptomic analysis also negated a direct impact on adipogenesis of SMARCAD1 as 
none of the well-characterised adipogenic factors reported differential expression 
between experimental and control groups. However, Smarcad1-/- mice show an 
increase in the number of tissue-resident macrophages within white adipose tissue, 
possibly indicative of adipocyte dysfunction and death within the tissue.  
 
Interestingly, during high fat diet challenge, Smarcad1-/- mice demonstrate an increased 
weight-gain when compared to wild-type (Smarcad1+/+) mice, which is accompanied by 
an increase in the size of subcutaneous white-adipose tissue. Measurement of the size of 
adipocytes suggests that the increase in tissue mass is driven by an increase in the 
number of adipocytes present (hyperplasia) rather than an increase in the size of the 
adipocytes itself. These observations are further supported by experiments using mouse 
embryonic fibroblasts, where again no difference in adipogenesis was observed, 
although a difference in proliferation and the proportion of cells within the S and G2 
phase of the cell cycle were present. 
 
Taken together these data suggest that responses of SMARCAD1-deficient mice to 
metabolic challenges are influenced more by cell turnover and proliferation, rather than 
direct metabolic-signalling based responses.                                   .
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6.1 General Discussion. 
6.1.1 Biological impact of murine SMARCAD1 loss. 
 
Mice lacking SMARCAD1 demonstrate a number of phenotypic features compared to 
control mice: fewer viable female -/- offspring are produced than males; in males, there 
is a difference in body mass over time, an increase in serum triglycerides and free fatty 
acids, increasing liver size over time, an increase in the number of adipose-tissue 
resident macrophages and a loss in intestinal intraepithelial lymphocytes with age. 
Some of these observations are in agreement with a previous knockout model of 
Smarcad1 (Schoor et al 1999), in which the numbers of viable -/- offspring were 
reduced and surviving -/- mice weighed less than +/+ or +/- littermates. Indeed, the 
phenotype of +/+ and +/- mice were reported to be similar, and results from this thesis 
suggest that the level of SMARCAD1 peptide produced or resident in murine tissues is 
equivalent between heterozygous +/- and homozygous +/+ mice. 
 
While the cause of the reduced number of Smarcad1-/- offspring was not investigated 
during this study, it is possible that other factors linked to peri- or pre-natal mortality 
from other mouse models can provide clues as to what underlies this loss. For example, 
genes on the X-chromosome are normally dosage controlled in females, whereby a 
number of genes are epigenetically silenced during widespread heterochromatin 
formation across one of the X-chromosomes (known as X-inactivation) (Lyon, 1961; 
Sidhu, Minks, Chang, Cotton, & Brown, 2008). Loss of this control can be lethal during 
embryonic development; indeed, mice generated that produced offspring unable to 
inactivate the X-chromosome were also unable to produce viable female offspring 
(which died early in embryonic development) (Marahrens, Panning, Dausman, Strauss, 
& Jaenisch, 1997). Given the link to heterochromatin with SMARCAD1 – and 
furthermore the binding of SMARCAD1 to PARP1 (Rowbotham et al 2011) which itself 
has been shown as an important factor in X-inactivation (Menissier de Murcia et al., 
2003) – it is possible that the loss of SMARCAD1 impacts X-inactivation, thereby 
reducing the number of viable female offspring.  
 
In the absence of a mechanistic link to X-inactivation, other factors (e.g. metabolic 
factors) may underpin perinatal lethality. As an example, non-shivering thermogenesis 
generated by brown adipose tissue (BAT) is critical to neonatal survival. Mice with 
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defects in BAT function are prone to neonatal hypothermia and mortality 
(Charalambous et al., 2012). As differences in white adipose tissue-related metabolism 
are apparent in Smarcad1-/-mice, it is possible that BAT-related function is also 
abnormal. Investigation of BAT in Smarcad1-/- mice vs controls would provide insight 
into this as a possible mechanism for perinatal mortality and later onset characteristics. 
 
Other phenotypic features of this Smarcad1 knockout model were noted but not 
investigated within this study, for example Smarcad1-/- males have smaller testes than 
control male mice. It should not be discounted that this may influence aspects of the 
phenotype reported in this study, i.e. it is likely that Smarcad1-/- males have lower 
serum levels of testosterone than +/+ mice, which is known to impact fat metabolism 
and the immune system. A number of studies have shown that reduced testosterone 
levels are linked to obesity (Fui, Dupuis, & Grossmann, 2014), and there is evidence that 
testosterone itself antagonizes adipogenesis (Zerradi, Dereumetz, Boulet, & Tchernof, 
2014). A number of other studies have linked androgens (such as testosterone) to 
immune suppression - including suppressed antibody responses, inflammatory 
responses and B- and T-cell development (Trigunaite et al 2015). However, as lower 
testosterone levels in Smarcad1-/- mice is likely, this would more likely increase 
numbers of immune cells/immune cell subsets, which was not observed. In either case, 
future experiments using testosterone supplementation would help to address the role 
of testosterone in the phenotype of these knockout mice.  
6.1.2 Logistical limitations and Smarcad1-/- mice experimental groups. 
With the large number of mice required in each experimental group e.g. for iIEL studies, 
the development of a new genotyping method to allow increased sample turnover was 
essential for efficient colony management. The design of a new genotyping PCR strategy 
with primer pairs designed for a <700bp amplicon provided a robust assay applicable to 
crude DNA extracts (such as NaOH extracted DNA from neonatal ear-punches). 
However, as fewer Smarcad1-/- offspring were produced cf. Smarcad1+/+ or +/- mice, 
the production of large experimental groups and subsequent aging up to 1 year limited 
the number of experiments possible within the time and financial constraints of this 
project. 
 
Interestingly, western blot analysis of Smarcad1+/+ and +/- mice suggested that peptide 
expression in muscle was equivalent irrespective of the gene copy number, although 
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expression in WAT, BAT and Pancreas mirrored the levels of cellular mRNA seen in the 
duodenum.  A recent study investigating how far cellular mRNA levels influence peptide 
abundance within the cell (Liu et al 2016) noted that mRNA levels alone do not always 
predict protein levels, and additional factors (such as protein turnover) must be taken 
into account. Given the relative levels of SMARCAD1 peptide in +/+ vs +/- mice, future 
breeding strategies aimed at producing +/- and -/- litter mates may facilitate increased 
numbers of appropriate experimental groups. 
 
6.1.3 Impact of SMARCAD1 loss on murine intestine IELs. 
As mentioned, all areas studied within this thesis would have benefitted from increased 
sample numbers, especially for the study of gamma delta T-cell iIEL numbers. A shift in 
the number of γδ T-cells found in the spleen suggests that a systemic loss of γδ T-cells 
may occur with age in these mice. To understand better the origin of such loss, 
investigation of the thymus (in which key stages of T-cell development takes place) 
would provide insight into this source. The identification of SMARCAD1 expression in 
the thymus by western blot lends weight to the possibility that age-related changes in 
the thymus underpin any T-cell phenotype seen, although influences beyond the thymus 
should not be discounted. 
 
The loss of intestinal IELs has been reported under a number of conditions, such as loss 
of an IEL survival factor (e.g. in Ahr-/- mice (Y. Li et al., 2011b)), metabolic challenge 
(e.g. high-fat diet, (Soares et al., 2015) dietary modification (da Silva Menezes et al., 
2003) and a lack of interaction with the gut microbiota (Jiang et al., 2013). Although the 
thymus is key to development of the majority of T-cells, this may not be the case with 
iIELs, as athymic mice still harbour intestinal IEL T-cells (of which the majority are γδ T-
cells ((Emoto, Emoto, Miyamoto, Yoshizawa, & Kaufmann, 2004; Hayday & Gibbons, 
2008). Hence, while SMARCAD1 is highly expressed in the thymus, aberrations in thymic 
function may not be the cause of age-related IEL loss in Smarcad1-/- mice. Furthermore, 
as no significant difference was found in iIEL numbers after lymphocyte-intrinsic (CD2-
Cre) loss of SMARCAD1, this would point toward any iIEL loss not being driven by cell 
intrinsic loss of SMARCAD1. On top of these results, as no clear cellular or microbiome-
related differences were observed in the small intestine of SMARCAD1 mice, the 
underlying cause of age-related iIEL loss is not likely due to direct T-cell intrinsic or 
intestinal influences. 
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In this study no microbiome-related differences were found between the small 
intestines of Smarcad1+/+ and -/- mice; however, the approach used to quantify the 
microbial phyla (qPCR) was one of limited resolution, and therefore provides only a 
gross overview of the populations present (Fierer, Jackson, Vilgalys, & Jackson, 2005). 
More subtle population changes cannot be ruled out, and hence deeper investigation of 
gut microbiota using next generation sequencing based strategies may unveil such 
differences previously overlooked (see Jovel et al., (2016) for a recent review). These 
could in themselves give clues as to the potential mechanism behind iIEL loss. 
 
Another potential driving factor in the loss of iIELs is constant stimulation through the 
T-cell receptor, leading to activation induced cell-death (AICD). Upon activation (via T-
cell receptor or CD3 co-receptor stimulation) γδ T-cells in the intestine undergo 
degranulation and cell death within 2-3 days (Ogata & Itoh, 2016). While AICD ensures 
clonal deletion of activated T-cells (and therefore prevents excessive immune-cell 
proliferation and inflammation), within the intestinal T-cell compartment this confers a 
“one-shot” response to immune challenge, as γδ T-cell iIELs do not undergo proliferation 
after stimulation and hence degranulate then die (Ogata, Ota, Nanno, Suzuki, & Itoh, 
2014). As it was recently discovered that T-cells can be activated by self-lipids (de Jong, 
2015), the potential exists that elevated serum lipids (such as those found in Smarcad1-
/- mice) activate T-cells and lead to AICD in γδ T-cell iIELs. 
 
The results from this study suggest that elevated serum lipids may contribute to iIEL 
loss in (aging) mice, hence it is clear that any future study must assess both the level of 
serum lipids in the context of age (and how these correlate to iIEL numbers), in addition 
to whether increased thymic atrophy also contributes to a natural drop in iIEL numbers 
at the same time. It is possible that an inability to replace lost/activated iIELs in 
Smarcad1-/- mice ultimately drives the observed phenotype.  
 
6.1.4 Impact of SMARCAD1 loss on murine WAT biology. 
Closer examination of physical characteristics such as body weight of Smarcad1-/- mice 
revealed little difference in weight up to the age of 16 weeks, and no difference was 
present at birth. However, the male Smarcad1-/- mice weighed significantly less five 
weeks after birth than +/+ counterparts, which reflects the difference seen in the 
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original Etl1 knockout study (Schoor et al 1999), although the magnitude was ostensibly 
greater in the original study. However, other characteristics mark the metabolism of 
Smarcad1-/- mice; serum levels of triglycerides and free fatty acids are elevated, and 
there is an increase in the number of adipose tissue macrophages present. Together 
these data suggest that there is some white adipose tissue dysfunction in the absence of 
SMARCAD1, as the presence of macrophages is associated with adipocyte death and 
lipolysis. Isolation and enumeration of adipocyte stem cells revealed that there were no 
significant differences in the number of adipocyte stem cells present in this tissue, and 
analysis of flow-sorted fractions by western blot demonstrated that SMARCAD1 is 
expressed in putative ASC (Lin-ve/ CD29+ve/CD34+ve/Sca1+ve) cells, with higher 
expression in the Lineage +ve fraction (likely from leukocytes). Subsequent culture and 
differentiation produced no significant difference in the adipogenic potential of these 
ASCs between Smarcad1+/+ and -/- mice. Any differences observed in white adipose 
tissue between Smarcad1+/+ and -/- mice are likely to either arise from the non-
adipocyte stem cell fraction (i.e. the stem cell niche) or other mechanisms aside of 
differentiation (e.g. proliferation or loss of potency). 
 
Interestingly, mice lacking SMARCAD1 challenged with a 60% high fat diet mice showed 
an increase in weight gain compared to +/+ counterparts, associated with a significant 
increase in the size of subcutaneous WAT. Examination of the size of adipocytes from 
high fat diet fed and normal chow mice suggest that there are no differences in the size 
of adipocytes (and hence adipogenesis) between +/+ and -/- mice. This implies that any 
differences observed are due to increased numbers of adipocytes within the tissue (cell 
hyperplasia) and again suggests that mechanisms outside of differentiation are 
responsible for phenotypic differences observed. 
 
To try to shed further light on the cellular changes brought about by the absence of 
SMARCAD1, mouse embryonic fibroblasts derived from Smarcad1+/- and -/- mice were 
assayed for differentiation and proliferation. In agreement with ASC studies, no 
significant difference was observed in adipogenic potential between Smarcad1+/- and -
/- MEFs. However, there was a decrease in proliferation seen between Smarcad1-/- 
derived MEFs over 72 hours, and examination of the cell cycle by FACS suggested that 
this was associated with an increase in -/- MEFS present (or retained) in S-phase. This 
could suggest that the supply of histones for newly synthesized/replicating DNA is 
affected in the absence of SMARCAD1, as a recent study revealed that histone supply 
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regulates transition through S-phase (Günesdogan et al., 2014). It should not be 
forgotten that SMARCAD1 is known to play a role in DNA-repair, and accumulation of 
DNA damage (in the absence of SMARCAD1) could also impact the cell cycle, as has been 
shown under other conditions of DNA damage (Barnum & O’Connell, 2014). 
 
6.1.5 Molecular impact of SMARCAD1 loss. 
Although the molecular impact of SMARCAD1 loss was not investigated in this study, a 
number of avenues remain available for future investigation. For example, the presence 
of the short isoform of SMARCAD1 in mice is yet to be confirmed, although it seems 
likely to be expressed in mouse given the conservation across species (Figure 16). In 
addition, the knockout approach used for this mouse model - targeting the catalytic 
ATPase domain of Smarcad1 – may still leave a shorter, truncated isoform of Smarcad1 
retaining exons 1 to 11. Whether this truncated isoform is indeed produced and can still 
bind to the proteins known to form a complex with SMARCAD1 (such as HDAC1/2, 
KAP1, G9a) was not investigated within this study. 
 
A number of other questions remains unanswered about SMARCAD1, for instance 
whether different complexes are formed with SMARCAD1 in different murine tissues 
such as the intestine and white adipose tissue. It is also possible that mutations in 
SMARCAD1 (or components that bind to SMARCAD1) drive inappropriate complex 
formation e.g. in cancer cells. Likewise, mutations in other factors present within a 
complex may drive the inappropriate sequestration of chromatin remodellers, leading to 
atypical remodelling of genomic loci within that cell type. Confirmation of remodelling 
complex components and related gene sequences would therefore address these 
possibilities. 
 
The lack of reduction of H3K9me3 levels in Smarcad1-/- MEFs observed in this study 
follows the observation in mESCs also lacking functional SMARCAD1 (Xiao et al 2017). 
As noted by the authors, this may reflect a cell-type specific effect, and further 
investigation of the different complexes formed with SMARCAD1 in different cell types 
would confirm this point. It is highly possible that – given the spectrum of 
cellular/functional impact reported for SMARCAD1 – the exact molecular impact of 
SMARCAD1 is determined to a large degree by the subunits to which it is associated,  
and therefore what cell type and at what time-point this complex is formed.  
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6.1.6 Concluding points 
 
The results described in this study point towards a WAT-metabolism phenotype of 
Smarcad1-/- mice, not related to changes in the microbiota. Furthermore, distal effects 
of this WAT-related phenotype may impact other factors such as γδ-T-cells, which can 
become activated by self-lipid. Of the γδ-T-cell types present in mouse, iIEL γδ-T-cells do 
not proliferate upon activation, and indeed apoptose within 3 days of activation - hence 
the loss observed in Smarcad1-/- mice may reflect a net loss with increasing serum fat 
content and reduced T-cell turnover/replacement during aging (e.g. due to thymic 
atrophy). 
 
With respect to the mechanism underlying the WAT-related phenotype in Smarcad1-/- 
mice, the data presented in this study suggest a model where the loss of SMARCAD1 
impacts cell turnover/proliferation rather than differentiation. The presence of elevated 
macrophage numbers in white adipose tissue implicate an increase in (adipocyte) cell 
death, white the reported expression of SMARCAD1 in stem cells would suggest that 
dysregulation of stem cell potency may underpin any tissue-related phenotype(s) seen. 
Further investigation (e.g. of adipocyte/mesenchymal stem cell) would clarify this point. 
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6.1.7 Proposed model for loss of SMARCAD1 impact. 
 
 
 
 
Figure  6.1.  Proposed model for mechanisms underlying SMARCAD1 impact. In 
the absence of SMARCAD1, tissue stem cells do not retail potency or self-renew as 
efficiently, and instead will prematurely differentiate or proliferate. It would be 
possible that excess differentiated or prematurely proliferative cells apoptose   
and are cleared by resident macrophages. Tissue resident stem cell numbers 
would be maintained by the influx of new pluripotent stem cells to maintain the 
homeostasis. 
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6.2 Future studies. 
 
A number of questions remain about the impact of SMARCAD1 on murine intestinal 
intraepithelial lymphocytes and white adipose tissue biology. Future studies could 
provide invaluable insight into these:- 
 
 Confirmation of the expression of the short isoform of Smarcad1 in mouse would 
provide more evidence for a conserved function of Smarcad1 across species. 
Isolation of RNA from murine skin and cloning/PCR based methods would 
potentially confirm this.  
 
 The expression of a truncated form of Smarcad1 (from the ATPase domain 
deleted mouse model) and subsequent interaction with known binding partners 
should be investigated. Bands of a similar size to the potential truncated form of 
SMARCAD1 (~100kDa) are regularly visible on α-SMARCAD1 probed western 
blots. Immunoprecipitation of SMARCAD1 (using available antibodies to the N-
terminal domain) and subsequent western blot for known binding partners 
(such as HDAC1/2, G9a and KAP1) using murine k/o cells would confirm these 
interactions are truly ablated. 
 
 To investigate further the age-related loss of iIELs, a large cohort of mice aged >1 
year would allow investigation of any thymus phenotype at this time point, such 
cell death/turnover. EdU incorporation would allow investigation of cell 
proliferation within the aged thymus, and simple measures of thymic size would 
show whether premature thymic atrophy occurs in Smarcad1-/- mice. The 
relative proportions of αβ to γδ T-cells by FACS would give some insight into 
whether thymic selection is affected at this age. 
 
 (It should be noted that athymic mice still harbour iIELs, and the developmental 
routes and origin of iIELs is unclear, although it is likely that the thymus is still 
largely influential in iIEL development).  
 
 Investigation of cell death in ex-vivo cells and cell cultures lacking SMARCAD1 
may give insight into whether cell turnover and/or stem cell survival is affected. 
This could be done rapidly with a fluorescein-labelled dUTP FACS application to 
the TUNEL reaction (Terminal deoxynucleotidyl transferase (TdT) dUTP Nick-
End Labeling). 
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 The loss of potency of adipocyte stem cells could be investigate by ex-vivo 
culture and simple qPCR screening for a known preadipocyte marker (such as 
Dlk-1)  
 
 Any transcriptomic impact of the lack of SMARCAD1 on murine ASCs should be 
investigated, although large numbers of mice are required to provide enough 
material RNA-seq (typically <5000 ASCs are isolated from each fat pad). 
 
 Co-culture experiments by combining different flow-sorted cell types from the 
stromal vascular fraction of white adipose tissue would give insight into how 
influential the niche is in adipocyte differentiation /adipogenesis. 
 
 Longer term aging studies on Smarcad1-/- mice would give insight into the 
impact of SMARCAD1 on mortality (e.g. do Smarcad1-/- mice die younger than 
+/+ counterparts?) and whether numbers of tissue-resident stem cells decline 
earlier in these knockout mice. 
 
 IP:Mass spectrometry to determine the subunit makeup of any SMARCAD1 
complex in specific cell types. 
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APPENDIX 1: Quantification of protein from western blot band signal 
intensity using GelQuantNET. 
 
 
Appendix 1: Measurement and quantitation of peptide following western blot using 
GelQuantNet software (see http://biochemlabsolutions.com/GelQuantNET.html ). Regions of 
interest are specified by the user, which should include a surrounding region of background 
signal. Numerical values based on band size and intensity are generated by the software, 
allowing the user to perform subsequent quantitative analysis. 
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APPENDIX 2: Detailed gating scheme for flow cytometric analysis of 
iIEL cell counts. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix 2: Gating scheme for iIEL FACS. Cells of appropriate size/granularity are selected 
using FSC/SSC gating, and clumped cells (“doublets”) along with dead cells are removed before 
subsequent analysis of cell surface markers using additional fluorescence channels. 
 Unstained                             Stained 
1. FSC/SSC 
2. Doublets 
3. Cell 
Viability 
4.CD3+ cells 
(T-cells) 
CD103+ 
γδ-T-cells 
CD8α+(β-) 
T-cells 
CD3+ 
population 
Initial discrimination 
based on size (FSC) 
and granularity (SSC) 
Single cell events 
versus cell aggregate 
(doublet) event 
discrimination using 
Side Scatter (SSC). 
Dead cell signal 
discrimination using 
viability stain (live 
cells are Negative). 
Selection of cells 
positive for T-cell 
marker (CD3+) 
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APPENDIX 3:  FACS of iIELs from HFD challenged Smarcad1 +/+ and   -
/- mice,  and control (Smarcad1 +/+ normal chow diet) mice. 
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Appendix 3: Preliminary data suggest that mice challenged with a high fat diet for 6 weeks lose 
intestinal (γδ-T-cell) IELs compared to control chow fed mice.  Both SMARCAD1+/+ and 
SMARCAD1-/- HFD mice  reported a reduction in iIEL numbers compared to controls, although 
further investigation using higher samples numbers from repeat experiment(s) would clarify 
any significant difference(s)  between the groups. 
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APPENDIX 4: Measurement of adipocyte sizes using Image J and a 
Watershed algorithm. 
 
 
 
 
 
 
 
Appendix 4: Adipocyte areas measured using images obtained from Image J software (post 
capture at 10x magnification). Initial identification of cell boundaries allows the Watershed 
algorithm to estimate adipocyte size based on a best-fit ellipse. Regions within the image 
without clear (cell) boundaries or presenting an area greater than pre-set thresholds are 
excluded. 
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APPENDIX 5: BioAnalyzer spectrometry of (whole-WAT) RNA-seq 
libraries. 
 
 
 
 
 
 
 
 
 
 
Appendix 5.  BioAnalyzer electrophoregram analysis of RNA-seq library content size and 
concentration. Samples had the following size peaks and concentrations: WAT1+/+ peak 
277bp, 445 [pg/μl], WAT2+/+ peak 276bp, 359 [pg/μl], WAT3 peak 343bp, 396 [pg/μl] 
and WAT4-/- peak 352bp, 340[pg/μl]. 
 
 
 
 
 
 
 
 
 
 
 
